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Hip fracture is the most serious complication of osteoporosis and a 
leading cause of excessive morbidity and premature mortality among elderly. 
It is projected that 50% of hip fracture cases will occur in Asia by 2050. Hence, 
the identification of risk factors for hip fracture provides important scientific 
evidence in strategizing intervention programs for fracture prevention. There 
is paucity of prospective epidemiologic data for hip fracture risk among Asian 
populations, who have distinct dietary habits, lifestyles and lower body mass 
index (BMI) as compared to their Western counterparts.  
The primary objective of this thesis was to assess dietary determinants 
of hip fracture risk. In addition, how change in body weight impacted the risk 
of hip fracture was not clear in a relatively thin population. Finally, 
longitudinal association between 5 bone turnover biomarkers (BTMs) were 
evaluated the first time for the utility in fracture risk. All study aims were 
achieved by using data from the Singapore Chinese Health Study. Incident hip 
fractures were followed up through 2010.  
In this thesis, several significant dietary determinants have been 
identified. In women, dietary vitamin B6 was inversely related to hip fractures 
with a significant 18-22% risk reduction across Quartile 2-4 relative to 
Quartile 1 (p for trend=0.002); and daily drinking 2-3 cups of coffee or 
equivalent caffeine intake was related to a significant 16% lower risk relative 
to coffee drinkers drinking < 1 cup per week. By contrast, in men, higher 
consumption of vegetables and total and specific carotenoids was associated 
with lower hip fractures by 26% to 39% (Quartile 4 versus 1) (all p for trend 
IX 
 
<0.05) with the most profound associations observed in lean men with BMI 
<20 kg/m
2
 (p for trend≤0.004). In the whole cohort, a greater adherence to the 
plant-based diet comprising vegetables, fruit and soy foods, namely the 
vegetable-fruit-soy (VFS) pattern or the Alternative Healthy Eating Index 
(AHEI) 2010 was inversely associated with hip fractures with a significant 34% 
and 32% reduction in risk in Quintile score 5 versus 1 respectively (p for trend 
<0.0001).  
In both genders, compared to stable weight (loss or gain <5 %), weight 
loss ≥10 % was associated with a significant 39 % increased risk over an 
average of 6 years, particularly in those with baseline BMI ≥20 kg/m2. No 
significant association, however, was found with weight gain. Finally, there 
was a dose-dependent positive relationship found in serum osteocalcin, 
procollagen type I N propeptide, aminoterminal and carboxyterminal cross-
linking telopeptide of bone collagen with a significant increased risk by 55-95% 
per SD increment for the respective BTM (all p for trend ≤0.006).  
In this thesis, the gender-specific difference in the relationship of 
several dietary factors (vitamin B6, carotenoids, vegetables, coffee /caffeine) 
with risk of hip fracture merits additional studies to assess the sex-
environment interactions in the development of osteoporosis and related 
fractures. Overall, these findings have important public health implications 
and may provide a foundation in strategizing interventions to reduce hip 
fractures among Asian populations and beyond. 
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Chapter 1. Introduction 
1-1. Epidemiology of osteoporosis and hip fracture 
 
Osteoporosis is a skeletal disorder that is characterized by low bone 
mass and deterioration of bone microarchitecture, with a consequence of 
increased risk in bone fragility and fractures (1). The current diagnosis of 
osteoporosis is based on a T-score of ≤ -2.5 defined by the World Health 
Organization (WHO) using bone mineral density (BMD) assessment measured 
by Dual-energy X-ray absorptiometry (DXA) in comparison of the average 
BMD of young and healthy women (2). This skeletal disorder is increasingly 
common with advancing age. It is estimated that over 200 million women 
worldwide suffer from osteoporosis (3), and about one in three women and 
one in five men over age of 50 years sustain at least one osteoporotic fracture 
during their lifetime (4). Due to the rapid increase in aging worldwide, a rise 
in incidence of osteoporotic fracture is expected globally.  Osteoporosis is of 
clinical and public health importance because osteoporotic fractures, 
particularly hip fractures, entail a substantial healthcare and societal burden 
among individuals above 50 years of age (5).  
The incidence of hip fracture is a useful international index to measure 
the frequency of osteoporosis (1, 5). This is because hip fractures account for 
more disability, mortality and healthcare expenditure than all other 
osteoporotic fractures combined (6); also, the vast majority of hip fracture 
cases get prompt medical attention and require hospitalization so that hip 
fracture incidence is easier to capture as compared to other fractures (5). In 




rapid increase in hip fracture incidence in the past two decades. Moreover, up 
to 50% of the total incident hip fracture cases are projected to occur in this 
region by year 2050 (7, 8). This is primarily because Asia hosts more than 50% 
of the world population as well as a large growth of aging populations. Hence, 
it is important to put osteoporosis and fracture prevention on public health 
agenda in Asia. In other parts of the world, the projection of incident hip 
fractures by year 2050 is also on a rising trend because of the increased 
number of aging populations (9). However, the regional proportions of total 
hip fracture cases estimated worldwide for North America, South America and 
Europe are 12%, 12.5% and 13%, respectively; and rates of 5.7% for Middle 
East, 4.4% for Russia and <1.0% for Oceana and Africa are projected by year 
2050.  
Regarding risk of hip fracture, the more developed regions, such as 
Taiwan, Singapore and Hong Kong were reported to have higher age-
standardized hip fracture rates (/100,000 persons) relative to the less 
developed regions in Asia (5, 10) and were at the high risk category as some 
of the developed countries in the West. This implicates that the change of 
environmental factors, such as diet and lifestyle may have contributed to the 
higher fracture risk in these developed regions in Asia (5). Urbanization is 
another contributing factor to the rising hip fracture incidence. Potential 
factors including reduced level of physical activity in leisure time as well as in 
occupations, lower serum vitamin D level due to less outdoor activities, 
change of dietary patterns that increased fast food consumption, and higher 




of hip fracture and lower BMD in urban residents compared to rural residents 
(11, 12).  
As a developed country in Asia, Singapore is the highest in the region 
to bear hip fracture risk among women over 50  years of age (13) and ranked 
in the high-risk category among 63 countries worldwide (5). An earlier study 
conducted in Singapore reported a secular trend of hip fracture incidence. 
Compared to the rate in 1960s, there was a 5-fold and 1.5-fold higher risk for 
women and men, respectively in 1998 (Figure 1-1) (14). According to the 
Asia-Pacific regional audit of 2013, about 55,000 Singaporean women over 50 
years suffered from osteoporosis in 2006 (13). With a dramatic increase in the 
aging population from 1.3 million today to 3.9 million in 2050, 46% of the 
total population will be 50 years or above in Singapore. Hence, the number of 
osteoporosis cases in Singapore is expected to increase even higher by 2050 
(13).  
Figure 1-1. Hip fracture incidence rate for men and women in Singapore, 
1958-1998  
 
[Figure reproduced from Koh et al., 2001; Osteoporos Int. (14)] 
 
Among ethnic groups in Singapore, the Chinese and Malays appeared 
to have higher risk of hip fracture than the Indians (5, 10). In line with this, a 




Malay and Indian ethnicity also found that BMD at different skeletal sites 
were significantly lower in the Chinese men as compared to men in the other 
two ethnic groups (15). Consistent with earlier reports (5, 6), healthcare 
burden and mortality after hip fractures are also high in Singapore. According 
to a small scale study of 70 hip fracture patients admitted to the Singapore 
General Hospital, the hospitalization cost for hip fractures was S$10,995 
(standard deviation: S$5,398) with a median hospital stay of 13.6 days  (16). 
In the same study, the one-year mortality rate post hip fracture surgery was 27 
% (17). In the Singapore Chinese Health Study, all-cause mortality risk was 
more than two folds up to one year and persisted at five years after diagnosis 
of hip fracture for men and women combined (18).      
1-2. Risk factors for osteoporotic fractures    
 
The clinical risk factors for osteoporotic fractures include age, sex, 
body weight, height, previous fractures, parental fracture in hips, current 
smoking, alcohol consumption, use of glucocorticords, rheumatoid arthritis, 
secondary osteoporosis, and femoral neck BMD according to the Fracture 
Risk Assessment Tool (FRAX) algorithm. The FRAX calculates a 10-year 
probability of a major fracture (hip, clinical spine, humerus or wrist fracture) 
as well as hip fracture (19). Smoking and alcohol consumption are two 
lifestyle risk factors in FRAX. In the Singapore Chinese Health Study, current 
smoking, length of years of smoking as well as smoking intensity by number 
of cigarettes smoked per day were associated with increased risk of hip 
fracture relative to never smokers, while alcohol consumption was not 
associated with hip fractures (20). Unfortunately, other clinical risk factors, 




rheumatoid arthritis, secondary osteoporosis, and femoral neck BMD are not 
available in this cohort. Thus, these factors could not be accounted for in the 
analysis in this thesis.  
From a public health perspective, lifestyle modification such as 
changes in diet and nutrition can be safely adopted in daily practice for bone 
health. This is particularly important as osteoporosis is a silent disease until a 
fracture happens (21). The role of nutrition in impacting different aspects of 
bones and fractures can be direct or indirect (Figure 1-2), from bone growth in 
early childhood, to young adulthood until reaching peak bone mass around  
age of 30 (22), to bone microarchitecture integrity, to postmenopausal bone 
loss in women and age-related bone loss in both genders, and to the 
subsequent fractures. Furthermore, hip fracture patients were found to have 
more prevalent and severe conditions of malnutrition and nutrient deficiency 
as compared to the general elderly populations (23). This suggests that 
nutrition may play an important role in fracture development.  
Figure 1-2. A conceptual model of the roles of nutrition in bone mass, bone 
loss, bone turnover and fractures  
 
[Figure reproduced from Rizzoli, 2008; Best Pract Res Clin Endocrinol Metab 





In this thesis, the primary focus is to identify nutritional determinants 
for hip fracture risk using dietary information collected at baseline to examine 
prospectively the relationship with risk of hip fracture. In the Singapore 
Chinese Health Study cohort, all nutrients and foods that were suggested to 
have potential beneficial associations with risk of hip fracture were examined, 
but only a few dietary factors were shown to have significant results. For other 
nutrients or food groups, such as vitamin C, D, E, calcium, potassium, 
magnesium, zinc, long-chain ω-3 fatty acids, protein, fish, they were not 
associated with risk of hip fracture, which could be due to the small 
differences between the hip fracture and non-fracture cases, non-differential 
misclassification for the dietary information recorded at baseline, or lack of 
statistical power to detect the significant associations. Hence, these nutrients 
or food groups are not discussed further in detail in this thesis.  
Based on the literature on nutrition and bone health, several research 
gaps were identified for the significant risk factors including vitamin B, 
carotenoids, vegetables, coffee and caffeine, and dietary patterns, which are 
the focus of the nutrition determinants in this thesis. In addition, change in 
body weight had never been examined in a population with relatively low BMI, 
thus the impact of body weight change and risk of hip fracture was also 
examined in this cohort. Bone turnover biomarkers play a central role in 
determining bone quality (25), and data between BTM and risk of hip fracture 
is scanty in Asian populations. Thus, BTM was examined for the potential 
utility in fracture prediction in this cohort. Other risk factors such as 
menopause, advanced aging, and other clinical risk factors including sex, body 




Although bone mass and falls are not available in the cohort data, thus, these 
variables could not be examined for the direct relationship with hip fractures 
nor could be further evaluated for confounding or mediating effects. This has 
been addressed as one of the limitations in this study.  
Hence, in this thesis, the first four aims are focused on identifying the 
roles of individual dietary components (Chapter 4, 5 and 6) and overall 
dietary patterns (Chapter 7) in the development of hip fracture. In addition, 
body weight change and bone turnover biomarkers (BTM) are examined for 
associations with incident hip fractures. Low body weight is a clinical risk 
factor for osteoporotic fractures (2) and Asians have relatively low BMI. The 
research question of interest is how the pattern of body weight change, which 
reflects nutritional and health status, impacts on hip fracture risk in a relatively 
thin population (Chapter 8). Last but not least, although low BMD is an 
important risk factor for osteoporosis, BMD only accounts for one aspect of 
bone physiology and less than 50% of fractures are attributable to BMD T-
score ≤2.5 alone (6). Another research question is to evaluate the utility of 
another bone surrogate marker, bone turnover biomarkers in relation to hip 
fracture risk (Chapter 9). In the following session, an overview of nutritional 
factors for bone health as well as a detailed literature review on the dietary 
determinants and risk factors of interest will be carried out to summarize the 
current findings in the literature to define research gaps in this thesis. 
1-3. Literature review on nutritional and other factors for 
fracture risk 
 
Accumulative evidence has been shown that beneficial foods and 




role of nutritional factors in bone health is complex and may involve total 
energy intake, overall dietary quality, food intake, and macro- and micro-
nutrients. For example, deficiency in total energy intake in elderly can lead to 
muscle atrophy, which in turn may increase propensity to fall and cause bone 
structure and bone mineral density to deteriorate (27). From the perspective of 
bone composition, calcium, vitamin D and protein are the most important 
contributing nutrients to the bone. This is because 97% of the total body 
calcium is contained in the bone, and bone matrix comprises predominantly 
collagenous protein, and vitamin D plays a critical role in the homeostasis of 
calcium (28). Due to the importance of these three nutrients in bone 
physiology, a brief review of the current opinions on calcium, vitamin D and 
protein is summarized below.   
1-3-1. Calcium and vitamin D 
 
Vitamin D in the form 1,25(OH)2D and parathyroid hormone (PTH) 
are the two most important hormones in the regulation of calcium 
homeostasis. When obligatory calcium loss occurs, it requires compensation 
through supplemental calcium intake or increased efficient intestinal 
absorption. Traditionally, supplementation of calcium and vitamin D is 
commonly recommended to elderly individuals who are deficient in calcium 
for the purpose of bone maintenance (29, 30). However, results from several 
meta-analyses of prospective cohorts and/or randomized control trials (RCT) 
are inconsistent on the efficacy of calcium and/or vitamin D supplements in 
fracture prevention. An earlier meta-analysis of prospective cohorts and 
RCTs by Bischoff-Ferrari and colleagues (31) reported no significant 




other two meta-analyses of clinical trials concluded a favorable effect of 
1,200mg/day calcium alone or combined with vitamin D supplementation on 
reduced bone loss (32) and fracture risk (32-34). On the other hand, while 
supplementation of vitamin D alone was reported to reduce hip and 
nonvertebral fracture risk in two meta-analyses (35, 36), other meta-analyses 
did not find evidence to support its preventive effect on improving bone 
mineral density (37) or reduced risk of falls and fractures (34, 37, 38). 
However, the majority of these meta-analyses appeared to reach a consensus 
that calcium monotherapy may not effectively reduce fracture risk, but 
combined supplementation with vitamin D may achieve a better efficacy in 
reduced fractures (32-34, 39, 40). The discrepancy among these meta-
analyses is likely due to the inclusion criteria of the studies in the meta-
analysis. For example, three of seven RCTs in the meta-analysis conducted by 
Bischoff-Ferrari and colleagues (31) had less than 50% compliance in the 
clinical trials in investigating calcium supplementation and fracture risk with 
non-significant results. By contrast, another study conducted by Tang and 
colleagues included 9 trials with a compliance rate at least 50% and showed a 
more apparent effect of calcium alone in the pooled analysis with an RR (95% 
CI) of 0.90 (0.80–1.00), albeit the result was borderline statistically 
significant (32). Similarly, Bischoff-Ferrari and colleagues (35, 36) have 
consistently found that a higher dose of vitamin D supplementation, 
particularly cholecalciferol at median (IQR) of 800 (792, 2000) IU, reduced 
risk of fractures by 14% and 30% for hip fractures among 12 RCTs (36). Both 
of the meta-analyses have used intention to treat and multiple sub-group and 




(39), their recent corrections (41) recalculated their data due to coding errors 
in the original analysis and reported that calcium and vitamin D 
supplementation was effectively reduced risk of hip fracture by 17% [RR (95 
% CI): 0.83 (0.69, 0.99)], whereas vitamin D supplementation alone was not 
shown to benefit lowering fractures. Compared to the studies conducted by 
Bischoff-Ferrari and colleagues (35, 36), only 4 trials were included with one 
trial of combined calcium and vitamin D in  the DIPART group study (39). 
The small number of cases in only 4 trials in the analysis may contribute to a 
low statistical power to observe the true effect. In the study conducted by 
Zheng and colleagues (38), each trial examined the effect of very high dosage 
of vitamin D (over 100,000IU) on fracture risk and did not find significant 
results. Very high dose vitamin D (over 100,000IU) was suggested to have a 
null effect on fracture risk (36). More controversially, several recent 
systematic reviews and meta-analyses revealed some potential adverse events 
including cardiovascular risk after calcium supplementation (42, 43), 
increased pancreatic cancer  after vitamin D supplementation (37), or increase 
risk of gastrointestinal symptoms and renal disease  after supplementation of 
calcium plus vitamin D (34). Conversely, other meta-analyses did not support 
the harmful effects of calcium on coronary heart disease or cardiovascular 
risk (40) or vitamin D on most cancer and cardiovascular outcomes (37). The 
mixed results for the safety of vitamin D and calcium supplementation 
remained unclear, since the trials included in each meta-analysis were not 
specifically designed to study the beneficial or advance effects in heart 
disease or cancer outcomes; furthermore, the numbers of these adverse events 




methodology is required to examine the safety of vitamin D and calcium 
supplementation.  
Taken together, the current evidence on calcium and vitamin D 
supplementation recommends achieving the current U.S. Recommended 
Dietary Allowance (RDA) for elderly individuals who are deficient in 
calcium and/or vitamin D for the prevention of osteoporosis and fractures (29, 
30, 44). The current RDA for calcium is 1,000 mg for male aged 51-70 years 
and 1,200 mg for female aged 51-70 years and all adults 71 years or above. 
For vitamin D, the current RDA is 600 IU for adults aged 51-70 years and 
800 IU for those 71 years and older (45). To prevent potential adverse 
outcomes from supplementation of calcium and vitamin D, the safest 
approach is probably through supplementing from the diet, such as dairy, soy 
products, deep-water fatty fish and fortified foods.   
1-3-2. Protein 
The association between dietary protein and bone loss or fracture risk 
is unclear from the existing literature (24). One theory is that high dietary 
protein may increase bone loss due to a generation of a high acid load (46, 47), 
which, in turn, may increase skeletal calcium release to buffer the excessive 
acid load and lead to increase bone mineral loss, bone turnover (48) and 
fracture risk (49). On the other hand, protein intake was associated with 
increased BMD in several studies (50, 51), which suggest that protein may 
favor bone growth via increasing growth hormone and insulin growth factor 
(IGF)-1, both of which are essential for bone anabolism (24). A positive but 
modest relationship was found between protein intake or supplementation and 




significant difference was found between animal and plant-based protein in 
relation to hip fractures (52), suggesting that the source of protein may not be 
important in hip fracture development. However, low protein intake may 
induce secondary hyperparathyroidism, which in turn reduced intestinal 
calcium absorption and increased bone loss (53).While more research is 
needed to elucidate the level of protein intake on bone health, maintenance of 
the recommended level is considered safe for skeletal health among elderly 
individuals (24).  
1-3-3. Other nutrients, foods and dietary patterns 
 
Besides calcium, vitamin D and protein, various nutrients and dietary 
components have been reported to have favorable impacts on bone health, but 
the results are inconsistent and the mechanistic pathways remain to be studied. 
These potentially beneficial nutrients include those with anti-oxidant property, 
such as vitamin A (carotenoids), vitamin C, vitamin E, vitamin K, flavonoids 
found in fresh fruit and vegetables, tea, and long-chain ω-3 fatty acids, vitamin 
B family involved in the one-carbon metabolism, minerals such as potassium 
and magnesium, and estrogen-like phytoestrogens that behave as natural 
selective estrogen receptor modulators. Because fresh fruit and vegetables 
contain various nutrients, minerals and flavonoids, consumption of these food 
groups may also have favorable impact on bone health outcomes (23, 54). As 
this thesis is focused on the significant findings of certain dietary factors for 
the risk of hip fracture in the Singapore Chinese Health Study, an overview of 
the nutrients and their potential function in bone health, including vitamins A, 
C, and K, potassium and magnesium, long-chain ω-3 fatty acids and 




review was carried out on the nutritional risk factors that were identified in 
this cohort, including soy isoflavones (20), B vitamins, carotenoid, fruit and 
vegetables, and coffee, tea and caffeine. Furthermore, because dietary patterns 
overcome the limitation of inter-correlation and interaction of different foods 
and nutrients, it was more sensible to adopt an overall diet than a single 
nutrient or food group for the prevention of fracture risk. An extended review 




Table 1-1. Overview of certain potential nutrients in bone functions and summary of outcomes in human studies 
 
Nutrients Food sources Primary functions in bone Summary 
Vitamin A (55)  
Liver, meats, eggs, milk 
products, and fatty fish 
Excessive retinol antagonizes vitamin 
D in calcium homeostasis. 
Excessive intake may reduce 
BMD and increase fractures. 
Vitamin C (55) 
Citrus fruit, juices, and fresh 
vegetables 
An important cofactor in the formation 
of collagen and synthesis of hydroxyl-
proline and hydroxylysine. 
Inconsistent results were found 
in observational studies.  
Positive effects appeared to be 
observed in vitamin C 
supplements. 
Vitamin K (56, 57) 
Meats, eggs, milk products, 
and fatty fish 
As a cofactor to assist carboxylation in 
the glutamic residues to form 
carboxylated osteocalcin. 
Although vitamin K may play 
a role in preserving BMD and 
reducing fracture risk, current 
data is scares and inconsistent, 
particularly in RCTs. 
K1 (phylloquinone) 
(predominant form in 
diet) 
Dark green leafy vegetables 
and fruit 
K2 (as menaquinones) 
Primary produced by the 
bacteria in the gut 
Potassium (58, 59) Fruit and vegetables 
Not certain. 1) It was postulated that 
potassium citrate or potassium 
bicarbonate as an alkaline salt regulate 
skeletal pH in reducing urinary 
calcium excretion; or lower 
parathyroid hormone (PTH) to 
increase calcium balance. 
Results from RCTs on BMD 
and bone turnover are 
inconsistent. 






apatite crystals in cortical bones; 
deficiency may reduce PTH and 
vitamin D in bone formation and may 
increase low-grade inflammation. 
magnesium on bones. 
Omega-3 fatty acids (61, 
62) 
Seafood and deep-water 
fatty fish 
Not clear. 1. The anti-inflammatory 
property may reduce pro-inflammatory 
cytokines in bone turnover; 2. 
Regulate calcium balance by reducing 
urinary calcium excretion. 
Currently no sufficient 
evidence is available on the 
positive effect of ω -3 fatty 
acids on osteoporosis. 
Flavonoids (55, 58, 63) 
Fruit, vegetables, grains, 
herbs, tea, wine, and juices 
Anti-inflammatory and anabolic 
effects in the bones. 
Most of the work has been 
done in animal models but 
very few clinical studies 
beyond soy isoflavones. 
 
BMD – bone mineral density; PTH - parathyroid hormone; RCT – randomized control trial
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1-3-3-1. Soy isoflavones  
 
 Phytoestrogens are natural compounds derived from a variety of plant-
based foods and physiologically exhibit estrogen agonist-antagonist activities 
(64). One of the major forms that have been studied extensively in health 
benefits is soy isoflavones, which includes genistein, daidzein, and glycitein 
(55, 64). The similar molecular structure of soy isoflavones (genistein and 
daidzein) as that of 17-β estradiol enables soy isoflavones to bind to the 
estrogen receptor and thereby behave as a natural selective estrogen receptor 
modulator to display weak estrogenic or anti-estrogenic properties, depending 
on the target tissue and the endogenous estrogen level (65). In the bone tissue, 
the binding of soy isoflavones to estrogen receptor (ER) is higher for ER-β 
than for ER-α so that soy isoflavones displays weak estrogenic effect, which is 
hypothesized to its bone anabolic effect in favor of bone formation. This 
hypothesis has been supported in accumulating experimental studies in vitro 
(66-69) as well as in ovariectomized rodent models (70, 71). The bone 
favorable effects of whole soy diet, soy milk  (72, 73) or soy isoflavones (74) 
include an enhancement of bone strength (72), bone density, trabecular 
thickness (73), femoral bone quality and type I collagen (74). However, the 
bone beneficial effect of soy isoflavone or soy protein was not convincing in 
male rats with androgen deficiency (63). One study showed no overall effect 
on bone density and mineral content in orchidectomized (ORX) male rats as 
compared to the sham operated rats (75). Other studies suggested that soy 
isoflavones or soy protein may not effectively protect against oxidative-stress 
induced by alcohol in bone turnover (76). Other than the favorable estrogenic 
effect, other proposed mechanisms in response to the bone anabolic effect of 
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soy isoflavones include its interaction with nuclear factor (NF)-κB or the 
mitogen-activated protein kinase (MEK)-extracellular-signal-regulated kinase 
(ERK) cascade couples (77, 78) and with vitamin D to increase 1(25)2OHD 
synthesis and the expression of vitamin D receptor (70, 79). 
In observational studies and randomized control trials in humans 
(Table 1-2), the results are not consistent, especially among Western 
populations using soy isoflavones supplementation (80-85). By contrast, Asian 
studies have consistently shown the favorable effect from soy (20, 86-89) 
except one RCT conducted in Taiwan (90). These studies seemed to suggest 
that the protective effect of soy food or soy isoflavones may be more apparent 
in postmenopausal women with habitual soy intake with a long follow-up time 
(20, 87) but not in premenopausal women (80, 85). In addition, several 
systematic reviews of RCTs concluded that soy isoflavones may significantly 
increase BMD (91, 92) and decrease bone resorption marker urinary 
deoxypyridinoline (DPD) (91, 92), particularly among postmenopausal 
women with a dosage over 75 mg/day of isoflavone extract (91, 92). However, 
no effect was found in other bone formation markers (91, 92). However, two 
other meta-analyses did not support a bone beneficial effect of soy isoflavones 
on BMD change in women (93, 94). Nevertheless, the discrepancy between 
the effect of soy isoflavones on bone health in postmenopausal women in the 
West and the East could be due to genetic differences in the uptake of the 
phytoestrogen and its effects on bone health benefits.   
Taking the existing evidence among human subjects together, soy 
isoflavones may potentially have protective effects in postmenopausal 
osteoporosis. Particularly, habitual soy intake appears to have profound bone 
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Follow-up Time (years) 
Exposures Outcomes Effects  Main Findings 
Cross-sectional Studies 
Greendale et al. 
2002 (84) 
1,927 U.S. women aged 
42-52 years from 
different ethnic groups, 
including African-
American, Caucasian, 





BMD of lumbar 
spine (LS) and 
femoral neck 
(FN) 
Positive: SI in 
Japanese 
women only 
Median intake was too low in African-
American and Caucasian women, but 
Japanese had higher intake than Chinese. 
Significant positive relationship was only 
found in peri-menopausal Japanese women.  
Ho et al. 2003 
(86) 
454 Chinese women  
mean aged 55 years 
within first 12 years of 
postmenopause 
Dietary soy 
protein (SP) and 
SI  
BMD of spine 
FN, trochanter, 
inter-trochanter; 




Significant positive relationship was found 
between soy intake and trochanter, 
intertrochanter as well as total hip and total 
body BMD in women ≥4 years after 
menopause.  
Atkinson et al. 
2012 (80) 
203 U.S. premenopausal 





BMD of hip, 
spine, FN or 
head 
No  
No association was found in BMD of hip, 
spine, FN and head. 
Longitudinal Studies 
Zhang et al. 
2005 (87) 
24,403 
Chinese postmenopausal  
Dietary soy intake 




Dose- dependent inverse relation was found 





women / 4.5   effect in early postmenopausal women.. 
keda et al. 2006 
(88)  
944 Japanese women 20-
79 years / 3 
Fermented 
soybeans (natto), 
tofu and other soy 
products 
BMD of distal 
radius, spine and 
hip  
Positive: natto 
No: tofu or 
other soy 
products 
In postmenopausal women only: Higher natto 
intake was positively related to total hip BMD 
at baseline and increased FN BMD and distal 
BMD. No association was found in 
premenopausal women. 
Koh et al. 2009 
(20) 
63,154 Chinese men and 
women 45–74 years/7.1  







Dose-dependent inverse relationship between 
tofu/SP/SI and hip fractures was found in 
women only. No association was found in 
men. 
Greendale et al. 
2015 (85)  
Same as Greendale 2002/ 
± 5 before or after final 
menstrual period (FMP) 
(SWAN) 
Dietary SI 
(genistein) at visit 
5 and 9 
BMD change 





Dose-dependent positive relationship between 
SI and BMD loss in LS and FN in Japanese 
women during 1 year before to 2 years after 
FMP.  No association was found in other 
ethnic groups. 
Interventions or Randomized control trials 
Anderson et al. 
2002 (81) 
 U.S. 28 women aged 21 
to 25 years / 1 
SI at 90 mg/day 
(n=15) and 
placebo (n=13) 
BMC and BMD No 
No significant change was found in BMD 
between the treatment (T) and control (C) 
groups. 
Brink et al.  
2008 (82) 
237 U.S. early 
postmenopausal 
women mean aged 53 
years with <3 years’ 
postmenopause / 1 
SI of 110 mg/d 
and placebo 
BMD of LS and 
total body; BTM  
No 
No significant changes were found in BMD or 









aged 40 and 60 years/2 
SI of 80 mg/d 
(n=135) or 120 
mg/d (n=136) and 
placebo (n=135) 
Total and regional 
body BMD and 
BMC  
Yes in total 
body BMD 
At dosage of 120 mg/d: Whole-body bone 
loss was smaller than placebo group at 1 year 
and 2 years follow-up; but no significant 
differences were found in regional BMD 
changes. 
Shedd-Wise et 
al. 2011 (96) 
173 U.S. postmenopausal 
women aged 46 – 63 
years/ 3 
SI supplement of 
[80 mg/d (n=56) 
or 120mg/d] vs 
placebo (n=61)  
Volumetric BMD 





BAP and SSI  
Modest effect  
Dosage of 120-mg/d: Protective of cortical 
BMD; 80 mg/d treatment protective of 
trabecular BMD when BAP increased. 
Levis et al. 
2011 (83) 
122  U.S. women 45 to 60 
years within 5 years of 
menopause and BMD T 
score> -2.0 each arm / 2  
SI supplement at 
200 mg/day or 
placebo.  
BMD change in 
spine, FN and 
total hip; NTx 
No 
No significant differences were found in 
BMD change or NTx between T and C 
groups. 
 
Tai et al. 2012 
(90) 
461 Taiwanese women 
aged 45-65 years / 2 




BMD of LS and 
FN; BAP and 
NTx 
No 
No significant differences were found in 








40 Chinese women aged 




SI supplement at 
90 mg/day for T 
group; placebo  
 
 
BMD at radius 






SI was positively related to tibia BMD and 






ALP: alkaline phosphatase; BAP: bone-specific alkaline phosphatase; BMC: bone mineral content; BMD: bone mineral density; BTM: 
bone turnover biomarkers; C: control; FMP: final menstrual period; FN: femoral neck; LS: lumbar spine; NTx: N-telopeptide; ODMA: 




1-3-3-2. B vitamins  
[This section is based on published review on “B-Vitamins and Bone Health–
A Review of the Current Evidence” Dai and Koh Nutrients 2015 (97)] 
 
  B vitamins in general are cofactors of the enzymes that are involved in 
the energy-producing metabolic pathways for the metabolism of carbohydrates, 
fats and proteins. In addition, B vitamins also play an important role in 
maintaining functions of the nervous system. Recently, the B vitamin family 
has been investigated for their possible roles in bone health in human studies. 
In addition, inadequate B vitamin intake has been reported among hip fracture 
patients. In this session, postulated mechanisms from animal work are 
summarized and a literature review of the current findings from observational 
studies and clinical trials is provided for B1 (thiamine), B2 (riboflavin), B3 
(niacin), B6 (pyridoxine), folate and B12 (cobalamin).  Table 1-3 summarizes 
the findings from observational studies in the literature. 
Vitamin B1 (Thiamin) 
Evidence of thiamin and bone health is scanty. One study among 
orthopedic patients reported that thiamin status was deficient among patients 
with femoral neck fracture but not among those who were admitted for 
elective total hip replacement (98). A recent review emphasized the major role 
of thiamin in metabolic function in cells and the consequent impairment of 
neuro-function in thiamin deficiency. Because thiamin deficiency can impair 
energy metabolism due to mitochondrial dysfunction in focal regions of the 
brain (99), this, in turn, can increase the risk of Alzheimer’s disease and 
cardiac failure, and therefore can increase the propensity to fall in the elderly 






Vitamin B2 (Riboflavin) 
 An early study which examined the offspring of rats fed with B2-
deficient diets reported that maternal B2 deficiency induced abnormal fetal 
development and skeletal malformation (101). Another in vitro experimental 
study showed that B2 and its photoproducts exerted beneficial effects on cell 
proliferation and alkaline phosphatase activity, and decreased RANKL 
(receptor activator of nuclear factor-κB ligand) / OPG (osteoprotegerin) ratio 
by enhancing the expression of OPG in the preosteoblastic MC3T3-E1 cells 
(102). These experimental studies indicate the important role of B2 as a 
coenzyme in major metabolic pathways for energy production and its 
biological property in bone cells.  
In observational studies, very few have examined the associations 
between B2 and bone health outcomes. Three studies conducted among 
Caucasian populations looked at dietary intake of B vitamins and found an 
interaction between the methylenetetrahydrofolate reductase (MTHFR) C677T 
gene polymorphism and B2 intake in relation to bone mineral density (BMD) 
or fracture risk (103-105). The proposed mechanism on riboflavin and bone 
health is related to the coenzymatic form flavin adenine dinucleotide (FAD), 
which is a cofactor for the MTHFR enzyme. Other studies suggest that the 
reduced activity of the so-called thermolabile MTHFR enzyme was seen in the 
TT genotype in the presence of insufficient B2 status (106). 
Vitamin B3 (Niacin) 
 
Studies examining the direct effect of B3 on bones are scanty. Two 




basal diet did not find differences in bone strength and mineral content of the 
tibia in young (one-day-old)  (107) and old (six-month-old) chicks  (108). 
However, a higher dosage of B3 weakened bone strength and increased bone 
breakage in both age groups of chicks, suggesting that excessive niacin 
consumption may increase bone fractures, although the mechanism has not 
been clearly elucidated. A cross-sectional study from Japan and a case-control 
study from Korea reported possible positive effect of niacin on BMD and 
reduced fractures, respectively (109, 110). However, due to the small number 
of participants and inherent biases from the study design, including selection 
bias, recall bias, and reverse causality, these results need to be validated by  
prospective studies. 
Vitamin B6 (Pyridoxine) 
Earlier work has been conducted in animals to examine the 
independent role of B6 in lysyl oxidase activity, collagen cross-linking 
formation, and bone mechanical property (111-115). As a cofactor for lysyl 
oxidase, B6, more specifically pyridoxal phosphate (PLP), is essential for the 
enzymatic action of lysyl oxidase in collagen cross-linking formation (112, 
115). Alternatively, B6 may act as a substrate of alkaline phosphatase in bone 
formation  (116) and play a role in calcification of new bone formation, as 
ornithine decarboxylase is a  B6-dependent enzyme in the regulation of the 
periosteal glucose 6-phosphate dehydrogenase (G6PD) activity (117).  
Epidemiologic studies relating B6 to bone health or fracture risk are 
limited. An early report stated that hip fracture patients had significantly lower 
serum PLP as compared to the fit ambulant outpatients (118). Three 




mass and/or fracture risk (119-121). The Rotterdam Study showed that lower 
dietary intake of B6 was associated with lower BMD and higher fracture risk 
(119), while the Framingham Osteoporosis Study reported that lower plasma 
B6 level was associated with higher bone loss and hip fracture risk (120). The 
role of vitamin B6 in fracture risk appeared to be independent of BMD and 
homocysteine, because further adjustment for these two variables did not 
affect the risk estimates substantially (119, 120). A cross-sectional study also 
showed that decreased vitamin B6 and folate levels were associated with 
weakened bone structure indicated by reduced trabecular number and 
thickness but not by BMD or homocysteine. Hence it is possible that 
deficiency in B6 and folate may be related to altered bone properties 
independent of homocysteine (122). 
Folate (vitamin B9) 
In experimental studies, one study thus far has investigated the effect 
of folate alone in osteoclast cultures (123). In the folate-deficient treated 
osteoclasts, resorption activity was found to be significantly increased  
compared to the folate treated cells (123). Furthermore, low concentrations of 
folate, B12 and B6 in osteoclasts resulted in accumulation of homocysteine 
and stimulation of resorption activity of osteoclasts in vitro (123) , but it did 
not influence the activity of human osteoblasts in vitro (124) . Alternatively, 
folate was suggested to have a comparable effect as tetrahydrobiopterin, a 
cofactor for the enzyme of nitric oxide synthase, whose isoform, in turn, 
promotes bone density and is a key mediator in the anabolic effects of 




density by helping to preserve optimal nitric oxide synthase activity in the 
bone cells (125).  
Several epidemiologic studies have shown a significant relationship 
between increased folate intake/level and increased BMD (126-131)  or 
reduced fracture risk (132, 133), while others have shown null associations 
(121, 134, 135). Among these studies, two prospective studies which 
examined the relationship between dietary intake of B vitamins and BMD or 
fracture risk suggested that dietary folate was a significant predictor for BMD 
measured at five years after the baseline, yet no relation was found with 
fracture risk (121, 131). 
B12 (Cobalamin) 
B12 was first revealed to be related to osteoporosis and fractures in 
patients with pernicious anemia (136, 137). The mechanistic pathways 
between B12 and different aspects of bone physiology are still unclear despite 
the evidence from in vitro or in vivo models. One study using human bone 
marrow stromal osteoprogenitor cells and UMR 106 osteoblastic cells 
suggested that B12 increased osteoblastic proliferation and alkaline 
phosphatase activity, implying a direct effect of B12 on proliferation and 
formation in the osteoblasts (138). By contrast, another in vitro study showed 
no direct effects of B12 on osteoblasts (human mesenchymal stem cells) or 
osteoclasts regarding cellular differentiation, formation or resorption activity 
or matrix calcification (139). However, B12 deficiency increased the level of 
homocysteine and methylmalonic acid (MMA), which, in turn, stimulated 




indirectly increase osteoclast formation through its effect on the elevation of 
MMA and homocysteine levels.  
The associations between B12 alone or with other B vitamins and bone 
health outcomes have been studied extensively in different populations, 
although the majority was conducted among Caucasian populations. Most 
studies did not find a significant association between B12 and BMD (103, 119, 
126, 127, 129, 130, 135, 140), bone turnover biomarkers (103, 135) or fracture 
risk (119, 121, 131-133), but some studies supported the protective role of 
B12 in preserving BMD (134, 141-144) or reducing fracture risk (120, 145). 
Based on the mixed results from these studies, the mechanism of B12 in bone 
health remains to be understood. It has been suggested that BMD may only 
partially explained the relationship between B12 and fracture risk in 
epidemiologic studies (120). For example, deficiency of B12 could contribute 
to neurological complications (146) to increase the risk of falls in the elderly, 
and/or affect BMD via its influence on homocysteine metabolism (134, 145). 
However, B12 deficiency may not be sufficient to affect bone quality if there 
is no accumulation of homocysteine in the bone tissues (147). 
Despite the conflicting results from observational studies, a few 
randomized clinical trials (Table 1-3) have been conducted to examine the 
effects of B6, folate and B12 supplementation in association with changes in 
bone turnover biomarkers (148-151) and fracture risk (152-154). Of note, 
dosage used in these studies ranged considerably among different trials. 
Although all of the trials showed a successful reduction of homocysteine level 
in the B vitamin [single or mix B vitamin(s)] supplementation treatment group, 




biomarkers or fracture risk. Only one study reported that the combined 
treatment with folate and B12 significantly reduced risk of hip fracture in 
Japanese patients following a stroke (153). It appears that the beneficial effect 
of folate and B12 in Japanese patients with residual hemiplegia following 
stroke could be through the improvement in the neurological and cognitive 
function among these patients, who were also at high risk to have severe 
neurological deficits and increased the propensity to fall. Another study 
conducted among a large cohort of Dutch elderly with elevated homocysteine 
showed that combined B12 and folate supplementation had no effect on 
osteoporotic fracture incidence. Furthermore, although exploratory subgroup 
analyses suggested a beneficial effect on osteoporotic fracture prevention in 
the elderly aged 80 years or above, the supplementation of B12 and folate was 
associated with increased incidence of cancer (154). Furthermore, a recent 
meta-analysis suggested a modest effect of B12 and homocysteine levels on 
fracture risk. The pooled analysis showed a 4% borderline significant decrease 
in fracture risk per 50 pmol/L increase in B12 concentration and a 4% 
statistically significant increase in risk of fracture per 1 mol/L increase in 
homocysteine level (155).  
Together, these findings from the clinical trials and meta-analyses 
imply a possible but modest effectiveness of B vitamins in bone protection. 
An optimal dosage for the efficacy of B vitamins in bone outcomes remains to 
be determined in human studies, and dietary regimens with vitamin B enriched 
foods should be considered for bone maintenance to avoid the potential 




















Serum folate, B12, and 
homocysteine 
BMD 
Yes: Folate.  
No: B12 
Folate predicted BMD;  
No association found in B12 or 
homocysteine. 
Dhonukshe-Rutten 
et al. 2003(144) 
194 free-living Dutch frail 





Yes: B12 in 
women 
B12 predicted BMC and BMD in women 
only. Women with marginal or deficient 
B12 increased risk of osteoporosis 
substantially. 





folate, and B12 ; 
MTHFR C667T 
polymorphism 
Femoral neck and 
lumbar spine BMD 
Yes: Folate.  
No: B12 
Folate predicted BMD. No correlation 
between MTHFR and folate or B12. Folate 
but not MTHFR predicted plasma 
homocysteine. 




RBC 5-MTHFR BMD Yes: Folate 
RBC 5-MTHF predicted BMD, but not 
plasma 5-MTHF.  
Morris et al. 
2005(134) 
1,500 U.S. White men and 
women  
Serum and RBC folate, 




Yes: B12;  
No: Folate 
No association was found between folate 
and BMD or osteoporosis. Significant risk 
observed in the lowest quartile of B12 vs. 
the highest quartile. A positive relationship 











serum folate, B6, B12 
and MTHFR genotypes 
BMD 
Yes: Folate; No: 
B6 and B12 
Folate significantly related to BMD. B6, 
folate and B12 significantly related to 
homocysteine level. Homocysteine 
appeared to be related to BMD. 
Holstein et al. 
2009(122) 
94 German men and 
women 
Fasting serum folate, 
B6, B12 
BTM: OC, TRAP; 
BMD, trabecular 
thickness, number, 
and area.  
Yes: B6, folate, 
B12 
OC is lower in those with low level of B 
vitamins. Trabecular thickness and area are 
lower in those with low folate. Trabecular 
number is lower in those with low B6. No 
association between B vitamins and BMD 
or homocysteine. 
Bozkurt et al. 
2009(141) 
178 postmenopausal  
Turkish women 
Serum homocysteine, 
folate and B12 
BMD at femoral 
neck and lumbar 
spine 
Yes: B12 ;  
No: Folate 
Only B12 predicted osteoporosis at the 
lumbar spine and femur. 






serum folate, and B12 
BMD, BTM: BAP 
and CTx 
No: Folate and 
B12 
Folate, B12 not related to BMD or BTM. 
But homocysteine was related to BTM. 
Rumbak et al. 
2011(140) 
131 Croatian women  
Plasma homocysteine, 
serum and red blood 
cell folate, and B12 
BMD from lumbar 
spine, femoral neck, 
total femur and distal 
radius 
No: Folate, B12 
No relation found for homocysteine, folate 






Macdonald et al. 
2004(103) 
1,241 Scottish women 
aged 45–54 years/6.6 years 
Dietary intake of B2, 
B6, folate and B12 
 BMD; BMD change; 
BTM, fPYD/Cr and 
fDPD/Cr and serum 
P1NP 
Yes: B2; No: 
B6, folate and 
B12 
B2 intake related to BMD in subjects with 
MTHFR TT homozygotes. No associations 
found in BMD change or BTM, nor in CC 
or CT genotypes. No associations were 
found in other B vitamins. 
Stone et al. 
2004(143) 
83 U.S. White women 65+ 





BMD and calcaneal 
bone mass. 
Yes: B12 
Women at lower serum B12 ≤ 280 pg/mL 
had higher rate of bone loss from the hip 
than those at B12 > 280 pg/mL. No 
association was found with site BMD or 
BTM. 
Dhonukshe-Rutten 
et al. 2005(145) 
615 men and 652 women 
aged 76 (SD 6.6) years/3 
years 
Homocysteine, B12 
status and the 




OC and of DPD/Cr 
and fracture risk 
Yes: B12 
Women with B12 < 200 pM and 
homocysteine > 15 µM had lower BUA, 
higher DPD/Cr, and higher OC. No 
differences in men between the different 
level of homocysteine and B12.  
 Lowest quartile of B12 increased fracture 
risk in women only.  
Ravaglia et al. 
2005(132) 
702 Italians aged 65–94 
years/4 years 
Serum folate, B12 and 
homocysteine 
Fractures 
Yes: Folate;  
No: B12 
Lowest folate quartile had  
2-fold increased risk vs. higher quartiles, 
but no dose-respondent relationship. No 
association between B12 and fracture risk. 
Tucker et al. 
2005(142) 
2,576 U.S. White men and 
women  
Plasma B12 
BMD at total hip,  
trochanter, Ward’s 
Yes: B12 
A positive relationship between plasma 





30–87 years  area, and femoral 
neck and at lumbar 
spine (cross-sectional 
analysis) 
lumbar spine for women. 
Gjesdal  et al. 
2007(133) 
4,766 Norwegian men 
and women 65–67 
years/12.6 years 
Plasma homocysteine, 





Yes: Folate;  
No: B12 
Homocysteine increased hip fracture in 
both genders. Folate inversely related to 
hip fracture in women only. No association 
was found for B12 or MTHFR genotypes. 
Yazdanpanah et al. 
2007(119) 
5,305 Dutch men and 
women aged 55+ 
years/6–7 years 
Dietary intake of B2, B6, 





Yes: B2, B6;  
No: Folate and 
B12 
B2 and B6 positively related to BMD, 
where B2 is the strongest predictor. 
Compared to the lowest 3 quartiles of B6, 
Q4 was related to 23% lower risk in 
vertebral fracture and 45% lower risk in 
non- fragility fracture. 
Cagnacci  et al. 
2008 (130) 
161 healthy  
postmenopausal women 






5 years follow-up) 
Yes: Folate  
No: B12 
Initial and 5-year follow-up assessments, 
as well as annual change of lumbar spine 
BMD was significantly related to serum 
folate. 
McLean et al. 
2008(120) 
1,002 U.S. White men 
and women aged 75 
years/4 years 
Plasma B6, folate  
and B12, homocysteine 
Femoral BMD at 
baseline and hip 
fracture  
Yes: B6, B12 
B6 inversely related to bone loss. B6 and 
B12 inversely associated with hip fracture 
risk, and risk remained elevated after 
adjusted for BMD and homocysteine. 









43–58 years/10 years 
Dietary intake and 
supplemented folate, B2, 
and B12 
BMD, fracture risk Yes: Folate and 
BMD  
at 5 years;  
No: Folate, B2 
or B12 
No association was found in folate, B2, or 
B12 with BMD (cross-sectional) or 
fracture risk. Folate predicted BMD at year 
5 significantly. 
Yazdanpanah et al. 
2008(105) 
5,305 Dutch men and 
women aged 55+ 
years/6–7 years 
Dietary intake of B2  
 and folate 
BMD fracture risk 
Yes: B2  
No: Folate 
The lowest quartile of B2 in women with 
TT genotype, bone loss was higher and had 
2-fold greater risk in fractures vs. CC type. 
B2 modified MTHFR C677T variant on 
fracture risk. No association was found 
with folate. 
Dai et al. 2013 
(121)  
63,154 Chinese men and 
women 45–74 years/13.8 
years 
Dietary intake of B1, B2,  
B3, B6, folate, and B12 
Hip fracture risk 
Yes: B6; No: 
other B vitamins 
Dose-dependent inverse relationship 
between B6 and risk of hip fracture in 
women only.  
 Intervention or randomized controlled trials 
Sato  et al. 
2005(153) 
628 aged 65+ years 
patients with residual 
hemiplegia after stroke 
for 1 year+ / 2 years 
T: Daily treatment with 5 
mg folate and  




Yes: folate and 
B12 
After two years, treatment group had lower 
homocysteine and placebo group had 
higher homocysteine. Hip fracture 
incidence was significantly reduced in 
treatment group. No difference in BMD. 
Herrmann et al. 
2006(149) 
61 healthy individuals 
aged 58 years (SD 8)/8 
weeks 
T: 0.4, 1 or 5 mg folate 
daily; C: placebo 
Serum HCY, folate, 
B12; BTM: OC, 
P1NP, and CTX. 
No: folate 
T vs. C: Folate increased, homocysteine 
decreased. No difference in BTM. 













132 aged 20–59 years 
Mexican women/3 
months 
T: B12 1 mg i.m. then 
500/day orally (n = 70); 
C: placebo (n = 62). 





Supplementation of B12 increased holoTC 
and lower MMA and homocysteine. But no 
difference found in BAP. 
Gommans et al. 
2013(152) 
8,164 Caucasian with 
recent stroke or transient 
ischemic attack/2.8 
year’s therapy and 3.4 
years follow-up. 
T: Daily 2 mg folate, 25 
mg B6 and 500 μg B12 
(n = 4089);  
C: Placebo (n = 4,075) 
Fracture risk; Serum 
homocysteine 
No: folate, B6 
and B12 
No significant difference in fracture risk 
between two groups. Homocysteine was 
lower in treatment group, but it did not 
predict fracture risk. 
Keser et al. 
2013(150) 
31 Croatian women aged 
65 years+ with 
homocysteine >> 10 
μmol/L/4 months 
T: 800 μg folate and 
1000 μg B12 (n = 17) 
daily, C: Placebo  
(n = 14) 
BTM: ALP and CTx 
No: folate and 
B12 
Treatment group had significantly lower 
homocysteine and higher serum folate or 
B12; But no difference in serum level of 
ALP or CTx. 
van Wijngaarden et 
al. 2014(154) 
2,919 Dutch aged 65 
years with elevated 
homocysteine  
(12–50 mmol/L)/2 years 
T: Daily 500 µg B12 and 
400 µg folate with 600 
IU D3  
C: placebo with 600 IU 
D3. 
Serum homocysteine, 
First time fracture 
Yes: folate and 
B12 in 80 
years+ 
Homocysteine significantly lower in the 
treatment group. Fracture risk did not differ 
between two groups. But significant lower 
risk was found in those 80 years+ in the 
treatment group. However, a higher risk of 
cancer also observed in the treatment 
group. 
 
ALP: alkaline phosphatase; BAP: bone-specific alkaline phosphatase; BMC: bone mineral content; BMD: bone mineral density; BTM: bone turnover biomarker; CTx: 





IU: International Unit; MMA: methylmalonic acid; MTHFR: methylenetetrahydrofolate reductase; OC: osteocalcin; P1NP: procollagen type I N propeptide; fPYD/Cr: free 





1-3-3-3. Carotenoids  
 
Carotenoids are primarily obtained from dietary intake of fruit and 
vegetables and have been reported to exert protection against osteoporosis 
(156). Major carotenoids that are present in human plasma are represented by 
α-, β- carotene, β-cryptoxanthin, lycopene and lutein (157). Structurally, 
carotenoids typically contain polyisoprene and are divided to carotenes and 
xanthophylls depending upon the presence of oxygen molecules (156, 158). 
Carotenes (unoxygenated caroteinoids) include α-, β-carotene and lycopene. 
Xanthophylls, where oxygen atoms are attached at the end groups, include β-
cryptoxanthin and lutein (156). The presence of a long chain conjugated 
double bonds endows carotenoids with antioxidant function (157, 158). The 
proposed mechanisms attributed to the beneficial health effects of carotenoids 
include regulation of cell growth, cell cycle arrest, enhancement of gap-
junctional communication, and induction of detoxifying enzymes, such as 
cytochrome P450-dependent monooxygenases (157, 159).  
Data from the experimental studies have demonstrated the anabolic 
effects of carotenoids in vitro and in vivo. Carotenoids, including α-, β-
carotene, and lutein, were reported to have direct stimulatory effects on 
osteoblastic differentiation through increasing alkaline phosphatase activity 
and osteopontin mRNA expression in the osteogenic cell line. Interestingly, β-
carotene was found to have the most potent effect as compared to other 
carotenoids (160). Lycopene is an abundant carotene found in tomato products. 
Experimental studies have shown its stimulatory effects on bone formation 




and in reactive oxygen species (ROS) induced osteoclasts (163). β-
cryptoxanthin was reported to promote bone formation and suppress bone 
resorption in cell culture models as well as in animal models. Its stimulatory 
effects on osteoblastic proliferation, differentiation and calcification and on 
increased expression of insulin-like growth factor (IGF)-1 and transforming 
growth factor (TGF)-beta1 mRNA were proposed to be due to the enhanced 
gene expression of the protein, as such effects were negated at the presence of 
cycloheximide, a protein inhibitor (164). On the other hand, osteoclastic 
formation was also inhibited by β-cryptoxanthin, which may involve the 
suppression of the receptor activator of NF-kappa B ligand (RANKL) (165, 
166). Similarly, increased mineral content, bone formation (167) as well as 
reduced bone loss were also observed in rodent models treated with β-
cryptoxanthin (168).   
Findings from majority of the observational studies are in support of 
the protective effect of carotenoids against bone loss or fracture risk except 
three studies (169-171) (Table 1-4).  Among those studies with positive effect 
of carotenoids on the bone outcomes, β-carotene (172-177) and lycopene (172, 
175, 176, 178) appeared to exhibit the most bone sparing effects. This might 
be due to the high antioxidant potency in these two carotenoids. It has been 
suggested that β-carotene and lycopene are more efficient antioxidants to 
scavenge free radicals compared to other carotenoids (179, 180). A few 
studies reported a direct negative relationship between serum lycopene level 
and oxidative stress markers, such as protein oxidation and lipid peroxidation; 
and  a positive relationship with antioxidant enzymes, such as superoxide 




182). Another study found an interaction between dietary β-carotene and 
smoking status in fracture risk where the protective effect was only found in 
ever smokers, indicating that the anti-oxidant property of β-carotene was an 
underlying mechanism in the relationship to lower fractures (183). These 
studies provided evidence in support of the antioxidant carotenoid mechanism. 
In summary, potentially dietary carotenoids may exert their bone beneficial 









Follow-up Time (years) 
Exposures Outcomes Effects  Main Findings 
Cross-sectional Studies 
Wattanapenpai-
boon et al. (172)  
Australian men aged 
27−78 years (n=68) and 




BMC and BMD 





In men: Lycopene was positively related to 
total body and LS bone mass; 
In pre-menopausal women: Lycopene and 
lutein/zeaxanthin were related to LS and total 
body BMC. 
In postmenopausal women: β-carotene was 
positively related to LS bone mass. 
Wolf et al. 2005 
(173)  
11,068 U.S. women aged 
50–79 years 
Dietary intake of α-, 
β-carotene, lycopene,  
β-cryptoxanthin and  
lutein+zeaxanthin; a 
subset of 379 subjects  
had serum carotenoids 
BMD of total 





Significant relationship was found between 
serum β-carotene and BMD. No significant 
association was found for other carotenoids. 




women aged 55-60 years 
Serum lycopene 




Negative relationship was found between 
serum lycopene and NTx or protein oxidation.  
Sugiura et 
al.2008(169)   







Radial BMD No 
No significant relationship was found in any 











women aged 50-60 years 
Serum lycopene after 
one-month lycopene-
depletion  
NTx and GPx, 
CAT and SOD 
Yes 
CAT and SOD was significantly decreased, 
while NTx was significantly increased. 












The “β-cryptoxanthin pattern" with  β-
cryptoxanthin and vitamin C was inversely 
associated with low BMD. 
Case-control Studies 
Zhang et al. 
2006 (183)  
1,215 U.S. men and 
women aged 50 years and 
above 




Yes: in ever 
smokers 
Reduced risk of fractures was only found in 
ever smokers. 
Sun et al.  
2014(174)   
726 elderly Chinese with 
hip fracture and 726 
control subjects 
Dietary intake of 
antioxidants, 






Dose-dependent inverse relationship was 




al.1999 (170)  
66,651 Swedish women 
aged 40 -76 years 
Dietary intake of 
antioxidants including 
β-carotene 
Fracture risk No No significant association was found. 
Barker et al. 
2005(171) 
1,246 British women 75 
years and older / 3.7 
Serum retinol and β-
carotene for cases: 
controls=1:3 
Any fracture, hip 
fracture risk 
No 
No significant relationship was found between 





Sahni et al. 2009 
(175)  
U.S. Framingham men 
(n=334) and women 
(n=540) averaged aged 













Men: Total carotenoids, β-carotene, lycopene 
and lutein+zeaxanthin were significantly 
related to trochanter BMD change; 
Women: Lycopene was significantly related to 
spine BMD change.  
Sahni et al. 2009 
(176) 
U.S. Framingham men 
(n=370) and women 
(n=576) averaged aged 
75 years / 17  
Same as above  Fracture risk 
Yes: total 
carotenoids, 
lycopene and β- 
carotene; No: α- 
carotene,  
β-cryptoxanthin 
Men and women combined: Higher total 
carotenoids or lycopene intake was 
significantly related to lower fractures. 
Marginal protective effect of β-carotene was 
found in hip fracture. 
Sugiura et al. 
2012(177) 
Japanese 146 men, 99 
pre- and 212 post-






Yes: β-carotene,  
β-cryptoxanthin 
Postmenopausal women: Inverse relationship 
of β-carotene / β-cryptoxanthin was found 
with risk of osteoporosis / osteopenia, and 
with bone loss of radius. 
Men or premenopausal women: No 
association was found.  




women aged 50-60 years 
/ 4 months 
Lycopene 
supplements of 30, 
70, 30, 0 mg/day in 
treatment groups and 






Lycopene supplementation in treatment group 
had significantly increased total antioxidant 
activity and reduced protein oxidation and 






BMC: bone mineral content; BMD: bone mineral density; BTM: bone turnover biomarkers; CAT: catalase; GPx:  glutathione peroxidase; LS: 




1-3-3-4. Fruit and vegetables  
Fruit and vegetables (F&V) are important dietary sources of 
antioxidants and comprise various vitamins, minerals, and polyphenols. The 
proposed mechanisms for the health benefits of F&V are attributed to the 
components in F&V include antioxidant functions, regulation of cell 
differentiation, cell cycle arrest and apoptosis, and induction of detoxifying 
enzymes (185). Another hypothesis is that minerals, that are precursors to 
bicarbonate ions such as potassium and polyphenols in fruit and vegetables, 
may reduce urinary calcium loss due to the alkaline nature to neutralize 
excessive metabolic acid to maintain an acid-base homeostasis (186, 187), 
which, in turn, may promote calcium balance in the bones (188-190). Some 
studies have shown that middle-aged women had significantly lower net 
endogenous acid production (NEAP) and increased urine pH after increasing 
F&V consumption from ≥ 5 to ≥ 9 servings within a period of 8 weeks (191). 
The drawback of this study, however, was a lack of control group. In another 
RCT with two-year potassium citrate supplementation at high and low dosage 
or 300 grams of F&V per day, however, did not show significant difference in 
BMD or BTM changes between the treatment and control groups 
in healthy postmenopausal women, suggesting that alkaline provision may not 
explain a long-term benefit of F&V consumption in the bones (192). On the 
other hand, the majority of the observational studies (Table 1-5) have found a 
positive relationship between consumption of fruit and/or vegetables and 
BMD at different sites (193-197) or an inverse association with fracture risk 
(198-200). So far, no meta-analysis has been conducted looking at the 




heterogeneity between studies. One systematic review that examined the 
relationship between dietary F&V and bone health outcomes in women aged ≥ 
45 years suggested that although there was a positive relationship with change 
in BMD in cross-sectional studies, the results from prospective cohorts or 
RCTs did not support the bone favorable impacts of F&V (189). The 
relationship between F&V and bone health remains unclear in postmenopausal 
women.  
Taken together, the existing evidence appears to suggest a long-term 
beneficial effect of habitual dietary intake of fruit and vegetables on bone 
mass and reduced fracture risk. While a short-term effect may lower NEAP, 
however, the dietary acid-alkaline hypothesis on bones was not convincing 
(192); no short-term effect was found in the intervention studies on BMD or 
BTM changes through increasing consumption of F&V (192, 201). These 
studies indicate that the alkaline nature of fruit and vegetable may not be 









Follow-up Time (years) 
Exposures Outcomes Effects  Main Findings 
Cross-sectional Studies 
Chen et al. 2006 
(193) 
670 postmenopausal 
Chinese women aged 48-
63 year 
Fruit and vegetable 
intake 
BMD of total 
body, spine, and 
hip. 
Yes 
Fruit intake was positively related to spine 
BMD. Vegetable intake was positively related 
to hip BMD. Combined F&V intake was 
positively related to total body, spine and hip 
BMD 
Zalloua et al. 
2007(194)  
Chinese men (n=5,848) 
and women (n=6,207) 
aged 25-64 years 
Fruit and vegetable 
intake 
BMD of  total 
body and hip 
Yes: Fruit 
No: Vegetables 
In men and women: Fruit intake was 
positively and significantly associated BMD. 
Li et al. 2013 
(195) 
Chinese teenagers 
(n=212), young women  
aged 20-34 years 
(n=371), and 
postmenopausal women 
aged 50-70 years (n=333) 
Fruit and vegetable 
intake 
BMD and BMC 
of total body, 
LS, hip and FN 
Yes: Fruit 
No: Vegetables 
Positive relationship was found between fruit 
intake and BMD and BMC.  
The more apparent relationship was found in 
boys and postmenopausal women. 
Liu et al. 2015 
(196) 
4,000 Hong Kong 
Chinese men and women 
aged 65 or older 
Habitual fruit and 
vegetable intake 
BMD of total 




Fruit intake was positively related to BMD of 








Xie et al. 2013 
(198) 
646 sex- and age-
matched cases and 
controls (1:1) of men and 
women aged 71 years on 
average 




Yes   
In men: Both F&V were inversely associated 
with hip fractures.  
In women: Vegetable  was 
inversely associated with risk of hip fracture 
Xu et al. 2009 
(199) 
209 postmenopausal 
women aged 50-70 years 
with fractures matched 
with controls by age 
Dietary intake 





Inverse relationship with forearm fractures 
was found in consumption of vegetable or 
fruit and vegetables combined.  
Longitudinal Studies 
Byberg et al.  
2014 (200)   
Swedish men (n=40,644)  
and women (n=34,947) 
aged 45-83 years / 14 
Dietary intake 





findings in both 
genders 
F&V intake was negative associated with hip 
fracture on a dose-response manner when 
consumption< 5 servings/day, but no 
additional benefit beyond 5 servings/day.   
Tucker et al.  
1999 (197)  
U.S. men (n=229) and 
women (n=399) aged 69-
97 years in the 
Framingham study 
Dietary intake of fruit, 
vegetables, potassium 
and magnesium  
BMD at baseline 
and 4-y 
longitudinal 
change in BMD 
Yes: men 
longitudinally but 
not in women 
In men: Fruit and vegetable intake was 
associated with BMD of FN, WA and radius 
at baseline and BMD change in WA; 
In women: F&V was related to baseline 
trochanter and radius only.  
Intervention Studies or RCTs 
Macdonald et al. 




aged 55–65 years/2 
Three treatment 
groups: 1) high-
dose; 2) low-dose 
potassium citrate; 3) 
BMD of LS and 




No significant difference was found in BMD 






300 g F&V/d; 4) 
placebo  
Ebrahimof et al. 
2009 (201)  
 
Iranian women with 
osteopenia aged 50-60 
years /12 weeks 
Treatment group: 6 
extra servings of 
F&V/d (n=23); 
Control: usual diet 
(n=22) 
BTM: serum OC 
and CTx 
No 
No significant difference was found in BTM 
changes between treatment and control 
groups. 
Neville et al. 
2014 (202)  
83 British aged 65-85 
years / 16 weeks 
Treatment group: ≥5 
servings of F&V; 
Control group: ≤2 
servings of F&V 
(usual diet) 
OC, CTx No 
No significant difference in BTMs was found 
between the two groups. 
Gunn et al. 2013 
(191) 
100 healthy post-
menopausal women from 
New Zealand 
Treatment group: ≥9 
servings of F&V in 1)  
generic types; 2) 
specific type; 3) 
placebo: usual diet 




1) and 2) groups: decreased urinary calcium 
loss; 2) group: decreased P1NP as compared 
to 3) placebo. 
 
BMD: bone mineral density; BMC: bone mineral content; BTM: bone turnover biomarker; CTx: carboxyterminal cross-linking telopeptide; (f) 
DPD/Cr: (free) deoxypyridinoline cross-links/Creatinine; F&V: fruit and vegetables; FN: femoral neck; LS: lumbar spine; OC: osteocalcin; 





1-3-3-5. Coffee, tea and caffeine 
 
The current Scientific Report of the 2015 Dietary Guidelines Advisory 
Committee in the U.S. (DGAC) has lifted coffee warnings for the general 
healthy populations. The guideline advised that moderate coffee or caffeine 
consumption (caffeine intake up to 400 mg/day) was not associated with major 
chronic disease risk, although the evidence in reducing risk of chronic diseases 
at this level of intake is less certain (203). For the bone, traditionally, the 
health concern of caffeine is a potentially deleterious effect in calcium balance, 
that caffeine may increase calcium excretion via decreasing renal reabsorption 
and intestinal absorption of calcium. Hence, if additional calcium intake is 
inadequate to compensate for the urinary loss of calcium due to caffeine 
consumption, high caffeine intake may affect bone loss (204). Experimental 
evidence is also in support of the detrimental influence of a high dosage of 
caffeine in the bones through increasing osteoclastogenesis via up-regulating 
RANKL and down-regulating OPG expression (205) or by activating 
p38 mitogen-activated protein (MAP) kinase to induce bone resorption 
markers, such as tartrate-resistant acid phosphatase (TRAP) and cathepsin K 
(206). In osteogenesis, caffeine was also found to reduce vitamin D receptor 
protein expression and vitamin D stimulated alkaline phosphatase activity 
(207) and to downgrade the expression of Cbfa1/Runx2, an essential 
transcriptional activator to the osteogenic lineage, to increase cyclic adenosine 
monophosphate (cAMP) to inhibit osteogenesis (208). By contrast, several 
recent studies showed that low to moderate dose of caffeine may enhance 
osteogenesis in cell culture model (209) and increase bone mass and strength 




effects of coffee may be attributable to the non-caffeine compounds, such as 
caffeic acid, chlorogenic acid, or trigonelline found in coffee (211, 212). 
 For tea, its bone beneficial effects were primarily attributed to (-)-
epigallocatechin-3-gallate (EGCG), a major catechin in tea. EGCG was found 
to increase osteogenesis in vitro (213), reduce bone loss (214) and improve 
microarchitecture (215) in ovariectomized rats. Similarly, polyphenols found 
in green tea was reported to improve bone microarchitecture through 
suppressing bone resorption (216). The postulated mechanism by tea 
polyphenols and EGCG in bone protection was suggested by suppressing 
matrix metalloproteinase (MMP), which was importation in bone matrix 
degeneration (217) or by inhibiting RANKL and thereby decreased gene 
expression of c-Fos and nuclear factor (NFATc1) of activated T-cells in the 
osteoclast precursors (218).   
In observational studies, three recent meta-analyses including studies 
up to February 2013 did not support the bone deleterious effect of coffee or tea 
drinking in risk of fractures, although stratified analysis by gender in these 
meta-analyses suggested a reduced risk in men but an increased risk in women 
between coffee consumption and fracture risk (219-221). Table 1-6 
summarizes the evidence from observational studies in the literature on coffee, 
tea and caffeine in relation to bone health. Among these studies, only three 
studies reported a bone favorable effect of coffee and bone mass (222-224), 
while the majority of the studies either suggested a negative impact of coffee 
on fractures or bone loss (225-229) or no association with bone outcomes 
(230-232). For tea, the bone favorable effect was found in some (233-236) but 




date has been conducted to assess the effect of caffeine or coffee on bone 
health.  
Taken together with the experimental and observational studies in the 
literature, it appears that studies incorporating different compounds in coffee 










Follow-up Time (years) 
Exposures Outcomes Effects  Main Findings 
Cross-sectional Studies 
Cooper et al. 
1992 (222)  
298 U.S. women 44-75 
years 
Coffee, tea and 
caffeine 
BMD of LS, femur 
and trochanter 
Positive: coffee 
No: tea, caffeine 
Drinking coffee was positively related to 
BMD of the femur vs. non-coffee 
drinkers. 
Hegarty et al. 
2000 (233)  
1,256 British women 
aged 65-76 years 
Tea 




Tea drinkers vs. non-drinkers had higher 
BMD of LS, trochanter and Ward's 
triangle. But no difference was found in 
FN BMD. 
Ilich et al. 2002 
(239)  
136 Caucasian women 
mean aged 68.6 years 
Caffeine, alcohol and 
smoking 
BMD of total body, 
LS, hip, forearm, 
and  trochanter 
Negative in subjects 
with Ca intake <750 
mg 
Daily intake of 200-300 mg caffeine was 
negatively related to BMD in all sites, but 
attenuated in subjects with ≥750mg of Ca 
at hip and trochanter. 
Case-control Studies 
Kreiger et al. 
1992 (237)  
534 Canadian 
postmenopausal women 
aged 50-84 years 
Lifestyle factors 
including coffee and 
tea 
Hip and wrist 
fractures 
No: coffee or tea 
Daily drinking ≥3 cups vs. <3 cups of 
coffee/tea was not related to hip or wrist 
fractures.  
Cumming et al. 
1994 (240)  
416 Australian men and 
women aged ≥65 years  
Lifestyle factors 
including caffeine 
Hip fracture No: caffeine 
No significant association was found 
between caffeine intake and hip fractures. 
Johnell et al. 
1995 (234)  
5,618 European women 
aged ≥50 years  
Lifestyle factors 





Drinking coffee was not related to hip 
fractures, while drinking tea was 





Suzuki et al. 
1997 (238)  
747 Japanese elderly 
aged ≥65 years 
Lifestyle factors 





Drinking ≥3 cups of coffee vs. non-
drinkers increased risk of hip fracture.  
Kanis et al. 1999 
(235)  
1,862 European men 
aged ≥50 years  
Lifestyle factors 





Drinking tea was related to significantly 
lower risk of hip fracture. 
Longitudinal Studies 
Kiel et al. (225) 
1990 
5,209 U.S. men and 
women aged 50-84 years 
/ 12  
Caffeine and coffee Hip fracture 
Negative: caffeine and 
coffee 
In men and women: Higher coffee (>2 
cups) and caffeine were related to 
increased hip fractures. 
Hernandez-
Avila et al. 1991 
(226) 
121,700 U.S. women 
aged 30 - 59 years/6y 
Caffeine, coffee, tea 
and caffeinated soda 
Hip fracture and 
forearm fracture 
Negative: coffee or 
caffeine 
No: tea 
Daily caffeine at top quintile (≥817mg/d) 
or ≥4 cups of coffee was related to 
increased risk of hip fracture.  
Cummings et al. 
1995 (241) 
9,516 U.S. white women 




Negative: caffeine per 
190 mg/day 
There was a statistically significant 
increased relationship between daily 
caffeine intake per 190 mg increase and 
risk of hip fracture.  
Harris et al. 
1994 (227)  
205 U.S. women mean 
aged 61 years / 1 y 
Caffeine from coffee, 
tea, cola and 
chocolates 
BMD/BMD change 
at spine and total 
body 
Negative: in women 
with low calcium 
intake 
Highest tertile of caffeine intake was 
related to bone loss in spine and total 
body among women whose calcium 
intake was below median; but no effect 
was found in women with calcium intake 
above median. 





1997 (228)  and women aged 43-66 
years/11 
including coffee intake in women 
No: in men 
coffee per day was related to increased 
risk. No association in other categories or 
in men. 
Hansen et al. 
2000 (231)  
 
34,703 postmenopausal 
U.S. women aged 55-69 
years/6.5  
Coffee, tea, cola and 
caffeine 
Total fractures and 
different site 
fracture 
Positive: caffeine in 
arm fractures; 
Negative: caffeine in 
wrist fractures; 
No: tea or coffee 
Greater caffeine intake was significantly 
related to higher risk of wrist fractures 
and negatively related to upper arm 
fractures. 
Hannan et al. 
2000 (230)  
1,132 U.S. men and 
women average aged 75 
years/4  
Risk factors including 
caffeine from coffee 
and tea 
BMD of FN, 
trochanter, WA, 
radius and LS. 
No: caffeine 
Caffeine intake was not associated with 
BMD changes. 
Hallstrom et al. 
2006 (229)  
31,257 Swedish women 
aged 40-76 years/10.3 
Coffee, caffeinated 
tea and caffeine Any fracture 
Negative: high coffee 
or caffeine intake in 
women with low 
calcium intake 
For those with calcium intake <700mg, 
the highest vs. lowest quintile of caffeine 
or daily drinking coffee of 4 cups vs <1 
cup/day was associated with increased 
fractures. 
Devine et al. 
2007 (236) 
Australian women aged 
70-85 years/5 
Tea 
BMD of total hip, 
FN, trochanter and 
intertrochanter. 
Positive 
Cross sectional: Tea drinking was 
positively related to higher hip BMD. 
Longitudinal: Tea drinkers relative to 
non-drinkers were negatively related to 
bone loss in total hip, FN, trochanter and 
intertrochanter. 
Trimpou et al. 
2010 (223)  
7,495 Swedish men aged 
46-56 years/>30 
Risk factors including 
coffee Hip fracture Positive 
Inverse relationship was found between 
coffee and risk of hip fracture across 1-2 








Hallstrom et al. 
2013 (224)  
 
 







Hip fracture, any 
fracture and BMD 
 
 




Drinking coffee ≥4 cups/d vs. <1 cup/d 
was related to lower BMD of LS and total 
body. Drinking coffee 1, 2-3, ≥4 cups per 
day was related to any fractures but a 
lower risk of hip fracture. 
Hallstrom et al. 
2014 (232)  
Swedish men 45-79 
years/11.2  
Coffee 
Hip fracture, any 
fracture 
No 
Drinking coffee ≥4 cups /d vs. <1 cup/d 
was not related to risk of hip or any 
fracture. 




1-3-3-6. Dietary patterns 
 
 Because potential bone beneficial nutrients and dietary factors are 
likely to interact and inter-correlate with each other (242), making it difficult 
or impossible to differentiate between them in the analysis, an evaluation of an 
overall diet and its impact on bone health and osteoporotic fractures is more 
sensible in practice and can provide a holistic perspective in the diet-hip 
fracture association.  
The primary findings from the observational studies examining the 
associations between dietary patterns and bone health (Table 1-7) showed that 
a diet that was rich in fruit and vegetables had favorable effects on bone mass 
or reduced fracture risk (243-247). Similarly, using a healthy dietary index 
such as the Dietary Approaches to Stop Hypertension (DASH) or the 
Mediterranean diet to assess the adherence to such index was also suggested to 
have bone beneficial effects (248-250). By contrast, unhealthy dietary patterns, 
such as a higher intake of processed food, sugar, refined starch, red meat, and 
high saturated fat (243, 244, 246, 251-253) was more likely to have negative 
impact on bone mass. Furthermore, studies also showed that dietary quality 
was inversely related to frailty in older men (254, 255) and women (255); and 
frailty was consequently an independent predictor for propensity of falls (256) 
and fracture risk (257, 258). These results suggest that healthful food groups, 
such as fruit, vegetables, and healthy protein sources from marine or plant 
sources, that are common in either a hypothesis driven (a healthy index) or a 
data driven (dietary patterns derived by factor analysis or principal component 
analysis) method may be responsible for fracture protection through its 




food groups and nutrients that are comprised in a healthy dietary pattern, 
characterized by a high intake of fruit, vegetables, marine or plant-based 
protein have been discussed in the earlier sessions on their possible 










Follow-up Time (years) 
Exposures Outcomes Effects  Main Findings 
Cross-sectional Studies 
Tucker et al., 
2002 (243) 
907 U.S. men and women 
aged 69–93 years 
6 dietary patterns  
BMD of FN, 
trochanter, WA 
and radius 
Positive: Fruit and 
vegetable pattern 
Negative: Candy 
No: other patterns 
In men: The “fruit and vegetable” pattern 
was positively related to hip and radius 
BMD. 
In both genders: The candy pattern was 
negatively related to WA, trochanter and 
FN BMD in men and negatively related to 
radius BMD in women. 
Hardcastel et al., 
2011(244) 
3,236 Scottish early 
postmenopausal women 
aged 50–59 years  
5 dietary patterns  
BMD of FN and 
LS; bone 
resorption 





foods, and snack food 
patterns. 
Processed foods and snack food patterns 
were negative associated with FN BMD. 
The “Healthy” pattern was associated 
with decreased bone resorption. 
McNaughton et 
al.2011 (246) 
527 Australian  women 
aged 18–65 years 
5 dietary patterns 
BMD of FN and 
LS; total body 
BMC 
Positive: a “healthy” 
pattern; 
Negative: a starch and 
meat pattern 
The high starch and meat pattern was 
inversely related to total body BMC. 
A pattern with rice, vegetable, fish, and 
legumes was positively associated with 
BMD and BMC. 





5 dietary patterns  
BMD of spine 
and FN 
Positive: Wine pattern 
Negative: a traditional 
English pattern 
The wine pattern was positively related to 
spine BMD. A traditional English pattern 







al. 2013 (250) 
933 Puerto Ricans aged 
47-79 years 
American Heart 
Association Diet and 
Lifestyle Score 
BMD of total 




Adherence to this dietary score was 
positively associated with BMD at all 
sites and inversely related to risk of 
osteoporosis and osteopenia. 




aged 45 years or over 
5 dietary patterns  
BMD of total 
body, LS,  hip 
and FN  
Negative: “Sweet 
foods, coffee and tea” 
pattern; 
No: other dietary 
patterns  
The “sweet foods, coffee and tea” pattern 
was inversely related to hip and total body 
BMD. 
Other patterns, including the “Healthy,” 
“Red meat and refined cereals,” “Low-fat 
dairy,” and “Western” patterns were not 
related to BMD.  
Shin et al. 2015 
(247) 
1,828  Korean middle 
aged men and women 
4 dietary patterns  
BMD of total 
body, LS, leg, 
arm and pelvis 
Positive: “Fruit, milk 
and whole grains” 
pattern; 
No: other patterns 
In men and women: the “Fruit, milk and 
whole grains” pattern was inversely 
related to lower BMD, while no 
relationships were found for other 
patterns, namely “Rice and kimchi,” 
“Eggs, meat and flour,” and “Fast food 
and soda.” 




aged 50-85 years 
3 nutrient patterns  
BMD of LS and 
FN 
Positive: Pattern with 
folate, total fiber, 
vitamins B6, A, C, K 
and potassium, β-
carotene, Mg, Cu, and 
Mn; No: other patterns 
The pattern with folate, fibers, vitamins 
B6, A, C, K and potassium, β-carotene, 
magnesium, copper, and manganese was 
positively related to BMD. Other nutrient 
patterns with high in vitamin B2, B12 and 
D, protein, calcium, phosphorus, zinc, and 





and other fatty acids but low in 
carbohydrate and vitamin B were not 
related to BMD. 
Longitudinal Studies 
Monma et al., 
2010(260) 
877 Japanese elderly 
aged 70 years or above / 
4 
Dietary patterns  fractures 
Positive: Meat pattern; 
Negative: vegetable 
pattern; No: traditional 
Japanese pattern 
A positive effect of meat pattern was 
found on fractures, while a negative effect 
on increased fractures was found in the 
vegetable pattern. 
Langsetmo et 
al., 2010 (251) 
6,539 Canadian men aged 
25-49 y and ≥ 50 y and 
pre- and post-menopausal 
women/5 
2 dietary patterns 






No: “nutrient dense” 
pattern 
The energy dense pattern was inversely 
related to FN BMD in older men and 
postmenopausal women. 
Langsetmo et 
al., 2011 (245) 
5,188 Canadian men aged 
≥50 y and 
postmenopausal 
Women /6.5 




dense” pattern  
No: “energy dense” 
pattern. 
The nutrient-dense pattern was inversely 
related to fracture risk in both genders 
with significant results found in women. 
Benetou et al., 
2012(249)  
188,795 European men 
and women with mean 
age 49 years /9 
Mediterranean diet 
with high fish and 
olive oil intake 
and low red meat 
intake" 
Hip fracture Modest effect in men 
In men, adherence with this diet had a 
marginal significant inverse relationship 





Samieri et al., 
2013 (261) 
1,482  French elderly 
men and women >70 
years /8 
3 nutrient patterns 
Fractures of 
wrist, hip and 
spine 
Positive: a pattern with 
Ca, P, B12, 
unsaturated fat and 
moderate alcohol; 
No: other two patterns: 
folate, retinol and B12; 
protein, fat, calcium 
High intakes of Ca, P, B12, proteins, and 
unsaturated fats and moderate alcohol 
were related to a lower risk of wrist and 
hip fractures. 
Intervention Studies or RCTs 
Lin 2003 (248) 
186 U.S. men and women 
aged 23-76 years 
Control or DASH 
(intervention group) 
diets with three 
different sodium level 
of 50, 100 and 150 
mmol/d for 30 days 
OC, CTx, PTH, 
urinary calcium 
Positive on bone 
turnover 
The DASH diet at different sodium levels 
significantly reduced serum OC and CTx 
compared with the control group. No 
difference in calcium or PTH was found 
between two groups. 
McTiernan et 
al., 2009(262)  
48,835 U.S. 
postmenopausal women 
50-79 years / 8.1 years 
Intervention (40% of 
women): A low-fat 
and higher intake of 
F&V and grain diet 
Control (60% of 
women): No dietary 
change 
Falls, BMD of 
hip, LS and total 
body, and  
fracture risk 
No: BMD or fracture 
risk 
Intervention group had lower risk of 
multiple falls but lower hip BMD at 3, 6 
and 9 years; no differences were found  in 
fracture risk between two groups.  
 
BMD: bone mineral density; BMC: bone mineral content; CTx: carboxyterminal cross-linking telopeptide; (f) DPD/Cr: (free) deoxypyridinoline 





1-3-4. Body weight change  
 
Low body mass index (BMI<20kg/m
2
) is an established independent 
risk factor for hip fracture from a meta-analysis (263) as well as in this cohort 
(20). As another modifiable risk factor, weight management is also important 
to monitor for healthy aging. This is particularly interesting to study as weight 
loss during aging is common and may vary between men and women (264, 
265). Men often gain weight until about 55 years of age, while women may 
experience postmenopausal weight gain until 65 years old and then followed 
by weight loss later in life (266). The latter occurs in part due to the re-
distribution of the fat and lean mass, where lean muscle tissue is replaced by 
fat particularly abdominal fat (265). Several mechanisms have been proposed 
on weight loss in association with increased fracture risk. Because lean mass 
was related to muscle strength and an independent contributor to hip BMD 
(267, 268), decreased lean mass in men and women was associated with 
increased frailty (269). In addition, lower lean mass may also reflect reduced 
level of testosterone in men (270, 271).  Hence, weight loss resulting 
decreased muscle mass may play a more important role in men than in women. 
In women, genetically they have more fat tissue as compared to men, thus 
weight loss is more involved in fat mass loss, which can contribute to a further 
decline of estrogen during menopause (272, 273). Collectively, weight loss 
contributes to bone loss and increased fracture risk in both sexes. Conversely, 
the relationship between weight gain and bone health is less straightforward. 
As BMD is positively related to BMI (274), weight gain may favor bone 
health by increasing weight bearing, mechanical loading and soft tissue 




gain in overweight or obese individuals may also increase risk of 
cardiovascular disease and type 2 diabetes, both of which are risk factors for 
fractures (277, 278). More recently, obesity and morbid obesity were 
suggested to have adverse associations with fracture risk (279, 280). Although 
there was an inverse relationship between BMI and fracture risk compared to 
normal weight (BMI=25kg/m
2
), such relationship became positive at BMI >30 
kg/m
2
 after adjusted for BMD (263). Some but not all observational studies 
have shown that obese postmenopausal women had a higher risk to develop 
fractures in the ankle, humerus, and lower and upper limb but not in the hip 
(281-283), while obese men had a higher risk to develop hip fracture 
compared to non-obese individuals (284). There are several speculations to 
explain why obese older adults may sustain higher fracture risk: Obesity was 
found to link with a higher frequency of falling due to reduced mobility, lower 
muscular strength, and abnormalities in muscle mass and function in a state of 
sarcopenic obesity. In addition, increased impact on the bones from a fall 
owing to a heavy body weight, lower circulating 25hydroxy vitamin D due to 
increased adiposity and decreased testosterone in obese men were also 
proposed to contribute to the adverse impact of obesity or morbid obesity 
(279-281) on fracture risk. All of these factors may thus increase fracture risk 
after extreme weight gain in older adults (274).        
Table 1-8 summarizes several longitudinal studies in the current 
literature. These studies are quite consistent in demonstrating weight loss as an 
independent risk factor for bone loss (285, 286) and fracture risk (286-295) in 
both men and women. Additionally, the intention of weight loss, either 




fracture risk (286, 295), although the association with risk of hip fracture was 
inconsistent. When baseline BMI was stratified, the results from three studies 
showed that weight loss ≥10% (288, 292) or ≥5% (286) was associated with 
significantly increased risk of hip fracture in all strata. In these three studies, 
the lowest BMI stratum was BMI<23kg/m
2
, it would be interesting to further 












Exposures Outcomes Effects  Main Findings 
Meyer et al. 
1995 (287) 
Norwegian  women 




Loss=3kg to gain of 
1.2kg, gain of 1.3kg 
to 5.5kg and gain 
≥5.6kg 
Hip fracture 
Positive: weight gain 
of 1.3-5.5 kg 
Negative: women 
who lost weight >3 
kg or gaining > 5.6 
kg. 
Women who lost >3 kg or gaining > 5.6 kg 
had a higher risk of hip fracture. 
Those gaining 1.3-5.5 kg had reduced hip 




3,683 U.S. women 
aged 67 years or 
above /8 
Weight loss in 
percent: weight loss 
≥10%, 5-<10%, 
stable weight: <5%, 






Both weight loss ≥10% was associated with 
increased risk and weight gain ≥10% was 
associated with decreased risk of hip fracture 
of borderline significance. 




65 years / 19.5  
months 





Per 10% loss in weight was associated with 




2,413 U.S. men 
aged 67 years men 
/8 
Weight loss in 
percent: weight loss 
≥10%, 5-<10%, 
stable weight: <5%, 







Both weight loss ≥10% was associated with 
increased risk and weight gain ≥10% was 






Meyer et al. 
1998 (291) 
Norwegian  women 
(n=19,938) aged 
48.6 years and men 
(n=19, 151) aged 
49.5 years /11.6 
 




weight change  
In both genders: Quartile (Q) 4 vs. Q1 weight 





women / 2.7 
 
Body weight change 




who lost weight 
≥5% 
Women who lost weight (≥5%) had higher FN 




2,180 U.S. women 









Weight loss ≥10% vs. loss<5% was associated 
with increased risk in women and similarly 
when stratified by age groups.  
Ensrud et al. 
2003 (286) 
6,785 U.S. elderly 
women/4.4 for 
BMD; /6.6 for hip 
fracture 
Weight loss >5%, 
stable weight 
(<5%), weight gain 










Weight loss was positively related to hip bone 
loss with the least loss in those who had 
weight gain.  
Weight loss as well as voluntary weight loss 










(gain: ≥10%, 5- 
<10%; stable 






who lost weight 
≥5% 
Women who lost ≥5% had a significant 
increased risk of fracture, which was 









Norwegian men (n= 
5,549) and women 
(n=5,428) aged 20 
to 54 years / 10 
 
BMI change -2, -1, 







Reduction in BMI (<2 kg/m
2
 vs. >1 kg/m
2
) 
was associated with increased nonvertebral 








Body weight change 
[≥5% for loss and 






of the upper and 
lower limbs, 





on sites. Positive: 
Intentional weight 
loss reduced hip 
fractures 
Weight loss was associated with higher risk of 
fractures in hip, upper limb and central body. 
Weight gain was associated with higher risk 
of fractures in upper and lower limbs.  
Compared to stable weight, 
unintentional weight loss was associated with 
higher risk of hip fracture and 
vertebral fracture, while 
intentional weight loss was associated with 





1-3-5. Bone turnover biomarkers 
 
  Hip fracture is the end-point measure for osteoporosis in this thesis. 
Although BMD was not measured in the cohort, the idea was to use a non-
invasive and easily measured bone surrogate markers to assess its 
predictability to risk of hip fracture. Because BMD only represents one of the 
risk contributors to osteoporotic fractures, disruption of bone 
microarchitecture or alteration in the amount and variety of proteins in bone 
can still increase the risk of fractures (296). In addition, studies showed that 
the proportion of fractures attributable to osteoporosis as solely defined by a 
BMD T-score of ≤−2.5 is 50% or less (6). Hence, an alternative marker to 
predict fractures may improve the predictability in additional to using BMD. 
Bone turnover biomarker (BTM) is one important bone surrogate marker that 
plays an important role in bone architectures, the degree of mineralization and 
mechanical resistance (Figure 1-3) (25). Therefore, BTM has potential of the 
applicability in fracture prediction (297, 298).  
BTMs reflect bone remodeling and thus reveal the metabolic activity 
of the bone (298). In normal healthy adults, bone remodeling is balanced so 
that bone mass is maintained. During aging, bone turnover is activated 
frequently, where bone resorption is faster than formation and thereby creates 
an unbalanced bone remodeling, which is the underlying mechanism of bone 
loss leading to fractures (25). The currently established BTMs mostly reflect 
the function of osteoblast or osteoclast (299) and many of them are related to 
the synthesis or degradation of type I collagen, enzymes found in the bone 








[Figure was adapted from Devogelaer et al. Rheum Dis Clin N Am (2011) 
(25).] 
 
The common bone formation markers include bone-specific alkaline 
phosphatase (BAP), an enzyme that is important in the formation of osteoid 
and bone mineralization (300); osteocalcin (OC), a bone-specific protein of 
the matrix and considered as a specific marker of osteoblasts (301); and 
amino-terminal propeptide of type I procollagen (P1NP), a precursor of bone 
collagen synthesized by osteoblasts (302). Bone resorption markers include 
degradation products of type I collagen, such as carbon-terminal peptide of 
type I collagen (CTx) and telopeptides of collagen crosslinks (NTx), that 
represent the carboxy- and amino-terminal cross-linked telopeptide of type I 
collagen, respectively (303), hydroxyprolin, pyridinium crosslinks 
(pyridinoline, deoxypyridinoline), osteoclast enzymes such as phosphatase and 
cathepsin K, and 5b isoenzyme of tartrate resistant acid phosphatase 
(TRACP5b). Recently, a joint effort by the International Osteoporosis 




Laboratory Medicine (IFCC) recommended using serum P1NP and serum 
CTx as reference BTMs for fracture risk prediction (298).  
Earlier epidemiologic studies have suggested using BTM as an 
independent risk factor for osteoporotic fractures (304, 305). Table 1-9 
summarizes these findings. These studies demonstrated a positive relationship 
of BTM with fracture risk, although the results varied depending on the 
specific bone turnover biomarker(s). More importantly, several studies have 
shown an independent relationship between a significant BTM and fracture 
risk after adjustment for BMD (306-309) or hormonal levels (309). However, 
a study among U.S. elderly men did not support the independent effect of 
BTM on fracture prediction, because the association was attenuated and 
became non-statistically significant after controlling for BMD (310). Among 
these studies, only 2 studies were conducted in Japanese elderly women (307, 
311) while other studies were primarily conducted in Caucasian populations. 
Both of the Japanese studies suggested that BTM was positively related to 
fracture risk (307, 311) and independent of BMD (307). Further, more data are 
needed in other ethnic groups, particularly to evaluate the predictability of two 









Follow-up Time (years) 
Exposures Outcomes Effects  Main Findings 
Cross-sectional Studies 
Zhao et al. 2011 
(312) 
1,724 Chinese 




BMD of LS, 
and total hip; 
Fractures 
Yes: serum CTx was 
related to increased  
fracture risk 
Negative correlation was found between 
serum CTx or P1NP and BMD.  
Women with fractures had significantly higher 
CTx compared to controls.  




Serum OC, P1NP 
and CTx 
 




All BTMs were negatively correlated with 
BMD at all sites. 
Longitudinal Studies 
Tamaki et al. 
2013 (311) 
 522 Japanese 
postmenopausal women / 
10 
Serum OC, BAP 
and urine CTx,  
tDPD and fDPD 
Vertebral  
fractures 
Yes: BAP, tDPD and 
fDPD 
In postmenopausal women over 5 years 
menopause, BAP, tDPD, and fDPD were 
positively related to fracture risk. 
Szulc et al. 1993 
(314) 
195 French women aged 




Hip fracture Yes: OC OC was positively related to hip fractures. 
Garnero et al. 
1996 (306) 
French women aged ≥74 
years in a nested case-
control study (case=160, 
control=480) / 22 months 
Serum OC, BAP, 
and urinary CTx, 
NTx and f D-Pyr 
Hip fracture  
Yes: CTx, D-Pyr 
No: BAP, OC, NTx 
CTx or D-Pyr was positively related to hip 
fractures independent of BMD. Combining 
low BMD and CTx or D-Pyr had a better 
prediction for hip fracture as compared to 





Vergnaud et al. 
1997 (307)  
Japanese women aged 
≥74 years in a nested 
case-control study 
(case=109, control=255) / 
22 months 
Urine OC Hip fracture  Yes:  OC 
OC was positively related to hip fracture 
independent of BMD.  
Chapurlat et al. 
2000 (315)  
French women aged ≥75 
years in a nested case-
control study (case=212, 
control=642) / 3.3 
Urinary and serum 
CTx, urinary f D-
Pyr 
Hip fracture  Yes: CTx, FD-Pyr 
Both serum and urine CTx and f D-Pyr were 
related to hip fracture risk. 
Bauer et al. 2009 
(310)  
5,995 U.S. men aged >65 
years for hip BMD; BTM 
were measure in  384 
fracture cases and  







Yes: P1NP, CTx (partly 
explained by BMD) 
No: TRACP5b  
P1NP or CTx was related to fracture risk but 
the relationship was attenuated after 
adjustment for BMD. 












Yes: BAP and CTx 
Both BTMs were significantly related to 
fracture risk. The relation is independent of 
BMD.  
Garnero et al. 
2000 (309)  
French women aged 50–
89 years in a nested case-
control study (case=55, 
control=380) / 5 
Urinary and serum 
CTx, urinary f D-
Pyr and serum 
BAP, P1CP, P1NP 
Osteoporotic 
fractures 
Yes: BAP and CTx 
BAP and CTx were significantly related to 
fracture risk. The  relationship remained 
statistically significant after adjustment for FN 
BMD or hormones including estradiol, SHBG 
and PTH 





Tromp et al. 
2000(316)  
348 Dutchwomen aged 
≥70 years / 5 
 







Yes: NTx for 
nonvertebral fractures 
No: OC, BAP, 
hydroxyproline, NTx for 
hip fractures 
Urinary NTx was significantly related to 






mean aged 62 years / 9.1 





No: OC, CTx 
Serum BAP was a significant risk factor for 
fragility fracture.  
Ivaska et al. 
2010 (318)  
1,040 Italian women aged  
75 years / 9 
Serum TRACP5b, 
CTx, OC, BAP, 





Yes: TRACP5b, CTx, 
OC, BAP 
High level of serum TRACP5b and CTx was 
associated with fracture risk up to 9 years of 
follow up. OC and BAP were associated with 
fracture risk up to 7.5 years. 
 
BAP: bone-specific alkaline phosphatase; BMD: bone mineral density; BTM: bone turnover biomarker; CTx: carboxyterminal cross-
linking telopeptide; (t) (f) DPD/Cr: (total) (free) deoxypyridinoline cross-links/Creatinine; free D-Pyr: free deoxypyridinoline; FN: 
femoral neck; LS: lumbar spine; NTx:  telopeptides of collagen crosslinks; OC: osteocalcin; P1NP: procollagen type I; TRACP5b: TRAP: 




Chapter 2. Specific aims of the study 
 
2-1. Research gap 
 
Asia hosts more than half of the world's population, where geographic, 
socio-economic, cultural, and religious factors vary considerably from those in 
the West. However, there is a dearth of epidemiology and clinical studies of 
osteoporosis and related fractures in Asia. This is despite 50% of the total hip 
fracture cases projected to happen in Asia by year 2050, which would create 
enormous economic burdens and substantially impact the quality of life among 
elderly throughout the region. Thereby, a greater emphasis towards 
osteoporosis and fracture prevention among Asian populations is critical 
within the next two to three decades. Particularly, there are very few 
population-based prospective cohorts studying risk factors including bone 
turnover biomarkers for incident hip fractures.  
Osteoporosis due to post-menopause is the main cause that drives the 
discrepancy between men and women in this disease. But it is still unclear 
how sex may play a role in interacting with other risk factors in the 
development of osteoporotic fractures. Hence, sex is the primary effect 
modifier in this thesis to explore the possible interactions in the relationship 
between the risk factors of interest and incident hip fractures. In addition, 
Asians have relatively low BMI compared to Western populations, yet low 
BMI<20kg/m
2
 is a risk factor for hip fracture development; and limited data is 
available in assessing the possible interaction between different risk factors 
and BMI in the contribution of fracture risk in a leaner population. 




derive dietary patterns and a healthy eating index in the evaluation of the 
association between overall diet and subsequent risk of hip fracture are 
another novelty in methodology in this thesis.  
In the Singapore Chinese Health Study, dietary intake of calcium and 
vitamin D is low. One explanation for this is the low intake of dairy products 
and uncommon use of vitamin supplementation in this study population. 
Furthermore, previous report from this cohort suggested that majority (86 %) 
of the subjects had 25(OH)D concentrations ≥50 nmol/l and 32% had ≥ 75 
nmol 25(OH)D (319). This suggested that participants in this cohort had 
sufficient serum vitamin D level, which was likely due to adequate sun 
exposure since there is 12-hour sun light through the year in Singapore. In 
addition to dietary intake of calcium, vitamin D, other potentially beneficial 
nutrients for bone health, such as vitamin C and E, potassium, magnesium, 
long-chain omega-3 fatty acids and protein were not associated with risk of 
hip fracture in men or women in this cohort. Hence, the following 
determinants were examined and comprised the specific aims for this thesis in 
this thesis. In addition, the impact of body weight change in a lean population 
whose majority had normal or underweight had never been examined. Further, 
data is scanty in the prospective relationship between bone turnover 
biomarkers and risk of hip fracture; therefore, a panel of 5 BTMs including the 
two analytes recommended by the IOF and IFCC were first examined in an 
Asian population.  





1. The association between dietary intake of B vitamins and risk of 
hip fracture (Chapter 4) 
2. The association between dietary intake of carotenoids and risk of 
hip fracture (Chapter 5) 
3. The association between dietary intake of coffee, tea and caffeine 
and risk of hip fracture (Chapter 6) 
4. The association between dietary patterns and risk of hip fracture 
(Chapter 7)  
5. The association between body weight change and risk of hip 
fracture (Chapter 8) 
6. The association of bone turnover biomarkers with risk of hip 




Chapter 3. General methods 
 
 In the Singapore Chinese Health Study, dietary information is available 
only at baseline (1993-1998). Hence, dietary exposures and the relevant 
covariates were recorded or derived from the food frequency questionnaire 
(FFQ) at baseline. Body weight change was based on the difference of the 
self-reported weight collected at the baseline and the follow-up assessments. 
Serum levels of bone turnover biomarkers were measured from the 
biospecimens collected during 1994-1999 and 2000-2005 prior to the hip 
fracture incidence occurred. The cut-off point for hip fracture incidence is 
from baseline (1993-1998) (Chapters 4-7), the follow-up assessment (1999-
2004) (Chapter 8), or biospecimen collection (1994-1999 and 2000-2005) 
(Chapter 9) until 31 December 2010 for all of the study aims.   
3-1. Study population  
 
All study aims were achieved by using the data in the Singapore 
Chinese Health Study, a population-based prospective cohort that was 
established to investigate diet, lifestyle factors, and risks of cancer and other 
chronic diseases (320). At recruitment between April 1993 and December 
1998, 63,257 Chinese men (n=27,959) and women (n=35,298) aged 45–74 
years, who resided in the government housing estates in Singapore were 
enrolled in the cohort study. During the enrolment period, 86 % of the 
residents in Singapore were living in these housing facilities. Thus, our study 
population represents the majority of the population of middle-aged and 
elderly in Singapore. The recruitment criteria also limited to two major dialect 




Fujian and Guangdong respectively in Southern China. Because of the number 
of the Hokkiens were 2.5 times of the Cantonese in Singapore, more Hokkiens 
than Cantonese were recruited. There were 15,617 (24.7%) Hokkien men, 
18,356 (29.0%) Hokkien women, 12,342 (19.5%) Cantonese men, and 16,942 
(26.8%) Cantonese women (320) in the Singapore Chinese Health Study 
cohort. This study was approved by the Institutional Review Board at the 
National University of Singapore. All of the participants provided written 
informed consent. 
3-2. Baseline assessment of diet and other covariates 
 
Baseline assessment was conducted through a face-to-face structured 
interview during the initial enrolment. Information was recorded by a trained 
interviewer using a structured questionnaire including demographics, medical 
history, tobacco smoking, alcohol consumption, usual habitual diet in the past 
year, physical activity, and detailed menstrual and reproductive history 
(women only). For cigarette smoking, participants were asked six questions on 
the length of time in ever smoking, the age beginning to smoke, the length of 
time in smoking cessation and the number of cigarettes smoked per day. For 
alcohol consumption, participants were asked the frequency of drinking each 
of the 4 types of alcoholic beverages: beer, wine, western hard liquor, and 
Chinese hard liquor. The physical activity portion of the questionnaire was 
modeled after the physical activity questionnaire used in the European 
Prospective Investigation in Cancer (EPIC) study, which has been shown to be 
valid and reproducible (321).  





 Habitual dietary intake during the past year at enrollment was recorded 
using a 165-item semi-quantitative validated Food Frequency Questionnaire 
(FFQ) to estimate consumption of foods and nutrients among all participants. 
The development of the structured quantitative FFQ was based on a pilot study 
of two 24-hour dietary recalls on a weekday and a weekend day among 200 
middle-aged and elderly Chinese housing estate residents (50 per gender per 
dialect group) in 1992. Standard recipes were developed based on the 
commercial cookbooks, home-made mixed dishes were estimated by local 
dietitians, and Hawker foods were estimated by direct weighing to determine 
the quantity of the food ingredients. Based on the estimated food intakes 
obtained from the pilot study, 165 food and drink items were identified and 
covered both single food items and mixed food dishes (320).  
3-2-2. Quantification and estimation of nutrients – The Singapore Food 
Composition Database 
 
The Singapore Food Composition Database was developed specifically 
for this cohort study and listed 96 nutritional and non-nutritional values per 
100 grams of the edible raw and cooked foods. The foundation of the food 
database was developed heavily based on the nutritional datasets published by 
the Department of Agriculture in the U.S. and also referenced from food 
composition tables from China, Malaysia and Taiwan. For the local common 
vegetables and soy products, laboratory measurements were performed by 
measuring the common cooked food items for the specific nutrient to 
determine the level of carotenoids, tocopherols, isoflavones and 




3-2-3.Validation of the FFQ 
The FFQ was subsequently validated among a subset of 810 random 
participants, to compare dietary intakes by 24-hour recalls on two different 
occasions and re-administration of the FFQ two months afterwards in 1994-
1997. The validation study showed similar distributions for all obtained food 
items and nutrients between the mean of the 24-hour recalls and the FFQ, with 
most mean pairs for energy and nutrients within 10% of each other’s values. 
For each dietary component, the correlation coefficient between the two food 
record methods was compared using three definitions developed by Walter 
Willet (322): 1) absolute intake by weight, 2) nutrient density by weight per 
1,000 kcal, and 3) calorie-adjusted nutrient value based on the residual method. 
The correlation coefficient for each dietary component ranged between 0.24 
and 0.79. This range of correlation coefficient was comparable to another 
validation study, the Hawaii-Los Angeles Multiethnic Cohort Study. For 
example, the correlation coefficient for β-carotene per 1,000 kcal was 0.59 and 
0.37 for Cantonese men and women respectively; and 0.49 and 0.59 for 
Hokkien men and women respectively. To estimate intakes of nutrients from 
the data obtained via the FFQ, we adapted different methods to obtain the 
dietary intake as accurate as possible. Taking dietary soy for example, total 
soy protein intake was the summation of the protein contents of soy foods 
listed in the FFQ. In addition, the concentrations of genistein, daidzein, and 
glycitein were measured in market samples of common soy foods in Singapore; 
thus, the dietary intake of soy isoflavone for a given participant was computed 
based on the summation of the genistein, daidzein, and glycitein content of all 




3-2-4. Dietary information at baseline 
 
Dietary information for each participant was only available at baseline. 
An in-person interview was performed to record habitual dietary intake in the 
past year using the 165-item semi-quantitative and validated FFQ as 
mentioned above. For each food item, consumption frequency as well as 
portion sizes were provided by each participant.  There are eight different 
frequency levels for solid foods, from “never to hardly ever, once a month, 2-3 
times a month, once a week, 2-3 times a week, 4-6 times a week, once a day to 
2 or more times a day” and nine consumption levels for beverages, from 
“never to hardly ever, 1-3 times a month, once a week, 2-3 times a week, 4-6 
times a week, once a day, 2-3 times a day, 4-5 times a day to 6 or more times a 
day.” Three portion sizes are provided for each food item: a number-based 
portion size is used for items that can be easily counted and for most food 





 (medium), and 85th (large) percentiles of the food amount from 
the pilot data for the development of the FFQ (320).  
3-3. Case ascertainment 
   
Hip fracture cases were identified using the ninth revision of the 
International Classification of Diseases (ICD-9) code 820 via the record 
linkage with the hospital discharge database of the MediClaim System, which 
captures inpatient discharge information from all public and private hospitals 
in Singapore, and further verified manually by surgical notes or medical 
records. After excluding four cases of traumatic fractures from road traffic 
accidents and one case due to cancer metastasis in the femur, 1,733 hip 




2010. We further excluded 103 prevalent cases of hip fracture that occurred 
before the cohort enrollment for these participants. As of December 31, 2010, 
only 47 participants (0.7%) from this cohort were known to be lost to follow-
up due to migration out of Singapore or for other reasons. All vital statistics 
were ascertained through record linkage with the population-based Singapore 
Registry of Births and Deaths. Hence, 1,630 incident hip fracture cases and 
61,524 participants without fractures were included in the final analysis for the 
aims on dietary determinants (Figure 3-1).  
Figure 3-1. Flow chart of the participants included for Chapters 4-7
 
 For body weight change in relation to hip fracture risk (Chapter 8), 
because change of body weight was based on the self-reported weight at both 
of the baseline (1993-1998) and the follow-up (1999-2004) assessments; and 
hip fracture incidence was counted from the follow-up assessment (1999-2004) 





included in the final analysis with 775 incident cases of hip fracture (Figure 3-
2). For the study of bone turnover biomarkers, 50 hip fracture case-control 
(1:1) sets per gender were randomly chosen among the cases who donated 
blood before hip fracture. For each case and control sets, they were matched 
for gender, age at study enrollment (±3 years), dialect group (Hokkien, 
Cantonese), date of study enrollment (±2 year), and date of biospecimen 
collection (±6 months). In addition, the selected controls must not have any 
fracture at the time of the fracture index case. More detail on the selection of 
cases and controls can be found in Methods in Chapter 9. 
Figure 3-2. Flow chart of the participants included for Chapter 8 
 
 
3-4. Statistical analysis   
Chapters 4-7 are focused on the dietary exposures of interest at 
baseline; person-years for each participant were counted from the date of 
baseline interview to the date of hip fracture diagnosis, death, migration, or up 
to 31 December 2010, whichever occurred first. For Chapter 8 on body weight 
 
Total participants at baseline  
(1993-1998) (n=63,257)  
 
Participants remained and 
completed the follow-up 
interview  (1999-2004) 
(n=52,322) 
Final analysis 


















Exclusion of  hip 
fractures prior to 
follow-up 
assessment 
(n=138)   
Exclusion of death, 
non-contactable, or 
unable to participate in 





change in relation to risk of hip fracture, person-years were counted from the 
date of the follow-up interview until 31 December 2010. And for Chapter 9, 
person-years were counted from the date of biospecimen collection to 31 
December 2010.  
To assess the association between each of the dietary factors and risk 
of hip fracture, Cox proportional hazards multivariable model was applied to 
estimate the relative risk by hazard ratios (HRs) and its corresponding 95% 
confidence intervals (CI), to compare a higher quartile/quintile intake level of 
the dietary factor relative to the lowest quartile/quintile intake level (except for 
coffee, tea and caffeine). Because dietary intake of coffee, tea and caffeine is 
not necessarily dependent on energy intake, absolute intake for coffee, tea and 
caffeine was used to categorize consumption in the analysis. The cut-offs for 
the quartiles/quintiles (using nutrient density method for nutrients) were based 
on the combined distribution of men and women in the whole cohort. In this 
thesis, nutrient density method was used rather than the residual method, in 
which nutrient intake is divided by total energy intake. The rationale to choose 
the nutrient density method is that this method is rather intuitive compared to 
the residual method. For example, nutrient density can be easily calculated 
directly for an individual without the use of any statistical models; its format is 
familiar to nutritionists as a measure of dietary composition. Furthermore, 
both earlier papers on energy adjustment methods for nutritional epidemiology 
(322, 324) comparing between the residual and nutrient density approaches 
concluded that both methods yielded closely similar results when an exposure 
variable is categorical. Nevertheless, the results were essentially unchanged 




To test the Cox proportionality assumption, the Schoenfeld residuals 
were examined by plotting a predictor (exposure of interest) against the 
follow-up time using “proc sgplot” and adding a loess curve to assess whether 
there was any relationship between the predictor and follow-up 
time. Alternatively, a cross product term for a predictor*log (follow-up time) 
was entered into the Cox model. If the interaction term was statistically 
significant (p<0.05), the proportionality assumption was not held. To test 
multicollinearity, all of the predictors were entered in a regression model. If 
the condition index was over 15 or the variance inflation factors (VIF) > 2.5 
(i.e. the tolerance < 0.4), multicollinearity was a concern.  
3-4-1. Covariates in the multivariable models 
 
The covariates that were selected for the full model were previously 
published risk factors for hip fracture in this cohort, including soy isoflavones 
(20) and diabetes mellitus (278), clinical risk factors and potential confounders. 
Confounding was evaluated by whether the covariate was related to exposure 
and outcome or inclusion of the covariate in the model would affect the effect 
size by at least 10%. Thus, the common covariates that were adjusted for 
included age (continuous), year at recruitment (1993–1995 and 1996–1998), 
dialect group (Hokkien, Cantonese), level of education (no formal education, 
primary school, secondary school or higher), BMI (<20, 20–23.9, 24–
27.9, >28 kg/m
2
), smoking status (never-smokers, ex-smokers, current 
smokers), moderate physical activity (none, 0.5–<4 hours/week, ≥ 4 
hours/week), baseline self-reported physician diagnosed history of diabetes 
mellitus (yes or no) and stroke (yes or no), menopause status (women only; 




only; yes or no). The rationale for the covariates included in the full model is 
explained as follows: Age (years), gender (whole cohort), and smoking status 
are clinical risk factors for hip fracture. Adjustment for year of recruitment 
minimized the systematic errors regarding subject enrolment in the study 
during a different time period. Dialect group was a recruitment criterion. In 
addition, Cantonese men appeared to have lower hip fracture risk than the 
Hokkien men (p<0.04). Level of education was related to participants’ socio-
economic status; those with higher education also tend to have a lower 
incidence of hip fracture. Both menopause and current use of hormone 
replacement (HRT) (women only) are risk factors for hip fracture due to the 
important physiological role of estrogen in postmenopausal osteoporosis. 
Other specific covariates were also adjusted for to reduce potential 
confounding effects, which were explained in the specific chapter.  
All statistical analysis was conducted using SAS Version 9.2 (SAS 
Institute, Inc., Cary, NC). All reported p values are two-sided; p<0.05 was 




Chapter 4.  Dietary intake of vitamin B in relation to 
risk of hip fracture 
[This chapter is primarily based on the published paper in Osteoporos Int 
(2013) 24:2049–2059. Dai et al. (121) ] 
 
4-1. Background 
 B vitamins have been recently investigated for their possible roles in 
maintaining bone health and fracture prevention. Most of the observational 
studies focused on the B vitamins that are cofactors involved in the one-carbon 
metabolism (325). However, each of the B vitamins has other physiologic 
roles as well. Cobalamin (vitamin B12) was first revealed to be related to 
osteoporosis and fractures in patients with pernicious anemia (136, 137), 
although cobalamin may directly impact osteoblastic (138) and osteoclastic 
(123) activities in vitro. Folate (vitamin B9) can indirectly affect bone 
remodeling because of its involvement in intracellular DNA methylation (326). 
Resorption activity was found to be increased in folate-deficient osteoclasts 
(123). Evidence from embryotic chicks showed that pyridoxine (vitamin B6) 
is a cofactor of lysyl oxidase (113), which is an essential enzyme to collagen 
cross-linking formation. Other animal studies also suggested that pyridoxine 
may play a role in bone formation (117). In contrast, results from 
epidemiologic studies on the relationship between B vitamins and osteoporosis 
or osteoporotic fractures were inconsistent, and almost all of these studies 
have been conducted in the Western populations (119, 120, 132, 145). 
Furthermore, evidence on the other B vitamins (thiamin, riboflavin, and niacin) 
is sparse. For example, a study among othopedic patients reported that thiamin 




among those with total hip replacement (98); riboflavin (vitamin B2) and its 
photoderivatives were shown to enhance bone formation in vitro (102); and 
high level of niacin (vitamin B3) was reported to have adverse effects on bone 
strength and growth in chicks (107). Thus far, there is no single epidemiologic 
study assessed the association between all of these B vitamins and fracture risk 
using prospective data from a population-based cohort. There is a rapid 
increase in incidence of hip fracture in Asia, and up to 50 % of total cases by 
year 2050 are projected to happen in this part of the world (8). Asian 
populations are known to have distinct dietary and lifestyle factors from their 
Western counterparts (320). However, prospective evidence on the association 
between B vitamins and hip fracture risk is lacking among Asian populations. 
Hence, the objective of this aim was to examine the relationship between 
dietary intakes of B vitamins (thiamin, riboflavin, niacin, pyridoxine, folate, 
and cobalamin) and risk of hip fracture among middle-aged to elderly Chinese. 
4-2. Methods 
 
 Study populations, baseline exposure assessment and case 
ascertainment have been described in Chapter 3.  
Statistical analysis 
 
 Chi-square test was used for categorical variables and Student’s t test 
was for continuous variables to examine the difference in distributions of 
baseline characteristics between cases and non-cases. For each study subject, 
person-years were counted from the date of baseline interview to the date of 
hip fracture diagnosis, death, migration, or the end of follow-up up to 31 
December 2010, whichever occurred first. As of 31 December 2010, only 47 




due to migration out of Singapore or for other reasons. Cox proportional 
hazards model was applied to assess the association between baseline dietary 
intake of B vitamins and hip fracture risk by comparing higher quartile intake 
levels of the nutrient relative to the lowest quartile intake level (327). 
Quartiles of intake for each energy-adjusted nutrient were based on the 
combined distribution of men and women in the whole cohort. The strength of 
the association between B vitamins and hip fracture risk was measured by 
hazard ratios (HRs) and its corresponding 95% confidence intervals. To 
examine linear trend, ordinal values of the quartile intake of each vitamin B 
was entered as a continuous variable in the Cox proportional hazards model. 
We did not identify any violation of the proportional hazard assumption nor 
multicollinearity among the covariates that were entered in the models.  
We first assessed the association in a basic model which was adjusted 
for parameters that included age (continuous), body mass index (BMI), year of 
recruitment (1993 – 1995 and 1996 – 1998), dialect group (Hokkien, 
Cantonese), level of education (no formal education, primary school, 
secondary school or higher), and total energy intake. Adjustment for year of 
recruitment minimized systematic errors regarding subject enrolment in the 
study during a different time period. There was a suggestive difference in diet 
found between two dialect groups (320), thus dialect group was also adjusted 
in our models. Adjustment for total energy intake in addition to the energy-
adjusted vitamin B (exposure of interest) is based on the multivariate nutrient 
density model (322). The covariates selected for the full model, taking into 
account the previously published risk factors for hip fracture (20, 278), were 




outcome or if inclusion of the covariate in the model affected the effect size by 
at least 10 %. Established risk factors for hip fracture in this cohort included 
smoking status, BMI, calcium intake, soy isoflavone intake, and history of 
diabetes (20, 278). Hence, our final model included the following covariates: 
age (continuous), year at recruitment (1993–1995 and 1996–1998), dialect 
group (Hokkien, Cantonese), level of education (no formal education, primary 
school, secondary school or higher), BMI (<20, 20–24, 24–27.9, ≥28 
kg/m2), smoking status (never, ex-smokers, current smokers), moderate 
physical activity (none, 2-<4 h weekly, 4+ h weekly), calcium (quartiles, in 
milligrams/1,000 kcal/day), soy isoflavones (quartiles, in milligrams/1,000 
kcal/day), total energy intake (in kilocalories per day), menopausal status 
(women only; yes, no), ever use of hormone replacement therapy (HRT) at 
recruitment (women only; yes, no), and baseline self-reported physician-
diagnosed history of diabetes mellitus and stroke. Further adjusted covariates 
for potential confounding, one at a time or simultaneously, to evaluate if there 
was at least 10% change of effect size as compared to the full model were also 
considered: vitamin D from diet (in international units/1,000 kcal/day), protein 
intake (in grams/ 1,000 kcal/day), potassium (in milligrams/1,000 kcal/day), 
zinc (in milligrams/1,000 kcal/day), caffeine (in milligrams/ 1,000 kcal/day), 
magnesium (in milligrams/1,000 kcal/day), and at least weekly use of vitamins 
(yes, no). 
We also performed sensitivity analysis for the association of B 
vitamins with hip fracture risk, excluding those who had reported extreme 
energy intakes (≤600 and ≥3,000 kcal) from the whole cohort or excluding 






), and diabetes mellitus have been identified as independent risk factors 
of hip fracture in this cohort (20, 278) and also in systematic reviews of other 
studies (263, 328, 329), we investigated possible interaction effects of these 
factors in the association of pyridoxine with hip fracture risk. 
4-3. Results 
 
Baseline characteristics of the study subjects of fracture cases and non-
cases are described in Table 4-1. Fracture cases constituted 1.6% among men, 
as compared to 3.3% among women; women accounted for 72.4 % of all hip 
fractures. Among the 1,630 incident hip fracture cases, the mean time interval 
between cohort enrollment and hip fracture diagnosis was 9.9 [standard 
deviation (SD) 4.5] years. The mean age at fracture was 74.4 (SD 7.5) years. 
Women had double the incidence rates of hip fractures (234 per 100,000 
person-years) than men (123 per 100,000 person-years) within the cohort after 
adjustment for age using the age distribution of the entire cohort. Compared to 
non-cases, both men and women with hip fracture were older at recruitment, 
less educated, more likely to smoke, had lower daily energy intake, and more 
likely to have self-reported history of physician diagnosed diabetes mellitus or 
stroke at recruitment. Vitamin supplementation was not common in this 
population, in which about 5 % of men and 8 % of women taking vitamin 
supplements. To directly compare dietary intakes of vitamins and minerals 
between cases and non-cases for both genders, these nutrients were presented 
after adjustment for total energy intake. Calcium intake was similar between 
cases and non-cases in either gender. Among women, hip fracture cases had 
lower dietary intake of vitamin D and soy isoflavones. For men, hip fracture 




recruitment compared to non-cases. For women, more cases were 
postmenopausal at recruitment relative to non-cases; use of hormonal therapy 
was uncommon and was only present in 4 % of women in the cohort. 
Average daily intakes of protein and B vitamins were compared 
between this cohort and those in the U.S. RDA (330). It appears that our study 
population had lower intakes of most B vitamins except cobalamin, and the 
most deficient nutrient was folate for both genders (Table 4-2). The top five 
food sources that contributed to each vitamin B in this cohort at the time of 
recruitment are described in Table 4-3. Grain products and animal meat were 
the common food sources for B vitamins in this cohort. Vegetable was the  
major food source for riboflavin and folate. There were weak to moderate 
correlations (range from 0.08–0.52) between intakes of individual B vitamins 
(Table 4-4). This result was expected as the sources of food for these B 
vitamins did not overlap considerably in this cohort.  
Tables 4-5a and 4-5b show the associations between dietary intake of 
B vitamins and risk of hip fracture in men and women separately. The results 
after further adjustment for other risk factors of hip fracture remained very 
similar as compared to the basic model. Among men (Table 4-5a), no 
significant association was found between dietary intakes of all of the B 
vitamins and hip fracture risk in both models. Among women (Table 4-5b), 
we observed a dose-dependent inverse relationship between dietary intake of 
pyridoxine and hip fracture risk (p for trend=0.002). Compared to the lowest 
quartile intake of pyridoxine (0.37– 0.61 mg/1,000 kcal/day), increasing 
dietary intake of pyridoxine across the higher quartiles reduced hip fracture 




fourth quartiles were comparable. The difference in risk estimates across 
quartile intakes was statistically significant between men and women (p for 
interaction=0.008). There was a weak positive association between dietary 
intake of thiamin and risk of hip fracture in women. However, further 
adjustment for other risk factors for hip fracture attenuated the association that 
became statistically non-significant. Riboflavin, niacin, folate, and cobalamin 
had null association with hip fracture risk in women. Further adjustment for 
vitamin D from diet (in international units/1,000 kcal/day), protein intake (in 
grams/1,000 kcal/day), zinc (in milligrams/1,000 kcal/day), caffeine (in 
milligrams/1,000 kcal/day), magnesium (in milligrams/1,000 kcal/day), and at 
least weekly use of vitamins (yes, no) did not change the effect estimate 
materially for pyridoxine (Supplemental Table 4-1). Adjustment for 
potassium (in milligrams/1,000 kcal/day) slightly attenuated the association 
between pyridoxine and hip fracture risk (p for trend=0.063). However, the 
change in the risk estimates was less than 10%. Compared to women in the 
lowest quartile of pyridoxine intake, HRs (95 % CI) for quartiles 2, 3, and 4 
were 0.84 (0.72 – 0.99), 0.82 (0.69 – 0.98), and 0.84 (0.68 – 1.03), 
respectively. The loss of statistical significance was attributable to widening of 
the confidence intervals due to certain degree of collinearity between dietary 
intake of potassium and pyridoxine (correlation coefficient=0.59). On the 
other hand, the moderate association between dietary potassium and hip 
fracture risk disappeared after adjustment for pyridoxine (p for trend=0.26). 
We further examined the association between dietary B vitamins and hip 




and the same covariates mentioned above. The results remained unchanged 
(Supplemental Table 4-2a and b). 
Sensitivity analysis for the B vitamin–hip fracture risk association 
after exclusion of participants with extreme energy intakes [≤600 (n=421) and 
≥3,000 (n=1,267) kcal] also yielded similar results (n=61,497). Results based 
on women who did not use any HRT were similar to those based on the entire 
dataset. There are very few HRT users (n = 1,301). As expected, after 
excluding women with history of HRT use, the effect estimate for pyridoxine 
and hip fracture risk among women without use of HRT (n=33,934, 
cases=1,169) yielded essentially the same result as compared to that as in 
Table 4-5b: Q2: HR= 0.82 (95% CI: 0.70- 0.95), Q3, HR= 0.78 (95% CI: 
0.67- 0.92), Q4, HR=0.78 (95% CI: 0.66- 0.92); p for trend=0.002. For women 
who were postmenopausal at recruitment, we had also computed years past 
menopause, because it might be possible that years past menopause has a 
bigger impact on hip fractures as compared to age alone for postmenopausal 
women. But our results suggested that age at recruitment [as a continuous 
variable, HR (95% CI): 1.15 (1.14, 1.16)] weighed more than years past 
menopause [as a continuous variable, HR (95% CI): 1.09 (1.08, 1.10)] after 
adjusted for the same covariates. When we replaced age at recruitment with 
years past menopause (the difference between age at menopause and age at 
baseline) for postmenopausal women in the model, the results remained 
essentially unchanged for the pyridoxine–hip fracture risk in women. The 
hazard ratios (95% CI) across quartile 2 to quartile 4 for pyridoxine and risk of 




0.77 (0.66–0.90), 0.72 (0.62–0.85), and 0.73 (0.61–0.86), respectively (p 
for trend <0.0001). 
 We further examined whether BMI and diabetes mellitus modified the 
protective effect of pyridoxine on hip fracture incidence in women (Table 4-6). 
When women were stratified by BMI <20 or ≥20 kg/m2, increasing pyridoxine 
intake was similarly associated with reduced risk of hip fracture for both 
groups of women with different BMI, although the test for trend was not 
statistically significant in women with BMI <20 kg/m
2
. The overall 
pyridoxine-hip fracture risk associations were comparable for both BMI strata 
(p for interaction=0.74). We also conducted stratified analysis for women by 
history of diabetes (Table 4-6). The reduction in hip fracture risk with 
increasing pyridoxine intake was primarily seen among women with no 
history of diabetes (p for trend = 0.0009). On the other hand, there was no 
association between dietary pyridoxine and hip fracture risk in women with 
history of diabetes (p for trend = 0.70). Diabetes significantly modified the 
protective effect of dietary pyridoxine intake on hip fracture risk (p for 
interaction = 0.04). 
 Finally, we also assessed other nutrients that may be associated with 
risk of hip fracture in the current study, and did not find significant 
associations with dietary intakes of protein, ω-3 fatty acids, vitamin D, 
calcium, zinc, or magnesium (Supplemental Table 4-3). 
4-4. Discussion 
 
To the best of our knowledge, this is the first prospective cohort study 
that most comprehensively explored the associations between different B 




study showed an inverse relationship between dietary intake of pyridoxine and 
hip fracture risk among elderly Chinese women. Other B vitamins, namely, 
thiamin (vitamin B1), riboflavin (vitamin B2), niacin (vitamin B3), folate 
(vitamin B9), and cobalamin (vitamin B12), did not show any associations for 
the risk of hip fracture. 
In the present study, we used nutrient density (energy-adjusted) for B 
vitamins to assess the B vitamin–hip fracture association, as we believe this 
is a more valid comparison between an Asian population and a Western 
population (320). When we compared daily average B vitamin intakes to those 
in several prospective studies from other Western populations regarding B 
vitamins and bone health, our study population had apparently lower intakes in 
B vitamins (103, 119). According to the US RDA (330), our study population 
consumed a diet with much lower B vitamins with the exception of cobalamin. 
In addition, B vitamin-fortified food or vitamin supplementation is uncommon 
in Singapore. These factors may explain why vitamin intake is lower in our 
cohort. 
Our finding on the association between intake of pyridoxine and 
reduced hip fracture risk is consistent with two recent population-based cohort 
studies, the Rotterdam Study (119) and the Framingham Osteoporosis Study 
(120). Yazdanpanah et al. (119) examined dietary intake of riboflavin, 
pyridoxine, folate, and cobalamin and found an inverse relationship between 
pyridoxine and fragility fractures as well as non-vertebral fractures among 
elderly Caucasians in Rotterdam. Similar to our findings, the Rotterdam Study 
did not find a statistically significant association between any of other three B 




B vitamins (pyridoxine, folate, and cobalamin) and homocysteine were 
quantified in elderly community-dwelling residents of Framingham. Using 
clinical cut points to define normal, low, or deficient vitamin status, those with 
deficient levels of pyridoxine had the greatest annual mean bone loss change 
and 73 % increased hip fracture risk as compared to those with normal levels. 
However, these risk estimates became attenuated and were not statistically 
significant after further adjusting for bone mineral density or homocysteine. 
This may suggest that the protective effect of pyridoxine on hip fracture could 
have been mediated via bone mineral density or the level of homocysteine 
(120). A Japanese cross-sectional study also supported our finding. Compared 
to age-matched postmortem controls, the authors found that women with 
intracapsular hip fracture had significantly lower plasma pyridoxal, higher 
plasma homocysteine levels, and reduced collagen cross-linking in high-
density bone (331). 
There are several potential mechanisms that pyridoxine may protect 
against hip fracture. One possible mechanism is that pyridoxine acts as a 
regulator of collagen cross-linking in bone via the expression of lysyl oxidase 
(113). Pyridoxine was shown to be an essential nutrient in collagen cross-
linking in chick bones (113). In addition, deficiency of pyridoxine decreased 
the activity of glucose-6-phosphate dehydrogenase in bone formation and 
callus in rats (117), suggesting that pyridoxine was important in fracture 
healing. In accordance, evidence from epidemiologic studies reported that 
patients with lower levels of pyridoxine had altered structural and 
biomechanical properties of femoral heads (122), reduced enzymatic cross-




Findings from the Rotterdam Study (119) and the Framingham Study (120) 
also showed that pyridoxine was associated with higher femoral neck bone 
mineral density. Furthermore, several animal studies suggested that pyridoxine 
could affect the central nervous system in rats or mice, which, in turn, affects 
the locomotor system (333), since pyridoxine is also an important coenzyme 
of the neurotransmitters γ-aminobutyric acid (333). Thus, deficiency of 
pyridoxine may also increase risk of falling and therefore risk of hip fracture. 
These experimental and observational evidences support our hypothesis that 
pyridoxine can affect fracture risk via its direct effects on bone and possibly 
affect the central nervous system to affect propensity to fall. 
Hyperhomocysteinemia has been shown to be a possible risk factor for 
osteoporotic fractures in recent epidemiologic studies (334). Since riboflavin, 
pyridoxine, folate, and cobalamin are involved in the one-carbon metabolism, 
which includes homocysteine degradation, it is biologically plausible that 
deficiency of any of these B vitamins may affect bone structure and 
mineralization. However, a previous study on a subpopulation (n=486) from 
this cohort showed that plasma folate had the strongest inverse relationship 
with homocysteine, followed by cobalamin, whereas pyridoxine exerted the 
weakest relationship (335). If homocysteine mediates the association between 
B vitamins and hip fracture risk, it is biologically plausible that folate would 
have the strongest protective relationship with hip fracture. Contrary to this, 
we did not observe an association between folate intake and hip fracture risk 
in either gender. Furthermore, several observational studies were unable to 
link elevated homocysteine with decreased bone mineral density (120, 336). A 




vitamin supplementation, which contained pyridoxine, folate, and cobalamin, 
did not affect bone turnover biomarkers (148). In line with these findings, the 
Rotterdam Study suggested that pyridoxine reduced hip fracture risk 
independent of homocysteine level (119). Hence, we conclude that the inverse 
association between pyridoxine and hip fracture risk may not be mediated via 
the effect of pyridoxine on homocysteine level. Unfortunately, we only had 12 
cases of hip fracture in the subpopulation with plasma homocysteine 
measurement. Therefore, we cannot further assess the interrelation among the 
one-carbon metabolic B vitamins, plasma homocysteine level, and risk of hip 
fracture in the current study. 
In this study, our novel finding that the protective effect of pyridoxine 
against hip fracture risk was limited to women supports the hypothesis of a 
gender-specific difference in bone degradation leading to fracture 
development. In the present study, we found that women, in general, have a 
twofold increase in risk of hip fracture compared to men, consistent with 
previous findings (337). Gender-specific difference for fracture risk has been 
attributed to differences in bone geometry and sex hormone deficiency (338). 
The rapid decrease of estrogen during the first decade after menopause has 
been postulated to lead to an accelerated phase of bone loss, followed by a 
slow and continuous phase during the later period (338). Following the 
evidence from several epidemiologic studies that reported a protective effect 
of pyridoxine on breast cancer in women (339, 340), experimental studies on 
cancer cells have suggested that pyridoxine may act as a regulator of steroid 
hormone, including estrogen, through its modulation of the transcriptional 




342). Since estrogen plays a substantial role in bone turnover (343) and 
pyridoxine may potentially modulate estrogen, this may explain why the 
protective effect of pyridoxine on hip fracture risk was observed only in 
postmenopausal women. 
Our previous study has shown a strong etiologic association between 
diabetes mellitus and increased hip fracture risk in the same cohort, where 
subjects with diabetes had about a twofold increased risk of developing hip 
fracture compared to those without diabetes (278). The present analysis 
suggests that pyridoxine appeared to have no protective effect in women with 
diabetes. Diabetes mellitus is known to influence hip fracture risk via 
alteration of bone turnover markers, mechanical deterioration, and decrease in 
bone strength (344, 345). We postulate that the protective mechanisms 
mediated by pyridoxine may not compensate for the aforementioned factors 
detrimental to bone health in patients with diabetes. Hence, the efficacy of 
pyridoxine in the prevention of hip fracture may be lost in women with 
diabetes. This hypothesis needs to be validated in further studies. 
The strengths of this study are its population-based design and the 
reduced likelihood of recall bias in exposure data, since they were obtained 
prior to hip fracture. Another strength is that case ascertainment through 
linkage with the nationwide hospital database can be considered complete, as 
Singapore is a small city-state with a system for easy access to specialized 
medical care, and practically all hip fracture cases would seek medical 
attention immediately and be hospitalized. The information from the database 
also allows us to differentiate prevalent cases from incident cases using the 




fracture. Food is not commonly enriched with micronutrients in Singapore. 
Hence, folate fortification won’t complicate our computation of folate intake 
in this study population.   A major limitation of this study is that dietary intake 
of B vitamins was recorded using a food-frequency questionnaire and diet 
assessment only at study recruitment. Dietary changes over time after baseline 
interview may lead to non-differential misclassification of intake, which 
would result in an underestimation of the true effect size of dietary pyridoxine 
and other B vitamins examined on hip fracture risk. Bone mass density (BMD) 
was not available at baseline measure, which could be viewed as a limitation. 
However, if low BMD is a physiological marker leading toward hip fracture, it 
may not confound the association between pyridoxine intake and risk of hip 
fracture. According to the WHO criteria, osteoporosis is defined as a BMD 
that lies 2.5 standard deviations or more below the average value for young 
healthy women (a T-score of ≤ -2.5 SD). A recent report on a consensus 
statement on the diagnostic criteria for severe osteoporosis in real-life clinical 
setting, stated that a large number of fractures occur in subjects with T-score 
above –2.5 [46]. This concurs with a recent WHO report that “the majority of 
osteoporotic fractures will occur in individuals with a negative test” for BMD 
(346). As both the components of the macro- and microarchitecture of bone 
influence bone strength, bone mineral density represents only one of the 
contributors to osteoporotic fractures. Even if bone mineral density is within 
acceptable range, disruption of bone microarchitecture or alteration in the 
amount and variety of proteins in bone can still increase the risk of fractures 




concentration, which prohibited us from assessing serum homocysteine in 
combination with B vitamins on risk of hip fracture.   
4-5. Conclusions 
 
In conclusion, this study revealed that dietary intake of pyridoxine is 
associated with reduced risk of osteoporotic hip fracture in non-diabetic 
women. The findings of the present study suggest that a balanced diet with 
sufficient pyridoxine intake may be beneficial in maintaining bone health. 
Future clinical trials are warranted to examine the effectiveness of vitamin B6 

















 Fracture cases 
(n=1,180) 
Non-cases (n=34,061) 
Age at recruitment, years (SD) 63.5 (7.0) 56.6 (7.9)  64.2  (6.7) 56.0 (7.9) 
Body mass index (SD) 22.4 (2.9) 23.0 (3.2)  23.2 (3.2) 23.2 (3.3) 
Level of education (%)      
        No formal education 17.1 10.8  57.5 39.8 
        Primary  62.9 51.0  34.3 39.1 
        Secondary or higher 20.0 38.2  8.2 21.1 
Smoking status (%)      
        Never smoker 34.2 42.1  85.7 91.4 
        Former smoker 28.7 21.7  4.2 2.5 
        Current smoker 37.1 36.2  10.1 6.1 
Alcohol consumption (%)      
        Daily drinkers 9.1 6.4  0.8 1.2 
Physical activity (%)      
Daily energy intake (kcal) (SD) 1,638.2 (614.5) 1,751.5 (608.6)  1,314 (454.2) 1,402.2 (472.4) 
At least weekly use of vitamin 
supplements (%) 
4.7 4.8  6.4 7.6 
Vitamin D (IU) (SD) 62 (37) 62 (35)  68 (47) 70 (43) 





 288 (145) 
((144.8) 
293 (137) 
(((137.3)(137.3) Soy isoflavones (mg/1,000 kcal/day) 
(SD) 
11 (9) 11 (8)  1  (10) 12.7 (9.7) 







All differences between cases and non-cases of hip fractures were statistically significant at 2-sided P <0.0003, except calcium, at least weekly 
use of vitamins for both genders, vitamin D, soy isoflavones for men, and BMI, alcohol consumption, physical activity for women (p>0.05).    
Physical activity (%)      
        None 72.0 75.3  79.5 80.0 
        0.5-3hr per week 13.3 15.5  12.6 12.7 
        >4 hr per week 14.7 9.2  7.9 7.3 
Postmenopausal (%)    96.7 71.6 
Hormone replacement therapy (%)    0.9 3.8 
Diabetes mellitus (%) 12.9 8.6  20.8 8.8 





Table 4-2. Comparison of average daily intake of protein and B vitamins in the Singapore Chinese Health Study (SCHS, n=63,154) with the U.S. 
RDA (330) for men and women (>51 years) 
 
  SCHS U.S. RDA 
Nutrient Men Women Men Women 
Protein intake (g/day) 65 54 56 46 
Thiamin (B1) (mg/day) 1.0 0.8 1.2 1.1 
Riboflavin (B2) (mg/day) 1.0 0.9 1.3 1.1 
Niacin (B3) (mg/day) 12.3 9.8 16.0 14.0 
Pyridoxine (B6) (mg/day) 1.2 1.0 1.7 1.5 
Folate (B9) (µg/day) 169 145 400 400 










Thiamin (B1) Riboflavin (B2) Niacin (B3) Pyridoxine (B6) Folate (B9) Cobalamin (B12) 
1 Fresh meat (16.3) Vegetable (11.5) Rice (12.0) Fish (15.3) Vegetable (33.7) Fish (36.0) 
2 Bread (13.1) Bread (10.7) Fish (10.6) Rice (14.6) Citrus fruit (9.4) Fresh meat (7.5) 
3 Noodle (11.0) Milk (9.4) Bread (8.8) Vegetable (12.6) Bread (8.3) Noodle (7.5) 
4 Rice (8.5) Fish (7.6) Fresh meat (8.6) Bananas (7.5) Noodle (5.3) Milk (7.0) 





Table 4-4. Pearson’s correlation between each B vitamin (partial on gender) 
 
  Riboflavin (B2)  Niacin (B3)  Pyridoxine (B6)  Folate (B9) Cobalamin (B12)  
Thiamin (B1)  0.50 0.52 0.40 0.42 0.28 
Riboflavin (B2)    0.25 0.33 0.48 0.52 
Niacin (B3)      0.37 0.20 0.35 
Pyridoxine (B6)        0.51 0.29 




Table 4-5a. Dietary intake of B vitamins in relation to hip fracture risk among 
men (n=27,913), The Singapore Chinese Health Study, 1993-2010 
 
               Basic model  Full model 
Characteristics Cases  HR
a
 95% CI  HR
b
 95% CI 
Thiamin (B1) (mg/1000 kcal /day) 
Q1 (0.24-0.49) 137   1.0   1.0  
Q2 (0.49-0.57) 106  0.94 0.73-1.22  0.95 0.73-1.23 
Q3 (0.57-0.65) 112  1.14 0.89-1.47  1.14 0.88-1.48 
Q4 (0.65-1.07) 95  0.97 0.75-1.26  0.96 0.72-1.26 
p for trend   0.78   0.89   
Riboflavin (B2) (mg/1000 kcal /day)  
Q1 (0.24-0.50) 127 1.0   1.0  
Q2 (0.50-0.59) 122 1.10 0.86-1.41  1.10 0.85-1.43 
Q3 (0.59-0.69) 98 0.91 0.70-1.18  0.90 0.66-1.21 
Q4 (0.69-1.25) 103 1.08 0.83-1.40  1.02 0.71-1.46 
p for trend  0.96   0.76   
Niacin (B3) (mg/1000 kcal /day) 
Q1 (3.36-6.19) 110 1.0   1.0  
Q2 (6.19-6.94) 120 1.18 0.91-1.53  1.19 0.92-1.54 
Q3 (6.94-7.72) 126 1.30 1.01-1.68  1.30 1.00-1.68 
Q4 (7.72-10.98) 94 1.04 0.79-1.37  1.00 0.75-1.31 
p for trend  0.54   0.75   
Pyridoxine (B6) (mg/1000 kcal /day) 
Q1 (0.36-0.61) 118  1.0     1.0  
Q2 (0.61-0.69) 117  1.20 0.93-1.55    1.23 0.95-1.59 
Q3 (0.69-0.78) 97  1.10 0.84-1.44    1.11 0.85-1.47 
Q4 (0.78-1.70) 118  1.27 0.98-1.64    1.29 0.99-1.68 
p for trend 0.13  0.11   
Folate (B9) (µg/1000 kcal /day) 
Q1 (37.14-79.00) 138 1.0   1.0  
Q2 (79.00-96.12) 103 0.88    0.68-1.14  0.90 0.69-1.17 
Q3 (96.12-117.21) 117 1.10    0.86-1.42  1.13 0.87-1.47 
Q4 (117.21-228.94) 92 1.00    0.77-1.31  1.02 0.76-1.37 
p for trend  0.60   0.53   
Cobalamin (B12) (µg/1000 kcal /day)      
Q1 (0.04-1.11) 117 1.0   1.0   
Q2 (1.11-1.45) 122 1.13 0.88-1.46  1.14 0.88-1.47 
0.87-1.48 
0.82-1.44 
Q3 (1.45-1.83) 111 1.13 0.87-1.47  1.13 
Q4(1.83-3.57) 100 1.10 0.84-1.44  1.08 
p for trend  0.48   0.58   
 
a
HRs were adjusted for age at recruitment (years), year of recruitment (1993-
1995, 1995-1998), dialect group (Hokkien, Cantonese), body mass index (<20, 








HR, further adjusted for smoking status (never, ex-smokers, current smokers), 
moderate physical activity (none, 2-<4 hrs weekly, 4+ hrs weekly), calcium 
(quartiles, mg/1,000 kcal/day), soy isoflavones (quartiles, mg/1,000 kcal/day), 
and baseline self-reported physician-diagnosed history of diabetes mellitus and 




Table 4-5b. Dietary intake of B vitamins in relation to hip fracture risk among 
women (n=35,241), The Singapore Chinese Health Study, 1993-2010 
 
               Basic model  Full model 
Characteristics Cases HR
a
 95% CI  HR
b
 95% CI 
Thiamin (B1) (mg/1000 kcal /day) 
Q1 (0.23-0.49) 278 1.0   1.0  
Q2 (0.49-0.57) 276 1.01 0.85-1.19  1.01 0.85-1.20 
Q3 (0.57-0.65) 291 1.05 0.89-1.24  1.04 0.88-1.24 
Q4 (0.65-1.34) 335 1.18 1.01-1.39  1.13 0.95-1.33 
p for trend  0.03   0.14   
Riboflavin (B2) (mg/1000 kcal /day)  
Q1 (0.25-0.50) 298 1.0   1.0  
Q2 (0.50-0.59) 304 1.13 0.96-1.33  1.11 0.94-1.32 
Q3 (0.59-0.69) 253 1.02 0.86-1.21  0.97 0.80-1.18 
Q4 (0.69-3.89) 325 1.04 0.89-1.23  0.92 0.73-1.15 
p for trend  0.91   0.29  
Niacin (B3) (mg/1000 kcal /day) 
Q1 (3.57-6.19) 360 1.0   1.0  
Q2 (6.19-6.94) 297 0.96 0.82-1.11  0.94 0.80-1.09 
Q3 (6.94-7.71) 261 0.97 0.83-1.14  0.95 0.81-1.11 
Q4 (7.71-10.90) 262 1.05 0.89-1.23  1.00 0.85-1.17 
p for trend  0.62   0.93   
Pyridoxine (B6) (mg/1000 kcal /day) 
Q1 (0.37-0.61) 417 1.0   1.0  
Q2 (0.61-0.69) 285 0.82 0.70-0.95  0.82 0.71-0.96 
Q3 (0.69-0.78) 249 0.79 0.68-0.93  0.79 0.67-0.93 
Q4 (0.78-1.76) 229 0.77 0.66-0.91  0.78 0.66-0.93 
p for trend  0.001   0.002  
Folate (B9) (µg/1000 kcal /day) 
Q1 (26.75-78.93) 334 1.0   1.0  
Q2 (78.93-96.10) 314 1.04 0.89-1.22  1.05 0.90-1.23 
Q3 (96.10-117.21) 265 0.96 0.81-1.13  0.98 0.82-1.16 
Q4 (117.21-331.46) 267 1.00 0.85-1.18  1.03 0.86-1.23 
p for trend  0.77   0.97   
Cobalamin (B12) (µg/1000 kcal /day) 
Q1 (0.01-1.11) 324 1.0   1.0  
Q2 (1.11-1.45) 282 1.02 0.87-1.20  1.01 0.86-1.19 
Q3 (1.45-1.83) 281 0.99 0.84-1.16  0.96 0.81-1.13 
Q4(1.83-6.28) 293 0.97 0.83-1.14  0.90 0.76-1.07 
p for trend  0.65   0.20   
 
a
HRs were adjusted for age at recruitment (years), year of recruitment (1993-
1995, 1995-1998), dialect group (Hokkien, Cantonese), body mass index (<20, 








HR, further adjusted for smoking status (never, ex-smokers, current smokers), 
moderate physical activity (none, 2-<4 hrs weekly, 4+ hrs weekly), calcium 
(quartiles, mg/1,000 kcal/day), soy isoflavones (quartiles, mg/1,000 kcal/day), 
menopausal status (women only; yes, no), use of hormone replacement 
therapy at recruitment (women only; yes, no), and baseline self-reported 






Table 4-6. Dietary intake of pyridoxine in relation to hip fracture risk among 
women (n=35,241) stratified by body mass index (BMI) and diabetes status, 
The Singapore Chinese Health Study, 1993-2010. 
 
 Women with BMI<20 kg/m
2






 95% CI Cases HR
a
 95% CI 
Pyridoxine (B6) (mg/1000 kcal /day) 
Q1 (0.37-0.61) 65 1.0  352 1.00  
Q2 (0.61-0.69) 27 0.58 0.37-0.92 258 0.86 0.73-1.01 
Q3 (0.69-0.78) 40 0.82 0.54-1.24 209 0.77 0.65-0.92 
Q4 (0.78-1.76) 32 0.77 0.49-1.22 197 0.78 0.65-0.93 
p for trend                  0.37               0.002 
 Women without diabetes  Women with diabetes  
 Cases HR
b
 95% CI Cases HR
b
 95% CI 
Pyridoxine (B6) (mg/1000 kcal /day)  
Q1 (0.37-0.61) 348 1.00  69 1.0  
Q2 (0.61-0.69) 225 0.79 0.66-0.93 60 1.00 0.70-1.42 
Q3 (0.69-0.78) 183 0.73 0.61-0.88 66 1.03 0.73-1.46 
Q4 (0.78-1.76) 178 0.75 0.62-0.91 51 0.91 0.62-1.33 
p for trend                 0.0009               0.705 
 
a 
Hazard ratios (HRs) were adjusted for age at recruitment (years), year of 
recruitment (1993-1995, 1995-1998), dialect group (Hokkien, Cantonese), 
level of education in categories (no formal education, primary school, 
secondary school or higher), total energy intake (kcal/day), smoking status 
(never, ex-smokers, current smokers), moderate physical activity (none, 2-<4 
hrs weekly, 4+ hrs weekly), dietary calcium intake (quartiles, mg/1,000 
kcal/day), dietary soy isoflavones intake (quartiles, mg/1,000 kcal/day), 
menopausal status ( yes, no), use of hormone replacement therapy at 
recruitment ( yes, no), and history of diabetes mellitus and stroke; CI: 
confidence interval.  
 
b
HRs were adjusted for the all variables listed above plus body mass index 





Supplemental Table 4-1. Dietary intake of pyridoxine in relation to hip fracture risk among women (n=35,241) with further adjustment for a 
relevant nutrient, The Singapore Chinese Health Study, 1993-2010 
 
 




Q1 (0.37-0.61) Q2 (0.61-0.69) Q3 (0.69-0.78) Q4 (0.78-1.76) p for trend 
Cases 417 285 249 229  
HR (95% CI) 1.0 0.82 (0.71, 0.96) 0.79 (0.67, 0.93) 0.79 (0.66, 0.93)  
HR
1
 (95% CI) 1.0 0.83 (0.71, 0.96) 0.79 (0.67, 0.93) 0.79 (0.67, 0.94) 0.003 
HR
2
 (95% CI) 1.0 0.80 (0.69, 0.94) 0.75 (0.63, 0.89) 0.75 (0.62, 0.90) 0.002 
HR
3
 (95% CI) 1.0 0.82 (0.70, 0.96) 0.78 (0.66, 0.92) 0.78 (0.66, 0.93) 0.002 
HR
4
 (95% CI) 1.0 0.82 (0.70, 0.95) 0.77 (0.66, 0.91) 0.78 (0.65, 0.92) 0.001 
HR
5
 (95% CI) 1.0 0.82 (0.70, 0.96) 0.78 (0.66, 0.92) 0.78 (0.65, 0.93) 0.002 
HR
6
 (95% CI) 1.0 0.82 (0.70, 0.96) 0.78 (0.66, 0.92) 0.78 (0.66, 0.93) 0.002 
HR
7
 (95% CI) 1.0 0.84 (0.72–0.99) 0.82 (0.69–0.98) 0.84 (0.68–1.03) 0.06 
Hazard ratio (HR) (full model): was adjusted for age at recruitment (years), year of recruitment (1993-1995, 1995-1998), dialect group 
(Hokkien, Cantonese), level of education in categories (no formal education, primary school, secondary school or higher), total energy intake 
(kcal/day), body mass index <20, 20-<24, 24-<27.9, ≥28 kg/m2), smoking status (never, ex-smokers, current smokers), moderate physical 
activity (none, 2-<4 hrs weekly, 4+ hrs weekly), dietary calcium intake (quartiles, mg/1,000 kcal/day), dietary soy isoflavones intake (quartiles, 
mg/1,000 kcal/day), menopausal status ( yes, no), use of hormone replacement therapy at recruitment ( yes, no), and history of diabetes mellitus 
and stroke; CI: confidence interval.  
HR1: Further adjusted for vitamin D (IU/1,000 kcal/day); 2: Further adjusted for protein (g/1,000 kcal/day); 3: Further adjusted for 
zinc (mg/1000kcal/day); 4: Further adjusted for caffeine (mg/day); 5. Further adjusted for magnesium (mg/1000kcal/day); 6: Further 




Supplemental Table 4-2a. Dietary intake of B vitamins in relation to hip 
fracture risk among men (n=27,913) using the residual method (322), The 
Singapore Chinese Health Study, 1993-2010 
 
                Basic model  Full model 
Characteristics Cases   HR
a
 95% CI  HR
b
 95% CI 
Thiamin (B1) (mg % /day) 
Q1 (-0.12-0.77) 145   1.0   1.0  
Q2 (0.77-0.88) 103  0.98 0.76-1.27  0.99 0.76-1.29 
Q3 (0.88-1.00) 103  1.12 0.87-1.45  1.11 0.85-1.46 
Q4 (1.00-2.68) 99  0.99 0.77-1.29  0.96 0.73-1.27 
p for trend   0.79   0.98   
Riboflavin (B2) (mg % /day) 
Q1 (0.06-0.80) 130 1.0   1.0  
Q2 (0.80-0.91) 122 1.23 0.96-1.58  1.26 0.97-1.63 
Q3 (0.91-1.06) 94 0.95 0.73-1.24  0.97 0.72-1.30 
Q4 (1.06-3.15) 104 1.09 0.84-1.41  1.10 0.78-1.55 
p for trend  0.94   0.93   
Niacin (B3) (mg % /day) 
Q1 (-0.78-9.77) 125 1.0   1.0  
Q2 (9.77-10.86) 117 1.16 0.90-1.50  1.16  0.90-1.50 
Q3 (10.86-11.93) 110 1.14 0.88-1.49  1.14  0.87-1.48 
Q4 (11.93-31.46) 98 0.99 0.76-1.29  0.96  0.73-1.25 
p for trend  0.98   0.80   
Pyridoxine (B6) (mg % /day) 
Q1 (-0.49-0.96) 137  1.0     1.0  
Q2 (0.96-1.08) 102 0.97 0.75-1.26    0.98  0.76-1.28 
Q3 (1.08-1.21) 90 0.98 0.75-1.28    0.97  0.74-1.28 
Q4 (1.21-4.16) 121 1.14 0.89-1.47    1.15  0.89-1.48 
p for trend  0.32     0.35   
Folate (B9) (µg % /day) 
Q1 (-37.38- 25.31) 146 1.0   1.0  
Q2 (125.31-49.35) 95 0.86 0.66-1.12  0.85 0.65-1.11 
Q3 (149.35-79.93) 116 1.15 0.90-1.47  1.15 0.89-1.50 
Q4 (179.93-801.08) 93 0.97 0.74-1.26  0.97 0.72-1.30 
p for trend  0.69   0.66   
Cobalamin (B12) (µg % /day) 
Q1 (-3.33-1.79)   123 1.0   1.0  
Q2 (1.79-2.28)   123 1.24 0.96-1.60  1.26 0.97-1.63 
Q3 (2.28-2.82)   102 1.12 0.86-1.47  1.14 0.87-1.50 
Q4(2.82-14.48)   103 1.12 0.86-1.46  1.13 0.86-1.50 
p for trend  0.52   0.51   
 
a
HRs were adjusted for age at recruitment (years), year of recruitment (1993-




20-<24, 24-<27.9, ≥28 kg/m2), level of education in categories (no formal 




HR, further adjusted for smoking status (never, ex-smokers, current smokers), 
moderate physical activity (none, 2-<4 hrs weekly, 4+ hrs weekly), calcium 
(quartiles, mg%, residual method), soy isoflavones (quartiles, mg%, residual 
method), and baseline self-reported physician-diagnosed history of diabetes 




Supplemental Table 4-2b. Dietary intake of B vitamins in relation to hip 
fracture risk among women (n=35,241) using the residual method (322), The 
Singapore Chinese Health Study, 1993-2010 
 
                Basic model  Full model 
Vitamin B Cases HR
a
 95% CI  HR
b
 95% CI 
Thiamin (B1) (mg % /day) 
Q1 (-0.12-0.77) 213 1.0   1.0  
Q2 (0.77-0.88) 366 1.12 0.94-1.33  1.12 0.94-1.33 
Q3 (0.88-1.00) 325 1.10 0.92-1.31  1.09 0.91-1.30 
Q4 (1.00-2.68) 306 1.27 1.06-1.51  1.18 0.99-1.42 
p for trend  0.02   0.12  
Riboflavin (B2) (mg % /day) 
Q1 (0.06-0.80) 252 1.0   1.0  
Q2 (0.80-0.91) 346 1.05 0.90-1.24  1.02 0.86-1.21 
Q3 (0.91-1.06) 280 0.99 0.84-1.18  0.91 0.74-1.11 
Q4 (1.06-3.15) 302 1.01 0.85-1.20  0.84 0.66-1.07 
p for trend  0.87   0.10  
Niacin (B3) (mg % /day) 
Q1 (-0.78-9.77) 308 1.0   1.0  
Q2 (9.77-10.86) 318 0.86 0.74-1.01  0.85 0.73-1.00 
Q3 (10.86-11.93) 313 0.95 0.81-1.12  0.92 0.78-1.09 
Q4 (11.93-31.46) 241 0.98 0.83-1.17  0.93 0.78-1.10 
p for trend  0.88   0.59  
Pyridoxine (B6) (mg %/day) 
Q1 (-0.49-0.96) 318 1.0   1.0  
Q2 (0.96-1.08) 358 0.88 0.75-1.03  0.87 0.75-1.02 
Q3 (1.08-1.21) 295 0.83 0.71-0.98  0.80 0.68-0.95 
Q4 (1.21-4.16) 209 0.78 0.65-0.93  0.77 0.64-0.92 
p for trend  0.004   0.002  
Folate (B9) (µg % /day) 
Q1 (-37.38-125.31) 276 1.0   1.0  
Q2 (125.31-149.35) 372 1.05 0.90-1.23  1.06 0.90-1.24 
Q3 (149.35-179.93) 288 0.98 0.82-1.15  0.98 0.82-1.17 
Q4 (179.93-801.08) 244 1.01 0.85-1.21  1.03 0.85-1.25 
p for trend  0.85   0.99   
Cobalamin (B12) (µg % /day) 
Q1 (-3.33-1.79) 264 1.0   1.0  
Q2 (1.79-2.28) 330 0.95 0.81-1.12  0.96 0.81-1.13 
Q3 (2.28-2.82) 310 0.91 0.77-1.08  0.89 0.75-1.06 
Q4(2.82-14.48) 276 0.93 0.78-1.10  0.86 0.71-1.03 
p for trend  0.34   0.06   
 
a
HRs were adjusted for age at recruitment (years), year of recruitment (1993-




20-<24, 24-<28, ≥28 kg/m2), level of education in categories (no formal 
education, primary school, secondary school or higher) and total energy intake 
(kcal); 
b
HR, further adjusted for smoking status (never, ex-smokers, current 
smokers), moderate physical activity (none, 2-<4 hrs weekly, 4+ hrs weekly), 
calcium (quartiles, residual method), soy isoflavones (quartiles, residual 
method), menopausal status (women only; yes, no), use of hormone 
replacement therapy at recruitment (women only; yes, no), and baseline self-





Supplemental Table 4-3. Other nutrients from the diet in relation to risk of 
hip fracture, The Singapore Chinese Health Study, 1993-2010 (n=63,154) 
  Men (n=27,913) Women (n=35,241) 
Other nutrients Cases HR 95% CI Cases HR 95% CI 
Protein (g/1,000kcal /day) 
Q1 (5.83-13.50) 145 1.0  303 1.0  
Q2 (13.50-15.12) 114 0.93 0.72-1.19 299 0.97 0.82-1.14 
Q3 (15.12-16.80) 103 0.93 0.72-1.22 281 0.98 0.83-1.17 
Q4 (16.80-29.03) 88 0.90 0.67-1.19 297 0.95 0.80-1.13 
p for trend  0.47   0.65  
ω-3 fatty acids (% kcal) 
Q1 (0.10-0.41) 151 1.0  301 1.0  
Q2 (0.41-0.49) 117 0.94 0.73-1.20 280 0.97 0.82-1.14 
Q3 (0.49-0.58) 98 0.86 0.66-1.13 308 1.04 0.88-1.23 
Q4 (0.58-1.52) 84 0.84 0.63-1.13 291 0.96 0.81-1.14 
p for trend  0.20   0.86  
Vitamin D (I.U./1,000kcal/day) 
Q1 (0-38.05) 124 1.0  329 1.0  
Q2 (38.05-58.26) 127 1.16 0.90-1.49 258 0.98 0.83-1.16 
Q3 (58.26-86.86) 101 0.98 0.74-1.31 261 1.00 0.84-1.19 
Q4 (86.86-238.4) 98 1.11 0.80-1.54 331 0.91 0.75-1.10 
p for trend  0.80   0.41  
Calcium (mg/1,000kcal/day) 
Q1 (27.3-190.1) 136 1.0  256 1.0  
Q2 (190.1-240.2) 138 1.32 1.03-1.69 284 1.10 0.92-1.30 
Q3 (240.2-312.5) 87 0.93 0.70-1.23 273 1.10 0.92-1.32 
Q4 (312.5-948.8) 88 1.12 0.94-1.49 363 1.13 0.95-1.35 
p for trend  1.00   0.20  
Zinc (mg/1,000kcal/day) 
Q1 (1.62-3.93) 124 1.0  277 1.0  
Q2 (3.93-4.26) 117 1.09 0.85-1.41 274 0.99 0.83-1.17 
Q3 (4.26-4.60) 119 1.17 0.90-1.53 290 1.03 0.86-1.22 
Q4 (4.60-15.90) 89 0.95 0.70-1.28 366 1.02 0.86-1.22 
p for trend  0.98  0.73   
Magnesium (mg/1,000kcal/day) 
Q1 (75.18-142.90) 125 1.0  241 1.0  
Q2 (142.90-156.71) 120 1.10 0.85-1.43 256 0.90 0.75-1.07 
Q3 (156.71-172.88) 112 1.19 0.90-1.59 314 0.93 0.78-1.12 
Q4 (172.88-352.18) 93 1.09 0.79-1.52 369 0.87 0.72-1.06 
p for trend 0.48   0.25    
 
HRs were adjusted for age at recruitment (years), year of recruitment (1993-
1995, 1995-1998), dialect group (Hokkien, Cantonese), body mass index (<20, 
20-<24, 24-<27.9, ≥28 kg/m2), level of education in categories (no formal 
education, primary school, secondary school or higher) and total energy intake 




physical activity (none, 2-<4 hrs weekly, 4+ hrs weekly), calcium (quartiles, 
mg/1,000 kcal/day), soy isoflavones (quartiles, mg/1,000 kcal/day), 
menopausal status (women only; yes, no), use of hormone replacement 
therapy at recruitment (women only; yes, no), and baseline self-reported 





Chapter 5. Dietary intake of total and specific 
carotenoids and risk of hip fracture 
[This chapter is primarily based on the published paper in the 




Evidence from in vitro and in vivo studies suggests that reactive 
oxygen species (ROS) may increase osteoclastogenesis (348-350), osteoclastic 
differentiation (348, 351), or suppress osteoblastic differentiation (352, 353). 
Therefore, increased oxidative stress may play an important role in age-related 
bone loss (354, 355) that leads to osteoporotic fractures. Dietary antioxidant 
carotenoids, primarily derived from fruits and fresh vegetables, have been 
reported to promote bone formation in experimental studies (161, 356) and to 
protect against osteoporosis and related fractures in some but not all 
epidemiological studies (169, 175, 176, 184, 357, 358). Additionally, lycopene, 
a carotenoid, was shown to inhibit osteoclast formation in rat bone marrow 
cultures (163), and was negatively related to bone resorption biomarkers and 
oxidative stress in postmenopausal women (178, 181). Taken together, these 
data raised a hypothesis that antioxidant carotenoids may counteract the 
adverse effect of ROS in bone remodeling and therefore can potentially 
protect against osteoporotic fractures. While leanness has been established as 
an independent risk factor of hip fracture (20, 263, 359), several observational 
studies have reported that low body mass index (BMI) could be related to 
increased oxidative stress (360-362), particularly, in men (361). Hence, one of 
the hypothesized mechanisms on antioxidant carotenoids in bone protection is 




suppressing osteoclastic activities (348, 351) through the receptor activator of 
nuclear factor-kappaB (NF-κB) ligand (RANKL) expression and signaling 
mechanism (Figure 5-1).  
Figure 5-1. Proposed mechanism for carotenoids in bone turnover 
 
 
[Figure adapted from Wauquier et al., 2009. Trends in Molecular Medicine. (354)] 
 
The aim of this study was to assess the association between dietary 
total and specific carotenoids, including α- and β- carotene, β-cryptoxanthin, 
lycopene and lutein/zeaxanthin, and risk of hip fracture among elderly men 
and women. In addition, we also evaluated whether BMI modified the 
associations between these dietary components and risk of hip fracture among 
middle-aged and elderly in an Asian population, who generally have lower 








Baseline assessment on BMI 
 
Baseline information was recorded as described in Chapter 3. More 
detail was given for self-reported body weight in this aim. During the baseline 
interview, participants were asked to self-report their current body weight and 
height. There were 9,781 cohort participants with unknown weight, 97 with 
unknown height, and 192 with both unknown weight and height. BMI is 
calculated as weight in kilograms divided by height in meters squared (kg/m
2
). 
For those with missing weight and/or height, BMI was calculated using 
imputed weight and/or height derived from the linear regression equation: 
Weight = y-intercept + gradient X height, where the values for the y-intercept 
and gradient were derived from the gender-specific weight-height regression 
lines obtained from all cohort participants with known heights and weights. If 
only weight or height was reported, the known value was entered in the 
equation above to estimate the missing value. If both weight and height were 
not reported, the sex-specific median value from the cohort was used for the 
missing height, so that the missing weight was calculated from the equation 
mentioned above. This method of imputed BMI was reported previously (364).  
Statistical analysis 
 
For each study subject, person-years were counted from the date of 
baseline interview to the date of hip fracture diagnosis, death, migration or 31 
December 2010, whichever occurred first. Cox proportional hazards 
regression was used to assess the association between baseline dietary 
carotenoids, fruits and vegetables, and hip fracture risk by comparing higher 
quartiles to the lowest quartile (322). Quartiles of each energy-adjusted food 




in the whole cohort. The strength of the association between a dietary factor 
and hip fracture risk was estimated by hazard ratios (HRs) and their 
corresponding 95% confidence intervals (CI). To examine linear trend, ordinal 
values of the quartile of each dietary component was entered as a continuous 
variable in the Cox proportional hazards model. The Cox proportionality 
assumption was tested by entering the product term of dietary 
fruit/vegetable/carotenoids*log (follow-up time) into the Cox model. The p-
value for the interaction term was not statistically significant, thus, no 
violation of the proportional hazard assumption was identified. To test 
multicollinearity, after all of the covariates were entered in the Cox model, the 
condition index was less than 15, suggesting multicollinearity was not an issue.  
All models in the analyses included the following covariates: age 
(continuous), year at recruitment (1993-1995 and 1996-1998), dialect group 
(Hokkien, Cantonese), level of education (no formal education, primary school, 
secondary school or higher), BMI (kg/m
2
, continuous), smoking status (never 
smokers, ex-smokers, current smokers), moderate physical activity (none, 2-
<4 hrs weekly, 4+ hrs weekly), calcium (mg/1,000 kcal/day), soy isoflavones 
(mg/1,000 kcal/day), pyridoxine ((mg/1,000 kcal/day), total energy intake 
(kcal/day), menopause status (women only; yes, no), use of hormone 
replacement therapy at recruitment (women only; yes, no), baseline self-
reported physician-diagnosed history of diabetes mellitus (yes, no) and stroke 
(yes, no). Adjustment for total energy intake in addition to the energy-adjusted 
dietary component (exposure of interest) is based on the multivariate nutrient 




To study the BMI-hip fracture risk association and to assess the 
modifying effects of BMI on the diet-hip fracture risk associations, we only 
included participants with known body weight and height in these analyses. 
Thus, those with imputed BMI were not included in these analyses.  Hence, 
52,792 cohort participants who reported body weight and height at baseline 
were included in the analysis including 1,238 hip fracture cases in this 
subgroup. Subjects were stratified by BMI levels of < 20, 20 - < 25, and ≥ 25 
kg/m
2
, which is based on the previous finding that BMI < 20 kg/m
2
 is a risk 
factor for hip fracture in this cohort (20) and a meta-analysis of 12 population-
based cohort studies (263); and that BMI ≥25 kg/m2 is the current cut-off for 
overweight proposed by the World Health Organization (365) which is  
applicable to Asian populations (363). Heterogeneity of the diet-hip fracture 
risk associations among different BMI levels was tested using an interaction 
term (product between diet and BMI) included in the Cox regression model. 
Finally, we performed a sensitivity analysis for the diet-hip fracture risk 
association after excluding subjects who had reported extreme energy intakes 
(≤ 600 and ≥ 3000kcals). For the present analysis, we had a priori hypothesis 
that total and specific carotenoids were protective against hip fracture risk.  
The p values were thus not adjusted for multiple testing; p < 0.05 was 
considered statistically significant. 
5-3. Results 
 
In the whole cohort, compared to women, men were older in age, more 
educated, and had greater proportion of habitual smokers and alcohol drinkers. 
The mean BMI in the study population was 23.0 kg/m
2
.  The distribution of 




prevalence of diabetes mellitus and stroke (Table 5-1). Seventy-two percent of 
women were post-menopausal at enrollment, but only 3.7% of them reported 
use of hormone replacement therapy. Regarding dietary intakes, according to 
the U.S. Recommended Dietary Allowance (RDA) values (366), both men and 
women in our cohort had adequate intake of protein (Table 4-2 in Chapter 4). 
Absolute intakes of vegetables were comparable between the two genders, 
although fruit intake was higher in men than in women. Overall, absolute 
dietary intake of total carotenoids for men was about 5% higher than women.  
Among all carotenoids that were examined, β-carotene had the highest 
correlation with total carotenoids (Pearson correlation coefficient r= 0.91), 
followed by lutein/zeaxanthin and lycopene. Among specific carotenoids, β-
carotene was highly correlated with α-carotene and lutein (r=0.77 and 082, 
respectively). Total carotenoids were better correlated with vegetables (r=0.84) 
than with fruits (r=0.64). The correlation between different types of vegetables 
and carotenoids reflect the dietary source of the carotenoids; green vegetables 
were best correlated with lutein/zeaxanthin, and yellow-orange vegetables 
with α-carotene (Pearson’s correlation coefficients between dietary intake of 
carotenoids and food groups/specific vegetables or fruit in Supplemental 
Table 5-1.     
Table 5-2 shows the relations between dietary vegetables, fruits and 
carotenoids, and hip fracture risk for men and women separately. There was a 
statistically significant dose-dependent inverse relationship with hip fracture 
risk for total, green or yellow-orange vegetables in men (p for trend≤0.002), 
but not in women. Men in the highest quartile of total vegetables had 




Consumption of tomato products or fruits was not associated with hip fracture 
risk in either gender. Similarly, statistically significant inverse associations 
between nutrient density of total or specific carotenoids, including α-, β-
carotene and lutein/zeaxanthin, and risk of hip fracture were seen in men (p for 
trend < 0.05), but not in women. The strongest association was observed in 
dietary β-carotene. Compared with men in the lowest quartile, men in the 3 rd 
or 4
th
 quartile of β-carotene experienced a statistically significant 37% 
decrease in risk of hip fracture (p ≤ 0.005). However, gender did not modify 
the association between dietary total vegetable/carotenoids and risk of hip 
fracture (P for interaction is 0.11 and 0.28, respectively). Nutrient density of β-
cryptoxanthin or lycopene was not associated with hip fracture risk in either 
men or women. The results were essentially the same using gender-specific 
cut-points for the definition of quartiles for the food and nutrient variables 
included in this study (Supplemental Table 5-3). As expected, the 
consumption of total vegetables and carotenoids were highly correlated in our 
cohort with a Pearson’s correlation coefficient of 0.84. We hypothesized that 
the protective effects of vegetables were mediated via their carotenoids. When 
we put both intake levels of vegetables and specific carotenoid, such as β-
carotene, in the same model, there was a loss of statistical significance due to 
the high collinearity of both variables. However, the association remained 
stronger for β-carotene (p for trend=0.081) than for vegetables (p for 
trend=0.27), supporting our hypothesis that the protective effect of vegetables 
was likely to be mediated by carotenoids such as β–carotene.  Finally, we re-
analyzed the data by treating food/nutrient densities as continuous variables, 




between dietary carotenoid and hip fracture risk were 0.0055 for men and 0.35 
for women.   
  BMI was inversely related to risk of hip fracture in men (Table 5-3). 
Compared with BMI < 20kg/m
2
, men with BMI 20 - < 25 and ≥ 25 kg/m2 had 
hip fracture risk reduced by 18% and 33%, respectively (p for trend = 0.016). 
There was a 9% reduction of hip fracture risk for women with BMI ≥ 25 
kg/m
2
 compared with women with BMI < 20 kg/m
2
, but the difference was not 
statistically significant between two genders (p for interaction=0.137) (Table 
5-3). When BMI was analyzed on a continuous scale, for each unit increase in 
BMI, risk of hip fracture was reduced by 5.5% [HR (95% CI): 0.95 (0.92-
0.98), p=0.001] in men, and only by 1.0% [HR (95% CI): 0.99 (0.97-1.01)] in 
women. Further adjustment for dietary protein did not materially change the 
effect size of this BMI-hip fracture association. 
Figure 5-2 shows the associations between total 
vegetables/carotenoids and hip fracture risk stratified by BMI for men. Among 
men with BMI < 20 kg/m
2







 quartile of total vegetable consumption were 0.60 (0.35-1.03), 0.49 (0.26-
0.92), and 0.22 (0.08-0.64), respectively, compared with the 1
st
 quartile (p for 
trend = 0.0008). A null association was observed between total vegetables and 
hip fracture risk in men with BMI ≥ 25 kg/m2. The difference in the protective 
associations with total vegetables by BMI categories was statistically 
significant (p for interaction=0.011). Similarly, the associations between total 
carotenoids and reduced hip fracture risk in men by BMI categories were also 
statistically different (p for interaction=0.022). Using total 




association in each BMI stratum yielded essentially the same results, p=0.0002 
and p=0.0086 for total vegetables and total carotenoids, respectively, for men 
with BMI <20 kg/m
2
.  
 For vegetable subtypes, the inverse association between dietary green 
or yellow-orange vegetables and hip fracture risk was present in men with 
BMI < 20 kg/m
2
, but generally attenuated in men of the higher BMI categories 
(Table 5-4). For specific carotenoids, α-, β-carotene or lutein/zeaxanthin, the 
reduction in hip fracture risk was again the greatest in men with BMI <20 
kg/m
2
 (Table 5-4). On the other hand, the associations between fruits, 
vegetables and carotenoids (total and specific) and hip fracture risk were 
generally null across all strata of BMI among women (Supplemental Table 5-
2). There was no relationship between protein and risk of hip fracture in either 
men [HR (95% CI): 0.94 (0.85, 1.03)] or women [HR (95% CI): 1.03 (0.97, 
1.09)]. Further adjustment for dietary protein did not materially alter the 
results described. In addition, using the residual method adjusting for the same 
covariates and total energy in the analysis, the results remained the same for 
both genders, so did the results after excluding those with extreme caloric 
intake (Supplemental table 5-3).  
5-4. Discussion 
 
 The present study demonstrate that there was a statistically significant 
inverse relationship for hip fracture risk in men with dietary total vegetables, 
green vegetables and yellow-orange vegetables, as well as total and specific 
carotenoids, α-, β-carotene and lutein/zeaxanthin. In addition, BMI modified 




fracture risk, with an apparent protective effect of vegetables/carotenoids on 
hip fracture risk in lean men (<20 kg/m
2
), but not in their heavier counterparts.  
This study population had comparable vegetable intake with other 
Western populations (175, 367), although intake of carotenoids was lower 
(176). This is possibly due to relatively low prevalence of supplement use in 
this cohort (only about 5% of men and 8% of women reported use of oral 
supplements). More than three quarters of total carotenoids in this population 
were sourced from dietary intake of total vegetables, and another 10% from 
fruit. Green vegetables provided 62% and 80% of β-carotene and 
lutein/zeaxanthin, respectively; 72% of α-carotene was provided by yellow-
orange vegetables; fruits contributed 99% of β-cryptoxanthin; melons and 
tomato products contributed 47% and 29% of lycopene, respectively.  
Although several cross-sectional studies found positive associations 
between vegetables and reduced hip fracture risk (193, 197, 368), most of the 
results in prospective cohorts or intervention studies failed to reach statistical 
significance (192, 367, 369). A recent systematic review also concluded no 
clear beneficial effects of fruit and vegetables on bone health in 
postmenopausal women over 45 years of age (189). This concurs with our null 
findings among women, where the protective effects of carotenoids or 
vegetables were weakened and became non-statistically significant after 
further adjustment for other lifestyle and dietary covariates. This suggests that 
other lifestyle factors, particularly other dietary nutrients, may confound the 
association between carotenoids/vegetables and hip fracture risk for women. 
We have previously reported dietary isoflavones (20) and pyridoxine (121) as 




postulate the plausible mechanisms for these two nutrients are related to their 
effects on estrogen, which play a critical and dominant role in bone turnover in 
women (343). Thereby, it is possible that the effect of oxidative stress on bone 
health may be less pronounced in postmenopausal women, which may explain 
the null association between carotenoids/vegetables and hip fracture risk for 
women. In the Framingham Osteoporosis Study, statistically significant 
protective effect of total carotenoids on hip fracture risk was reported when 
men and women were combined in the analysis (176). Nevertheless, our 
finding of an inverse association between vegetable/carotenoid and hip 
fracture risk in men is generally consistent with other findings from the 
Framingham study that also supported a stronger protective role of carotenoids 
in men. In the Framingham Study, dietary vegetables protected longitudinal 
bone loss at the trochanter and Ward’s area in men, whereas no association 
was found in women (197). The Framingham study also reported that more 
apparent protective effects from multiple carotenoids, including total 
carotenoids, β-carotene, lycopene and lutein/zeaxanthin, were significantly 
related to trochanter BMD in men but less so in women (175). Furthermore, 
testosterone may increase the bioavailability of carotenoids (370). Our 
observed protective effect of carotenoids on hip fracture risk in men only 
could reflect the male hormonal effect on carotenoid uptake and the biological 
effect. 
We propose that the benefits of carotenoids on bone might be via their 
counteractive effects against oxidative stress, which has been shown to play a 
possible etiologic role in age-related bone loss and consequent osteoporotic 




differentiation (348, 351) through the nuclear factor-kappaB (NF-κB) ligand 
(RANKL) expression and signaling mechanism. Besides the antioxidant 
function of carotenoids, other mechanisms of non-antioxidant functions can 
also be responsible for their roles in bone health. In vitro and animal studies 
have demonstrated that the carotenoid family may exert dual anti-catabolic 
and pro-anabolic activities in bone by antagonizing the same NF-κB signal 
transduction pathway to suppress osteoclast differentiation and promote 
osteoblast mineralization (371). Furthermore, several in vitro studies have also 
reported that β-carotene, lycopene and β-cryptoxanthin may have direct 
stimulatory effects in the proliferation, differentiation and alkaline 
phosphatase activity of osteoblasts (160, 161, 372). Collectively, these 
evidences suggested the beneficial effects of carotenoids on bone turnover.    
In addition to the high carotenoid content in vegetables, another 
possible mechanism for the favorable impacts on bones includes the alkaline 
nature of vegetables. In particular, potassium citrate (KH2C6H5O7).or 
potassium bicarbonate (KHCO3) as an alkaline salt in vegetables may 
neutralize excess metabolic acid to maintain an acid-base homeostasis (186, 
187) and to promote calcium balance in bones (190). However, in the current 
study, dietary potassium was not associated with hip fracture risk in either 
gender (121). Further adjustment for potassium did not change the effect 
estimate for the relationship between carotenoids and hip fracture risk [HR (95% 
CI) for Quartile 4 vs. 1: 0.58 (0.42, 0.81), p-trend=0.0006 for men and 0.89 
(0.73, 1.07), p-trend=0.42 for women). In our study, there was a null 
association between dietary vitamin C and hip fracture risk in either gender 




1.10 (0.90, 1.35), p-trend=0.30 for women). Although the Framingham 
Osteoporosis study showed that the use of supplementary vitamin C was 
associated with reduced fracture risk, there was no association with dietary 
vitamin C (373). Furthermore, the NHANES III study also showed no effects 
of dietary or serum ascorbic acid measures on bone mineral density and risk of 
self-reported fracture (374).  
The novel finding of the current study is that the reduction in hip 
fracture risk associated with vegetables and carotenoids was most pronounced 
in lean men with BMI < 20 kg/m
2
. BMI is an established independent risk 
factor of osteoporosis from accumulative evidence (263, 359), and appears to 
influence risk of hip fracture similarly between two genders (263). The 
proposed mechanism of a higher BMI as a protective factor against 
osteoporotic fractures has been attributed to greater weight-bearing in the 
loading bone sites for both genders (275), and increased endogenous estrogen 
produced in adipose tissues for postmenopausal women (375). However, our 
findings suggest that BMI significantly influenced on hip fracture 
development in men but had a non-statistically significant association in 
women. Low BMI has been associated with increased oxidative damage 
indexed by 8-hydroxy-2’-deoxyguanosine (360-362), particularly in men (361); 
and the molecule, 8-hydroxy-2’-deoxyguanosine, is considered a reliable 
biomarker for the measurement of systemic oxidative stress (376). Following 
this, we speculate that lean men possibly have higher oxidative stress in bones 
leading to hip fracture, and the antioxidant effects of carotenoids may 
counteract this mechanism of osteoporosis (e.g. the RANKL pathway) related 




major storage site for carotenoids (377), the effects of insufficient carotenoid 
intake could be expected to be more apparent in lean subjects due to reduced 
storage and bioavailability.    
The weaker association between BMI and hip fracture risk in women 
may be due to a possible non-differential misclassification of BMI, as some of 
the postmenopausal women in our cohort may experience weight gain after 
recruitment during menopause (378). In addition, it is plausible that the 
deleterious effect of a rapid decline of estrogen outweighs that of leanness 
related to oxidative stress on hip fracture development among postmenopausal 
women. If this is true, this is another possible explanation for the null 
association in lean women <20 kg/m
2
. Taken together, our findings support 
the “estrogen-centric” role in postmenopausal osteoporosis and related 
fractures (20, 379).  
To our best knowledge, the current study is the first study to examine 
dietary carotenoids and hip fracture risk in a middle-aged and elderly Asian 
population. The strength of this study is the large number of incident hip 
fracture cases identified from a population-based prospective cohort with a 
long follow-up time. Since supplementation was relatively uncommon in this 
study population, nutrient consumption computed from dietary intake using 
the food frequency questionnaire was considered valid and relevant. Another 
strength is the presumed lack of recall bias in exposure data since they were 
obtained prior to disease diagnosis. Singapore is a small city-state with a 
system for easy access to specialized medical care. Since practically all hip 
fracture cases will seek medical attention immediately and be hospitalized, our 




hospital database can be considered complete. Finally, we included all 
established and other possible risk factors for hip fracture as covariates in our 
regression-based risk models to minimize the likelihood of spurious 
associations resulting from insufficient control of confounding. Limitations of 
this study include the possible misclassification of dietary intake from the use 
of a food-frequency questionnaire. However, such misclassifications are non-
differential in nature, resulting in an underestimation (as opposed to an 
overestimation) of the true relative risk. Although the use of self-reported 
body weight and height could be prone to non-differential misclassification 
and thus lead to under-estimation of the BMI-hip fracture risk association. 
Self-report of body weight has been shown to be highly valid across many 
populations (380) and specifically in Asians. A review of 64 studies suggested 
the difference between the self-reported and objectively measured body mass 
index was generally null or slightly underestimated (less than 1 kg/m
2
) for 
those with BMI less than 30kg/m
2
 (381), and 97% of our study population had 
BMI <30 kg/m
2
. Another limitation of this study is the lack of measurements 
on bone mineral density (BMD) at baseline, which may confound the 
relationship between BMI and risk of hip fracture, as BMD is closely related 
to body weight (382). Finally, we did not include any biological measurement 
for oxidative stress in our study, and were therefore unable to confirm our 
hypothesis.   
5-5. Conclusions 
 
In conclusion, the findings of the present study suggest that dietary 




especially in lean elderly men. Our epidemiologic findings are supported by 
experimental data that have provided mechanistic pathway in the role of 
carotenoids in regulating the biology of osteoblasts and osteoclasts. Future 
research in mechanistic and intervention studies is warranted to evaluate the 
effect of carotenoids in relation to osteoporotic fractures among middle-aged 





Table 5-1. Baseline characteristics of men and women who participated in the 
Singapore Chinese Health Study (n=63,154) 
 
Characteristics Men (n=27,913) Women 
(n=35,241) Age at recruitment, years, mean (SD) 59.6 (7.9) 56.3  (8.0) 
56.0 (7.9) 
Body mass index, mean (SD) 23.0 (3.2) 23.2 (3.3) 
23.2 (3.3) 
        <20 kg/m
2
(%) 16.1 14.9 
        20-25 kg/m
2
(%) 62.3 63.2 
        ≥25 kg/m2(%) 21.6 21.9 
Level of education (%)  
        Secondary school or higher 37.9 20.7 
Smoking status (%)  
        Ever smokers 58.1 8.8 
Alcohol consumption (%)  
        Daily drinkers 6.4 1.2 
Physical activity (%)   
        No 75.3 79.9 
        0.5-3hr per week 15.4 12.7 
        ≥4 hr per week 9.3 7.4 
Diabetes mellitus (%) 8.7 9.2 
Stroke (%) 1.8 1.2 
Postmenopausal (%)  72.4 
Hormone replacement use, yes (%)  3.7 
Dietary intake   
  Total energy intake (kcal), mean(SD) 1,749.7 (608.9) 
 
1,399.3 (472.0) 
  Total protein intake (g), mean (SD) 65.2 (25.9) 54.4 (21.5) 
  Total vegetables (g/day), mean (SD) 111.3 (65.6) 110.0 (61.9) 
       Green vegetables (g/day), mean 
(SD) 
67.4 (41.6) 66.3 (39.6) 
       Yellow-orange vegetables (g/day), 
mean (SD) 
7.3 (8.4) 8.5 (8.8) 
       Cruciferous vegetables(g/day), 
mean (SD) 
44.1 (29.6) 43.4 (28.3) 
       Tomato products(g/day), mean (SD) 7.7 (9.5) 7.3 (9.1) 
  Total fruit (g/day), mean (SD) 212.7 (177.1) 194.4 (162.2) 
  Total carotenoids (µg/day), mean (SD) 5,800.4 (3,884.0) 5,541.6 (3,495.8) 
  α-carotene (µg/day), mean (SD)  240.9 (275.8) 268.2 (287.9) 
  β-carotene (µg/day), mean (SD) 2,125.6 (1,514.3) 2,197.4 (1,472.7) 
  β-crytoxanthin(µg/day), mean (SD) 270.3 (343.0) 240.8 (327.6) 
  Lycopene (µg/day), mean (SD) 1,307.0 (1,707.6) 950.3 (1,300.2) 





Table 5-2. Dietary intake of vegetables, fruits and carotenoids in relation to hip fracture incidence for men (n=27,913) and women (n=35,241), 
The Singapore Chinese Health Study, 1993-2010. 
 
 
Men (quartile of energy-adjusted intake) 
 
Women (quartile of energy-adjusted intake) 
 
 Q1 Q2 Q3 Q4 
p for 
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Hazard ratios (HRs) were adjusted for age at recruitment (years), year of recruitment (1993-1995, 1995-1998), dialect group (Hokkien, Cantonese), body 
mass index (kg/m2), level of education in categories (no formal education, primary school, secondary school or higher), total energy intake (kcal), smoking 
status (never smokers, ex-smokers, current smokers), physical activity (none, 2-<4 hrs weekly, ≥4hrs weekly), calcium (quartiles, mg/1,000kcal/day), soy 
isoflavones (quartiles, mg/1,000kcal/day), vitamin B6 (quartiles, mg/1,000kcal/day), menopausal status (women only; yes, no), use of hormone replacement 
therapy at recruitment (women only; yes, no), baseline physician-diagnosed history of diabetes (yes, no) and stroke (yes, no). CI, confidence interval.
Lycopene    




















Table 5-3. Body mass index in relation to hip fracture incidence in men and women, The Singapore Chinese Health Study, 1993-2010.  




Men(n=23,918) Women (n=28,874) 
Cases HR 95% CI Cases HR 95% CI 
<20 85 1.00  164 1.00  
20-<25 211 0.82 0.64-1.06 468 0.93 0.78-1.11 
≥25 70 0.67 0.49-0.93 240 0.91 0.74-1.11 
p for trend  0.016   0.384  
 
Hazard ratios (HRs) were adjusted for age at recruitment (years), year of recruitment (1993-1995, 1995-1998), dialect group (Hokkien, 
Cantonese), level of education in categories (no formal education, primary, secondary or higher), smoking status (Never smokers, Ex-smokers, 
Current smokers), total energy intake (kcal/day),  physical activity (none, 2-<4 hrs weekly, ≥4hrs weekly), total energy (kcal), calcium 
(quartiles, mg/1,000kcal/day), soy isoflavones (quartiles, mg/1,000kcal/day),  vitamin B6 (quartiles, mg/1,000kcal/day), baseline physician-
diagnosed history of diabetes (yes, no) and stroke (yes, no). HR
*
, adjusted for above plus menopausal status (women only; yes, no) and use of 




Figure 5-2. Hazard ratio (95% CI) for hip fracture by quartiles of total 
vegetables (panel A) or total carotenoids (panel B) in men (n= 23,918), 





Hazard ratio (95% CI) for hip fracture by quartiles (Q1–Q4) of dietary intake 
of total vegetables (A) or total carotenoids (B) in men, according to levels of 
body mass index. Models were adjusted for age at recruitment (years), year of 
recruitment (1993-1995, 1995-1998), dialect group (Hokkien, Cantonese), 
level of education in categories (no formal education, primary, secondary or 
higher), smoking status (Never smokers, Ex-smokers, Current smokers), total 
energy intake (kcal/day),  physical activity (none, 2-<4 hrs weekly, ≥4hrs 
weekly), total energy (kcal), calcium (quartiles, mg/1,000kcal/day), soy 
isoflavones (quartiles, mg/1,000kcal/day), vitamin B6 (quartiles, 
mg/1,000kcal/day), baseline physician-diagnosed history of diabetes (yes, no) 




Table 5-4. Dietary intake of vegetables and carotenoids in relation to hip 
fracture incidence for men (n= 23,918), according to levels of body mass 
index, The Singapore Chinese Health Study, 1993-2010.  
 BMI<20 kg/m
2
 20≤BMI<25 kg/m2 BMI≥25 kg/m2 
 Cases 
(n=85) 
HR 95% CI 
Cases 
(n=211) 
HR 95% CI 
Cases 
(n=70) 
HR 95% CI 
Green vegetables (g/1000kcal/day) 
Q1 (<28) 45 1.00  76 1.00  16 1.00  
Q2 (28-40) 27 0.97 0.59-1.59 51 0.90 0.62-1.29 25 1.72 0.91-3.26 
Q3(40-55) 9 0.35 0.17-0.75 46 0.93 0.64-1.36 17 1.43 0.70-2.90 
Q4 (≥55) 4 0.23 0.08-0.66 38 0.91 0.60-1.39 12 1.29 0.58-2.86 
p for trend  0.0004  0.67   0.604 
P for interaction   0.004    
Yellow-orange vegetables (g/1000kcal/day) 
Q1(<1.8) 42 1.00  65 1.00  28 1.00  
Q2 (1.8-3.7) 23 0.77 0.46-1.30 65 1.14 0.81-1.62 19 0.76 0.42-1.36 
Q3 (3.7-6.8) 11 0.44 0.22-0.86 50 1.06 0.72-1.54 18 0.86 0.47-1.57 
Q4 (≥6.8) 9 0.49 0.23-1.04 31 0.81 0.52-1.25 5 0.27 0.10-0.70 
p for trend  0.009  0.42   0.02  
P for interaction   0.752    
α- carotene (µg/1000kcal/day) 
Q1 (<59.8) 41 1.00  65 1.00  23 1.00  
Q2 (59.8-114.4) 20 0.66 0.39-1.14 57 0.96 0.67-1.34 21 0.96 0.52-1.74 
Q3 (114.4-212.3) 16 0.65 0.36-1.18 53 1.04 0.72-1.51 16 0.81 0.42-1.57 
Q4 (≥212.3) 8 0.41 0.19-0.89 36 0.87 0.57-1.34 10 0.60 0.28-1.29 
p for trend  0.02   0.70   0.18  
P for interaction   0.406    
β- carotene (µg/1000kcal/day) 
Q1 (<850.4) 48 1.00  69 1.00  24 1.00  
Q2 (850.4-1235.4) 21 0.69 0.41-1.18 66 1.20 0.85-1.70 20 0.94 0.51-1.73 
Q3 (1235.4-1772.4) 11 0.42 0.21-0.84 39 0.82 0.54-1.25 16 0.92 0.47-1.80 
Q4 (≥1772.4) 5 0.27 0.10-0.70 37 1.03 0.66-1.61 10 0.68 0.31-1.53 
p for trend  0.0008  0.68   0.41  
P for interaction   0.054    
Lutein/Zeaxanthin (µg/1000kcal/day)  
Q1 (<781.8) 41 1.00  67 1.00  18 1.00  
Q2 (781.8-1104.2) 28 1.07 0.65-1.75 62 1.22 0.85-1.74 22 1.48 0.78-2.80 
Q3 (1104.2-1544.1) 10 0.46 0.22-0.93 44 1.00 0.68-1.49 17 1.32 0.66-2.63 
Q4 (≥1544.1) 6 0.40 0.16-0.97 38 1.10 0.71-1.70 13 1.38 0.64-3.01 
p for trend  0.009  0.87   0.45  
P for interaction   0.015    
Lycopene (µg/1000kcal/day)       
Q1 (<191.9) 24 1.00  59 1.00  11 1.00  
Q2 (191.9-451.9) 29 1.53 0.87-2.67 52 0.97 0.66-1.41 23 1.81 0.87-3.75 
Q3 (451.9-858.4) 17 0.94 0.50-1.77 62 1.11 0.77-1.61 21 1.52 0.72-3.23 
Q4 (≥858.4) 15 1.28 0.65-2.56 38 0.82 0.53-1.28 15 1.26 0.54-2.91 
p for trend  0.85   0.64   0.80  
P for interaction   0.844    
 
Hazard ratios (HRs) were adjusted for age at recruitment (years), year of  
recruitment (1993-1995, 1995-1998), dialect group (Hokkien, Cantonese), 
body mass index (kg/m
2




education, primary school, secondary school or higher), total energy intake 
(kcal), smoking status (never smokers, ex-smokers, current smokers), physical 
activity (none, 2-<4 hrs weekly, ≥4hrs weekly), calcium (quartiles, 
mg/1,000kcal/day), soy isoflavones (quartiles, mg/1,000kcal/day), vitamin B6 
(quartiles, mg/1,000kcal/day), menopausal status (women only; yes, no), use 
of hormone replacement therapy at recruitment (women only; yes, no), 
baseline physician-diagnosed history of diabetes (yes, no) and stroke (yes, no). 





Supplemental Table 5-1. Pearson’s correlation coefficient between dietary intake of carotenoids (µg/day) and vegetables (g/day), the Singapore 
Chinese Health Study, 1993-2010 
 
  Total carotenoids α-carotene β-carotene β-cryptoxanthin Lycopene Lutein/Zeaxanthin 
Total 
carotenoids 
  0.64 0.91 0.39 0.71 0.82 
α-carotene    0.77 0.17 0.24 0.44 
β-carotene     0.29 0.41 0.82 
β-cryptoxanthin      0.25 0.21 
Lycopene       0.31 
Total vegetables  0.84 0.60 0.85 0.23 0.37 0.89 
Green 
vegetables 
0.80 0.45 0.80 0.20 0.32 0.94 
Yellow-orange 
vegetables 
0.62 0.94 0.74 0.14 0.23 0.44 





Supplemental Table 5-2. Dietary intake of vegetables and carotenoids in relation to hip 
fracture incidence for women (n=28,874), according to levels of body mass index, The 
Singapore Chinese Health Study, 1993-2010. 
P for interaction          0.545 
 
          BMI < 20 kg/m
2
 20 ≤ BMI < 25 kg/m2          BMI ≥ 25kg/m2 
 Cases 
(n=164) 
HR (95% CI) 
Cases 
(n=468) 
HR (95% CI) 
Cases 
(n=240) 
HR (95% CI) 
Total vegetables (g/1000kcal/day) 
Q1 (<49) 49 1.00  116   1.00  54 1.00  
Q2 (49-67) 35 0.78 (0.50-1.22) 123 0.99 (0.78-1.29) 59 0.94 (0.65-1.36) 
Q3(67-89) 50 1.19 (0.75-1.81) 123 0.99 (0.76-1.29) 58 0.83 (0.57-1.22) 
Q4 (≥89) 30 0.66 (0.40-1.09) 106 0.87 (0.65-1.17) 69 0.90 (0.60-1.34) 
p for trend  0.41   0.38   0.51  
P for interaction   0.604     
Green vegetables (g/1000kcal/day) 
Q1 (<28) 48 1.00  123 1.00  49 1.00  
Q2 (28-40) 45 1.13 (0.74-1.71) 105 0.81 (0.62-1.05) 60 1.07 (0.73-1.56) 
Q3(40-55) 33 0.9 (0.57-1.43) 117 0.96 (0.74-1.25) 60 1.01 (0.68-1.49) 
Q4 (≥55) 38 1.06 (0.67-1.69) 123 0.95 (0.73-1.25) 71 1.10 (0.74-1.63) 
p for trend  0.96   0.95   0.73  
P for interaction  0.522     
Yellow-orange vegetables (g/1000kcal/day) 
Q1(<1.8) 35 1.00  112 1.00  49 1.00  
Q2 (1.8-3.7) 44 1.15 (0.74-1.81) 128 0.97 (0.75-1.26) 62 1.03 (0.71-1.51) 
Q3 (3.7-6.8) 42 1.03 (0.65-1.63) 118 0.84 (0.64-1.09) 62 0.91 (0.62-1.33) 
Q4 (≥6.8) 43 1.06 (0.66-1.71) 110 0.83 (0.63-1.09) 67 0.98 (0.66-1.43) 
p for trend  0.96   0.10   0.74  
P for interaction  0.949     
Total carotenoids (µg/1000kcal/day) 
Q1 (<2,315) 52 1.00  136 1.00  57 1.00  
Q2 (2,315-3,283) 38 0.84 (0.54-1.29) 120 0.87 (0.68-1.12) 67 1.09 (0.76-1.57) 
Q3 (3,283-4,577) 32 0.82 (0.51-1.32) 114 0.88 (0.67-1.14) 53 0.83 (0.56-1.24) 
Q4 (≥4,577) 42 1.14 (0.70-1.85) 98 0.81 (0.60-1.10) 63 0.96 (0.63-1.46) 
p for trend  0.70   0.20   0.56  
P for interaction  0.869     
α- carotene (µg/1000kcal/day)    
Q1 (<59.8) 32 1.00  108 1.00  56 1.00  
Q2 (59.8-114.4) 45 1.12 (0.71-1.77) 125 0.83 (0.64-1.08) 61 0.87 (0.60-1.25) 
Q3 (114.4-212.3) 36 1.02 (0.63-1.67) 129 0.95 (0.73-1.23) 61 0.80 (0.55-1.16) 
Q4 (≥212.3) 51 1.44 (0.90-2.31) 106 0.82 (0.62-1.09) 62 0.81 (0.55-1.19) 
p for trend  0.16   0.36   0.27  
P for interaction  0.166     
β- carotene(µg/1000kcal/day) 
Q1 (<850.4) 47    1.00   117 1.00  45 1.00  
Q2 (850.4-1,235.4) 41 0.95 (0.61-1.46)  124 0.90 (0.69-1.16) 71 1.33 (0.91-1.95) 
Q3(1,235.4-1,772.4) 34 0.82 (0.51-1.31)  118 0.89 (0.68-1.16) 52 0.92 (0.61-1.40) 
Q4 (≥1,772.4) 42 0.96 (0.59-1.54)  109 0.82 (0.61-1.09) 72 1.16 (0.77-1.76) 





Hazard ratios (HRs) were adjusted for age at recruitment (years), year of recruitment (1993-
1995, 1995-1998), dialect group (Hokkien, Cantonese), level of education in categories (no 
formal education, primary, secondary or higher), smoking status (Never smokers, Ex-smokers, 
Current smokers), total energy intake (kcal/day),  physical activity (none, 2-<4 hrs weekly, ≥
4hrs weekly), total energy (kcal), calcium (quartiles, mg/1,000kcal/day), soy isoflavones 
(quartiles, mg/1,000kcal/day),  vitamin B6 (quartiles, mg/1,000kcal/day), menopausal status 
(yes, no), use of hormone replacement therapy at recruitment (yes, no), baseline physician-
diagnosed history of diabetes (yes, no) and stroke (yes, no).  
CI, confidence interval.
Lutein (µg/1000kcal/day) 
Q1 (<781.8) 46 1.00  115 1.00  50 1.00  
Q2 (781.8-1,104.2) 43 1.06 (0.69-1.62) 114 0.88 (0.68-1.15) 54 0.92 (0.63-1.36) 
Q3 (1,104.2-1,544.1) 33 0.87 (0.55-1.39) 108 0.88 (0.67-1.15) 59 0.90 (0.61-1.33) 
Q4 (≥1,544.1) 42 1.05 (0.67-1.67) 131 0.97 (0.74-1.27) 77 1.06 (0.72-1.57) 
p for trend  0.97   0.86    0.73  
P for interaction  0.602     
Lycopene (µg/1000kcal/day)   
Q1 (<191.9) 55 1.00  185 1.00  75 1.00  
Q2 (1,91.9-451.9) 53 1.47 (0.99-2.17) 126 0.96 (0.76-1.21) 77 1.40 (1.01-1.94) 
Q3 (451.9-858.4) 34 1.15 (0.73-1.80) 88 0.83 (0.64-1.08) 50 1.00 (0.69-1.45) 
Q4 (≥858.4) 22 1.00 (0.59-1.70) 69 0.84 (0.62-1.13) 38 0.89 (0.59-1.36) 
p for trend  0.97   0.13   0.44  




Supplemental Table 5-3. Results for total vegetables/carotenoids in relation 
to risk of hip fracture using gender-specific cut-off in nutrient density, residual 
method, and exclusion of extreme caloric intake (≤600 and ≥3,000 kcal) for 
men and women. 
 
 Men(n=27,913) Women (n=35,241) 
Gender-specific cut-off for density 
 
Cases HR2 (95% CI)  Cases HR2 (95% CI) 
Total vegetables (g/1,000kcal/day)  
Q1 (26.7, 38.8)1 146 1.0 Q1 (35.6, 49.2) 378 1.0 
Q2 (47.3, 55.1) 115 0.84 (0.66, 1.08) Q2 (59.1, 68.2) 307 0.98 (0.84, 1.14) 
Q3 (63.4, 73.4) 94 0.68 (0.52, 0.89) Q3 (78.1, 89.6) 280 1.00 (0.85, 1.18) 
Q4 (86.8, 115.3) 95 0.68 (0.51, 0.91) Q4 (106.0, 139.9) 215 0.89 (0.74, 1.07) 
p for trend  0.003   0.34 
Total carotenoids (µg/1,000kcal/day) 
Q1 (1206.8, 1836.0) 139 1.0 Q1 (1587.0, 2273.4) 399 1.0 
Q2 (2296.3, 2742.3) 129 0.95 (0.75, 1.22) Q2 (2797.9, 3284.6) 322 1.04 (0.89, 1.20) 
Q3 (3209.7, 3795.0) 101 0.79 (0.60, 1.04) Q3 (3823.8, 4477.0) 251 0.94 (0.79, 1.11) 
Q4 (4612.2, 6338.5) 80 0.66 (0.48, 0.90) Q4 (5439.6, 7467.5) 205 0.95 (0.78, 1.15) 
p for trend  0.005   0.42 
Residual method  
Total vegetables (g %/day) 
Q1 (-70.8, -43.2) 187 1.0 Q1 (-57.5, -39.2) 262 1.0 
Q2 (-27.9, -15.3) 120 0.88 (0.69, 1.12) Q2 (-26.8, -14.4) 335 0.90 (0.76, 1.07) 
Q3 (-1.7, -13.8) 83 0.71 (0.54, 0.93) Q3 (-1.3, 14.1) 334 0.99 (0.84, 1.18) 
Q4 (36.9, 88.3) 60 0.60 (0.44, 0.83) Q4 (37.0, 86.4) 249 0.91 (0.75, 1.10) 
p for trend  0.0005   0.63 
Total carotenoids (µg %/day) 
Q1 (1711.7, 3209.9)                 176 1.0 Q1 (2397.7, 3417.1) 272 1.0 
Q2 (4050.2,4716.9)                 121 0.93 (0.73, 1.19) Q2 ( 4099.4, 4771.2)                370 0.99 (0.84, 1.16) 
Q3 (5467.2, 6345.5)                 93 0.87 (0.66, 1.14) Q3 (5468.7, 6353.4)                 312 0.98 (0.82, 1.17) 
Q4 (7719.6, 10927.7)                 59 0.64 (0.46, 0.89) Q4 (7676.6, 10660.6)                 223 0.94 (0.77, 1.15) 
p for trend  0.01   0.57 
Exclusion of extreme caloric intake (density intake based on whole cohort) (n=61,497)  
Total vegetables (g/1,000kcal/day) 
Q1 (29.4, 43.4)                181 1.0 Q1 (32,6, 44.4)                 280   1.0 
Q2 (52.9, 61.6)               116 0.86 (0.68, 1.09) Q2 (53.4, 62.4)                 285 0.93 (0.79, 1.10) 
Q3 (71.0, 82.0)              88 0.75 (0.57, 0.98) Q3 (71.7, 82.9)               317 1.03 (0.87, 1.22) 
Q4 (97.0, 124.9)                 54 0.60 (0.43, 0.83) Q4 (98.6, 132.5)                 268 0.88 (0.73, 1.06) 
p for trend               0.001  0.40 
Total carotenoids (µg/1,000kcal/day) 
Q1 (1,321.2, 2,027.9)                 171 1.0 Q1 (1,418.8, 2,089.4)                 322 1.0 
Q2 (2,550.2, 3,019.2)                 118 0.85 (0.67, 1.09) Q2 (2,576.5, 3,053.1)                 299 0.96 (0.82, 1.13) 
Q3 (3,539.2, 4,161.1)                 91 0.81 (0.62, 1.06) Q3 (3,559.6, 4,188.8)                 278 0.97 (0.82, 1.15) 
Q4 (5,029.7, 6,780.6)                 58 0.65 (0.47, 0.90) Q4 (5,121.3, 7,160.2)                 248 0.95 (0.79, 1.15) 






 Inter-quartile range 
 
2
 Hazard ratios (HRs) were adjusted for age at recruitment (years), year of 
recruitment (1993-1995, 1995-1998), dialect group (Hokkien, Cantonese), 
body mass index (kg/m
2
), level of education in categories (no formal 
education, primary school, secondary school or higher), total energy intake 
(kcal), smoking status (never smokers, ex-smokers, current smokers), physical 
activity (none, 2-<4 hrs weekly, ≥4hrs weekly), calcium (quartiles, 
mg/1,000kcal/day), soy isoflavones (quartiles, mg/1,000kcal/day), vitamin B6 
(quartiles, mg/1,000kcal/day), menopausal status (women only; yes, no), use 
of hormone replacement therapy at recruitment (women only; yes, no), 
baseline physician-diagnosed history of diabetes (yes, no) and stroke (yes, no). 






Chapter 6. Consumption of caffeine, coffee and tea in 
relation to risk of hip fracture (currently under review) 
6-1. Background 
 
 Coffee and tea belong to the most widely consumed beverages in the 
world and have been studied extensively on its impact in health risk including 
osteoporosis and related fractures (216, 383). However, conflicting results 
have been shown in both experimental and observational studies. This could 
be due to the complexity of components in coffee and tea.  
Coffee is the major source of caffeine but also comprises of other non-
caffeine compounds such as cafestol, cholorognenic acid, caffeic acid and 
trigonelline (212, 383 ). In cell culture and animal models, caffeine at high 
dosage was reported to suppress osteogenesis (209), increase osteoblastic 
apoptosis (384) and osteoclastic formation and differentiation (205) in vitro; 
and inhibit bone growth, decrease bone mineral density (205, 384, 385), and 
affect bone healing in male rats (386). By contrast, caffeine at low to moderate 
dose may enhance osteogenesis in vitro (209) and increase bone mass and 
strength in ovariectomized rats (210). Additionally, non-caffeine compounds 
found in coffee such as caffeic acid, chlorogenic acid (387) or trigonelline 
(212) were reported to have unfavorable effects on the skeletons in 
ovariectomized rats. Hence, it is possible that the effect of coffee consumption 
on bone health may depend on the dose and composition of coffee consumed, 
for example, regular versus decaffeinated coffee. Tea is an important source of 
polyphenols and the level of caffeine is considerably lower than coffee based 
on volume. Studies have shown that polyphenols from black tea (theaflavin-3, 




formation and differentiation (217), reduced bone loss (214, 215) and 
improved microarchitecture (215) in ovariectomized rats.  
In observational studies, the overall results are generally null for the 
associations between consumption of coffee or tea and fracture risk. Three 
recent meta-analyses, including studies up to February 2013, examined the 
relationship between coffee consumption and risk of fractures (219-221) and 
showed a non-significant association with pooled relative risks ranging from 
0.94 to 1.30 for hip fracture (220, 221) and any fracture (219) comparing the 
highest to the lowest categories. For tea, inconsistent results were also shown 
in observational studies (216). The only meta-analysis on tea did not report 
any significant relationship with hip fracture risk (220). Furthermore, stratified 
analysis by gender in these meta-analyses suggested reduced risk in men but 
increased risk in women for the association with coffee consumption (195, 
220). Taking the existing experimental and observational evidence together, 
we hypothesized that the relationship between coffee or caffeine and risk of 
osteoporotic hip fracture might depend on the amount of intake and might 
differ between men and women. 
In addition to the significant increase of hip fracture cases in Asia by 
2050 (388), the coffee market in Asia has also been growing rapidly in the 
past 20 years and becomes the fastest growing market globally (389). 
Therefore, the objective of this study was to examine the relationship between 
intake of coffee and tea, as well as their estimated caffeine content, and risk of 
hip fractures in middle-aged and elderly Chinese men and women in 
Singapore. We further explored possible interactions between dosages of 






Dietary assessment of coffee, tea and caffeine  
 
Baseline assessment among all participants were conducted via a face-
to-face structured interview and the information included demographics, 
medical history, cigarette smoking, alcohol consumption, physical activity, 
and detailed menstrual and reproductive history (women only). Habitual 
dietary intake during the past year at enrollment was recorded using a 165-
item semi-quantitative validated Food Frequency Questionnaire (FFQ) to 
estimate consumption of foods and nutrients. The development and validation 
of the FFQ were reported in detail previously (320).  
For the intake of coffee and tea, participants were asked, on average, 
during the past year how often they consumed one cup of coffee (instant or 
freshly brewed), one cup of Chinese red tea or Ceylon tea (i.e., black tea), and 
one cup of green tea, such as jasmine tea, according to nine predetermined 
categories: never or hardly ever, 1-3 times a month, once a week, 2-3 times a 
week, 4-6 times a week, once a day, 2-3 times a day, 4-5 times a day, and 6 or 
more times a day. Because decaffeinated coffee was rarely consumed in our 
study population at the time of recruitment, all coffee consumed was assumed 
to be caffeinated in this study (320, 390). The dietary information on soda 
intake did not differentiate between caffeine and non-caffeine beverage, thus 
caffeinated soda was not examined in this study. The levels of caffeine intake 
were estimated from the Singapore Food Composition Table, which listed 96 
nutritional and non-nutritional values per 100 grams of the edible foods and 




tea were the two main contributors of caffeine and accounted for roughly 84% 
and 12% of the dietary caffeine in this cohort, respectively. 
Statistical analysis 
 
For each study subject, person-years were counted from the date of 
baseline interview to the date of hip fracture occurrence, migration out of 
Singapore, death, or 31 December 2010, whichever occurred first. For both 
coffee and tea drinking, we compared a higher intake category to less than 
weekly drinkers as the reference group. Since one cup of coffee contains 
approximately 100 mg caffeine (383), we studied daily caffeine intake in 
categories of 100-<200, 200-<300, or ≥300 mg versus <100 mg, which was 
the reference group. Cox proportional hazards regression was used to assess 
the association between consumption of coffee, tea or caffeine at baseline and 
hip fracture risk by comparing a higher intake category to the lowest 
(reference) category. We did not identify any violation of the proportional 
hazard assumption or multicollinearity among the covariates that were entered 
in the models. The strength of the association between a dietary factor and hip 
fracture risk was estimated by hazard ratios (HRs) and their corresponding 95% 
confidence intervals (CI). Furthermore, we evaluated whether gender may 
modify the associations with coffee/tea/caffeine, and confined the analysis to 
women who were postmenopausal at recruitment.  
We assessed the associations between coffee/tea/caffeine and risk of 
hip fracture in the Cox regression models with two sets of covariates. Model 1 
included the following covariates: age (continuous), year at recruitment (1993-
1995 and 1996-1998), dialect group (Hokkien, Cantonese), level of education 




index (BMI) (<20, 20–23.9, 24–27.9, ≥28 kg/m2), smoking status with 
intensity (never smokers, ex-smokers: 1-12 cigarettes/day, 13-22 cigarettes 
/day, ≥23 cigarettes /day; current smokers: 1-12 cigarettes/day, 13-22 
cigarettes /day, ≥23 cigarettes /day), moderate physical activity (none, 0.5-<4 
hrs weekly, ≥4 hrs weekly), at least weekly use of vitamins/minerals (yes, no), 
menopause status (women only; yes, no), use of hormone replacement therapy 
at recruitment (postmenopausal women only; yes, no), and baseline self-
reported physician-diagnosed history of diabetes mellitus (yes, no) and stroke 
(yes, no). In addition to these variables, model 2 included total energy intake 
(kcal/day), dietary calcium (mg/1,000 kcal/day in quartiles), dietary soy 
isoflavones (mg/1,000 kcal/day in quartiles), dietary pyridoxine (mg/1,000 
kcal/day in quartiles) and dietary β-carotene (µg/1,000 kcal/day in quartiles). 
These nutrients were shown to be significant protective factors against risk of 
hip fracture in this cohort (20, 121, 347). We also adjusted for black tea and 
green tea consumption (less than weekly, weekly to <daily, daily drinkers) 
when examining the association with coffee; and adjusted for coffee intake 
(less than weekly, weekly to <daily, 1 cup/day, 2-3 cups/day, and ≥4 cups day) 
when examining the association with tea. The cut-off of caffeine intake and 
the quartile definition for other energy-adjusted nutrients, such as soy 
isoflavones, vitamin B6, and β-carotene, were based on their distributions 
among both men and women combined in the whole cohort. Heterogeneity of 
the beverage/caffeine-hip fracture associations between men and women was 
tested with an interaction term in the models. Finally, we performed sensitivity 







About 70% of our cohort participants were daily coffee drinkers (≥1 
cup/day) and 47% were weekly tea drinkers (≥1 cup/week). Table 1 describes 
the baseline characteristics between cases and non-cases of hip fracture 
incidence for men and women separately. For both genders, compared to non-
cases, those with hip fractures were older, less educated, more likely to smoke, 
had lower dietary β-carotene and higher prevalence of self-reported diabetes 
and stroke. However, no difference between cases and non-cases was found in 
dietary intake of coffee, caffeine, vitamin D, calcium or use of multivitamin 
supplements. For men, while hip fracture cases had lower BMI and were less 
physically active than non-cases, there was no difference in dietary soy 
isoflavones and vitamin B6 between them. For women, compared to non-cases, 
those with hip fractures drank less tea, had lower dietary soy isoflavones and 
vitamin B6, and were more likely to be postmenopausal at recruitment. 
Among postmenopausal women, cases were also less likely to use hormone 
replacement at recruitment. No difference was found in BMI and physical 
activity between cases and non-cases among women (Table 6-1).     
Table 6-2 shows the relationship between consumption of coffee and 
risk of hip fracture for overall, men, women and postmenopausal women 
separately. The two models yielded very similar results. Compared with less 
than weekly drinkers, there was a non-statistically significant increase in risk 
of hip fracture with coffee drinking among men. By contrast, among women, 
the risk was decreased with coffee drinking and was the lowest among women 
drinking 2-3 cups/day (HR: 0.84; 95% CI: 0.71, 0.99). The risk estimates 




different between men and women (p for interaction = 0.04). However, 
drinking ≥4 cups/day was associated with a marginally significant 25% 
increase in risk (HR: 1.25; 95% CI: 0.96, 1.62, p=0.10) in the whole cohort 
with men and women combined; such increased risk was similarly observed in 
women (HR: 1.27; 95% CI: 0.92, 1.76) as well as in men (HR: 1.32; 95% CI: 
0.83, 2.12). Further analysis confined to postmenopausal women at 
recruitment yielded similar results, since 97% of hip fractures in women 
occurred among those who were postmenopausal at recruitment.  
The relationship between tea drinking and hip fracture risk is presented 
in Table 6-3. Further adjustment for dietary nutrients and coffee intake did not 
change the results materially. The association between tea drinking and risk of 
hip fracture was generally null regardless of the type of tea or gender, although 
there was a non-statistically significant reduction in risk observed in the 
highest intake categories. Similar results were also found among 
postmenopausal women at baseline.  
As expected, there was a high correlation between intake of coffee and 
caffeine; the partial Pearson’s correlation coefficient by gender between intake 
of caffeine and coffee was 0.87. Conversely, the Pearson’s correlation 
between intake of caffeine and tea was lower, r=0.36. The correlation between 
coffee drinking status (less than weekly drinkers, weekly-<daily drinkers, 1 
cups/day,  2-3 cups/day, ≥4 cups/day) and smoking status with intensity (never 
smokers, ex-smokers: 1-12 cigarettes/day, 13-22 cigarettes /day, ≥23 
cigarettes /day; current smokers: 1-12 cigarettes/day, 13-22 cigarettes /day, 
≥23 cigarettes /day) was positive but low, where the Spearman’s correlation 




caffeine intake was correlated with dietary soy-isoflavones, vitamin B6, β-
carotenoid, calcium or vitamin D, where the Pearson’s correlation coefficients 
ranged from -0.14 to -0.06.  
Table 6-4 shows the association between dietary caffeine and risk of 
hip fracture. We did not observe significant associations in the overall cohort 
or in men for any category of caffeine intake. However, in women, there was a 
statistically significant 14% decreased risk [HR (95% CI): 0.86 (0.74, 1.00), 
p=0.048] in those who had daily caffeine intake of 200-<300 mg as compared 
to those who consumed <100 mg. In addition, there was an increased risk in 
women with higher daily intake of ≥300 mg, albeit not reaching statistical 
significance. Such association became more apparent among postmenopausal 
women, and the difference in risk estimates associated with 200-<300 mg of 
caffeine intake and hip fracture risk between men and women were of 
marginal significance (p for interaction = 0.08). Sensitivity analysis excluding 
those who had reported extreme energy intakes (≤ 600 and ≥ 3,000 kcals/day) 
or using a sex-specific cut-off for dietary variables yielded similar results for 
coffee, tea and caffeine in relation to hip fractures. No interaction between 
coffee/caffeine with baseline BMI, self-reported history of diabetes, dietary 
calcium level and smoking status, all Ps-for-interaction >0.30.  
6-4. Discussion 
 
In this large prospective cohort of middle-aged to elderly Singapore 
Chinese, protective effect was found in postmenopausal women who drank 2-
3 cups of coffee per day or equivalent to caffeine of 200-<300 mg on hip 
fractures. In addition, daily coffee consumption of 4 cups or more was 




association was not statistically significant (p=0.10). However, no association 
was found with tea drinking. To the best of our knowledge, the current study is 
the first to report that the effects of coffee and caffeine on hip fracture risk 
may depend on dosage, and the possible protective effect at moderate dose of 
intake may only be limited to postmenopausal women. 
The available epidemiologic evidence on coffee or caffeine in relation 
to hip fracture is inconclusive. Some studies suggested that high coffee or 
caffeine intake was associated with increased risk of hip fractures (225, 226, 
228, 238), while others reported favorable relations (223) or null associations 
(224, 231, 232). In these studies, the cut-off for coffee or caffeine levels varied 
from one study to another. For example, in the Framingham study, there was a 
significant 69% and 82% increase in risk in caffeine intake of 2.5-3.0 units / 
day and of ≥3.5 units /day, respectively, comparing to 0-1.0 unit /day (225). In 
the Nurses’ Health Study, there was a significant trend between higher 
caffeine/coffee intake and risk of hip fracture (p<0.05). Women at the fifth 
quintile of caffeine intake (≥817 mg/day) had a significant 2.95-fold increased 
risk of hip fracture as compared to the first quintile (0- 191.9 mg/day), and 
women who drank coffee ≥4 cups/day had a significant 3.35-fold higher risk 
relative to those almost never drank coffee, yet there were no significant 
associations in other quintiles of caffeine or coffee categories (1-3/month to 2-
4/week; 5-6/week to 1/day and 2-3/day) (226). However, the hip fracture cases 
were very small (≤20) in each category in this study (226). In the Iowa 
Women's Health Study, there was a null association found in all coffee intake 
categories (1-4 cups/month, 2-7 cups/week, 2-5 cups/day and ≥6 cups/day) as 




In these two studies, it appears that a linear relationship was assumed between 
intake of coffee/caffeine and fracture risk (226, 231). The hip fracture cases 
were too small in the Nurses’ Health Study (226), thus the results could be due 
to chance. In the Iowa Women's Health Study, coffee of 2-5 cups/day was 
constructed in one category (231). This may have left out the optimal level of 
coffee/caffeine that has beneficial effects on bone health. In the present study, 
the cut-off values for coffee or caffeine were based on the evidence in 
experimental studies with a hypothesis of possible interactions between 
dosages of coffee/caffeine and gender in the association with hip fractures, 
that a moderate intake of coffee/caffeine may exert bone favorable effects 
while a higher intake may be detrimental to the bones. Consistent with our 
results, a 13% significant hip fracture reduction was found in Swedish women 
who drank 1 cup of coffee per day as compared to those drinking <1 cup of 
coffee/day (224).  
The favorable associations observed in postmenopausal women in this 
study are in line with findings from the recent experimental studies. One study 
showed that caffeine at 0.1mM promoted osteogenesis (209) and another study 
showed that caffeine equivalent to 2 cups of coffee increased trabecular bone 
structure, strength and mineralization in ovariectomized rats (210). At low to 
moderate dose, caffeine binds to adenosine receptor isoforms, such as A1 and 
A2B receptors in the bones to inhibit bone resorption (391) and increase bone 
formation (392), respectively. Conversely, high dosage of caffeine was shown 
to impair bone health in rats (205, 384, 386) and to increase bone resorption in 
cell culture models (205, 209, 384). In the present study, daily drinking 4 cups 




women combined (p=0.10), suggesting that caffeine and other non-caffeine 
compounds at high dosage may have unfavorable impacts on the bones. 
Experimental evidence has shown that caffeine at high dosage may increase 
calcium excretion via decreasing renal reabsorption and intestinal absorption 
of calcium (204), stimulate osteoclastogenesis through up-regulating RANKL 
(receptor activator of nuclear κB ligand) and down-regulating OPG 
(osteoprotegerin) expression (205), and may also reduce vitamin D receptor 
protein expression as well as vitamin D stimulated alkaline phosphatase 
activity in the osteoblasts (207) to reduce bone growth. In addition, non-
caffeine compounds at high dose, such as caffeic acid (387) and trigonelline 
(212), found in coffee may contribute to adverse bone outcomes in 
ovariectomized rats. High dose of trigonelline or caffeic acid from high intake 
of coffee may exert antiestrogenic-like effects to affect bone turnover in favor 
of bone resorption (212, 387). These experimental findings imply that 
compounds other than caffeine at high dose of coffee may further increase the 
risk of osteoporotic fracture.  
Interestingly, we found a gender-specific difference in moderate intake 
of coffee or caffeine in relation to incident hip fractures in postmenopausal 
women (p for interaction < 0.05). Although dietary soy isoflavones (20), 
vitamin B6 (121) and β-carotene (347) were found to be protective against hip 
fractures in this cohort, the correlation between any of these nutrients and 
coffee or caffeine intake is very low and ranged from -0.02 to -0.14 
(p<0.0001). Further adjustment for these nutrients in the Cox model did not 
change the significant relationship. This suggested that the effect of soy 




significant results in postmenopausal women with moderate intake of coffee or 
caffeine. Furthermore, the favorable relationship in postmenopausal women 
with moderate coffee or caffeine intake in our study is in agreement with 
findings from two experimental studies. Caffeine at 0.1mM was shown to 
promote osteogenesis in vitro (209) and caffeine equivalent to 2 cups of coffee 
was found to increase trabecular bone structure, strength and mineralization in 
ovariectomized rats but not in rats with normal estrogen levels (210). This 
suggested that the beneficial effects of moderate dose coffee or caffeine may 
be observed only in a state of estrogen deficiency. If this also applies to 
humans, it would explain the favorable impact of moderate dose of coffee or 
caffeine on hip fractures was only observed in postmenopausal women with 
estrogen deficiency but not in men, whose bone loss or fracture risk may be 
due to other mechanisms rather than estrogen deficiency (347, 354). Further 
studies are required to validate our results in postmenopausal women, and 
evaluate the effects of caffeine and non-caffeine compounds on bone 
physiology and bone outcomes at different dosages. Nevertheless, our results 
should be interpreted cautiously, as we cannot completely rule out other 
unmeasured / residual variables that may be related to fractures in the 
postmenopausal women who consumed moderate coffee / caffeine.  
The strength of this study is the large number of incident hip fracture 
cases identified from a population-based prospective cohort with a long 
follow-up time. Another strength is the presumed lack of recall bias in 
exposure data since they were obtained prior to disease diagnosis. Our case 
ascertainment through linkage with the comprehensive, nationwide hospital 




with a system for easy access to specialized medical care, and practically all 
hip fracture cases will seek medical attention immediately and be hospitalized. 
Finally, we included all established and other possible risk factors for hip 
fracture as covariates in our regression-based risk models to minimize the 
likelihood of spurious associations resulting from insufficient control of 
confounding. One limitations of this study is a possible misclassification of 
dietary intake of tea or coffee which was recorded from the food frequency 
questionnaire and only at baseline. However, such misclassifications are non-
differential in nature, resulting in an underestimation (as opposed to an 
overestimation) of the true relative risk. Another limitation of this study is a 
lack of information on decaffeinated coffee, which precludes our ability to 
compare the risk of hip fracture between regular and decaffeinated coffee to 
confirm our speculation on the possible harmful effects from non-caffeine 
compounds at high dosage of coffee consumption.  
6-5. Conclusions 
In conclusion, data from our study suggested that moderate coffee 
consumption of 2-3 cups/day or an equivalent intake of 200-<300 mg/day of 
caffeine may benefit postmenopausal women in lowering risk of hip fracture, 
while drinking ≥4 cups of coffee per day may pose possible risk in middle-
aged and elderly individuals. Additional mechanistic and intervention studies 
are warranted to differentiate the effects between regular and decaffeinated 
coffee, as well as to further define the influence of individual constituent in 
























Age at recruitment (years) 63.5±7.02 56.6 ±7.9 <0.0001 
 
64.2±6.7 56.0±7.9 <0.0001 
 Body mass index (kg/m
2
) 22.4±2.9 23.0 ±3.2 <0.0001 
 
23.2±3.2 23.2±3.3 0.78 
Body weight (kg)) 60.5±8.7 62.8 ±9.7 <0.0001 
 
55.1±8.2 55.7±8.5 <0.02 
Body height (cm) 164.3±6.5 165.2 ±6.4 <0.0001 
 
154.1±6.1 154.9±5.8 <0.0001 
 Level of education, n (%)   <0.0001 
 
  <0.0001 
         Secondary or higher 90 (20.0) 10,485 
(38.2) 
 97 (8.2) 7,186 (21.1)  
Smoking status, n (%)   0.0007   <0.0001 
         Never smokers 154 (34.2) 11,555 
(42.1) 
 1,011 (85.7) 31,135 (91.4)  
        Former smokers 129 (28.7) 5,958 (21.7)  50 (4.2) 846 (2.5)  
        Current smokers 167 (37.1) 9,950 (36.2)  119 (10.1) 2,080 (6.1)  
Moderate physical activity, n (%)   0.0003   0.78 
None 324 (72.0) 20,687 
(75.3) 
 938 (79.5) 27,232 (80.0)  
0.5 - <4 hours/week 160 (13.3) 4,245 (15.5)  149 (12.6) 4,330 (12.7)  
≥4 hours/week 66 (14.7) 2,531 (9.2)  93 (7.9) 2,499 (7.30)  
Coffee (cups/day) 1.6±1.3 1.5±1.3 0.55 1.2±1.2 1.3±1.1 0.54 
Daily tea drinkers, n (%) 126 (28.0) 8,021 (29.2) 0.27 161 (13.6) 5,762 (16.9) 0.0005 
Daily green tea drinkers 72 (16.0) 4,237 (15.4) 0.11 105 (8.9) 3,413 (10.0) 0.04 
Daily black tea drinkers 61 (13.6) 4,271 (15.6) 0.13 59 (5.0) 2,605 (7.7) 0.0007 








Chi-square test was used for categorical variables; Student’s t-test was used for continuous variables. 
2
 All such values are mean± SD. 
3  
I.U., international unit. 
At least weekly use of vitamin 
supplements, n (%) 
21 (4.7) 1,325 (4.8) 0.88 75 (6.4) 2,583 (7.6) 0.12 
Vitamin D (I.U.
3
) 62±37 62±35 0.94 68±47 70±43 0.18 
Calcium (mg/1000kcal/day) 244±94 
 
3.9) 








 Vitamin B6 (mg/1000kcal/day) 0.70±0.16 0.70±0.15 0.73 0.68±0.15 0.71±0.15 <0.0001 
 β-carotene (mg/1000 kcal/day) 1.09±0.64 1.23±0.74 0.0002 1.40±0.79 1.59±0.92 <0.0001 
 Diabetes mellitus, n (%) 58 (12.9) 2,357 (8.6) 0.001 246 (20.8) 38.8 (8.8) <0.0001 
<0.0001 
 
Stroke, n (%) 22 (4.9) 482 (1.8) <0.0001 
 
38 (3.2) 394 (1.2) .  
 Postmenopausal women, n (%)    1,141 (96.7) 2,438 (71.6) <0.0001 






Table 6-2. Consumption of coffee in relation to risk of hip fracture, The Singapore Chinese Health Study, 1993-2010 
 
 Less than weekly  Weekly to <daily 1 cup/day 2-3 cups/day ≥4 cups/day 
Overall (n=63,154)     
      Hip fracture cases 364 136 620 439 71 
                   Person-years 176,294 78,892 313,959 266,610 34,204 
     HR
1 
(95% CI) Reference 0.96 (0.79, 1.17)    0.96  (0.85, 1.10)  0.94  (0.81, 1.08) 1.29 (0.99, 1.67) 
 
     HR
2 
(95% CI) Reference 0.96 (0.79, 1.17)    0.97   (0.85, 1.11)  0.93  (0.80, 1.07) 1.25 (0.96, 1.62) 
Men (n=27,913)     
                   Hip fracture cases 81 43 142 159 25 
                   Person-years 69,777 35,024 114,348 131,436 21,123 
    HR
1 
(95% CI) Reference 1.21  (0.84, 1.75)   1.13  (0.86, 1.49) 1.20  (0.91, 1.57) 1.30 (0.82, 2.07) 
    HR
2 
(95% CI)  Reference 1.22 (0.84, 1.77)    1.14  (0.86, 1.50) 1.20  (0.90, 1.59) 1.32  (0.83, 2.12) 
Women (n=35,241)     
                  Hip fracture cases 283 93 478 280 46 
                  Person-years 106,516 43,868 199,610 135,175 13,081 
   HR
1 
(95% CI) Reference 0.88  (0.70, 1.12) 0.91  0. (0.79, 1.06) 0.85  (0.72, 1.01) 1.35  (0.98, 1.85) 
 
   HR
2 
(95% CI) Reference 0.89  (0.70, 1.12) 0.93  (0.80, 1.07) 0.84  (0.71, 0.99) 1.27  (0.92, 1.76) 
Postmenopausal women (n=25,522)     
                 Hip fracture cases 275 90 466 266 44 
                 Person-years 74,431 29,918 142,778 96,436 9,519 
  HR
1










Hazard ratios (HRs): HRs
1
 were adjusted for gender (whole cohort), age at recruitment (years), year of recruitment (1993-1995, 1995-1998), 
dialect group (Hokkien, Cantonese), body mass index (<20, 20-23.9, 24-27.9, ≥28 kg/m2), level of education in categories (no formal education, 
primary school, secondary school or higher), smoking status with intensity (never smokers, ex-smokers: 1-12 cigarettes/day, 13-22 cigarettes 
/day, >23 cigarettes /day; current smokers: 1-12 cigarettes/day, 13-22 cigarettes /day, >23 cigarettes /day), physical activity (none, 0.5 - <4 hrs 
weekly, ≥4 hrs weekly), at least weekly use of vitamins/mineral (yes, no), menopausal status (women and postmenopausal women; yes, no), use 
of hormone replacement therapy at recruitment (women only; yes, no), baseline physician-diagnosed history of diabetes (yes, no) and stroke (yes, 
no); HRs
2
 were further adjusted for total energy intake (kcal), calcium quartiles, mg/1,000kcal/day), soy isoflavones (quartiles, g/1,000kcal/day), 
vitamin B6 (quartiles, mg/1,000kcal/day), black tea drinking frequency (<weekly, weekly, daily drinkers) and green tea drinking frequency 





Table 6-3. Consumption of tea in relation to risk of hip fracture, The Singapore Chinese Health Study, 1993-2010 
 
Any tea Black tea Green tea  












  Daily  
Overall (n=63,154)        
Cases 993 350 287 1,276 234 120 1,224 229 177 









































Men (n=27,913)        
Cases 215 109 126 309 80 61 309 69 72 







































Women (n=35,241)       
Cases 778 241 161 967 154 59 915 160 105 











































Postmenopausal women (n=25,522)       
Cases 751 237 153 934 152 55 883 156 102 











































(95% CI) were adjusted for gender (whole cohort), age at recruitment (years), year of recruitment (1993-1995, 1995-1998), dialect group 
(Hokkien, Cantonese), body mass index (<20, 20-23.9, 24-27.9, ≥28 kg/m2), level of education in categories (no formal education, primary 
school, secondary school or higher), smoking status with intensity (never smokers, ex-smokers: 1-12 cigarettes/day, 13-22 cigarettes /day, >23 
cigarettes /day; current smokers: 1-12 cigarettes/day, 13-22 cigarettes /day, >23 cigarettes /day), physical activity (none, 0.5 - <4 hrs weekly, ≥4 
hrs weekly), at least weekly use of vitamins/mineral (yes, no), menopausal status (women and postmenopausal women; yes, no), use of hormone 





(95% CI) were further adjusted for total energy intake (kcal), calcium quartiles, mg/1,000kcal/day), soy isoflavones (quartiles, 
mg/1,000kcal/day), vitamin B6 (quartiles, mg/1,000kcal/day), black tea drinking frequency (<weekly, weekly, daily drinkers) and green tea 
drinking frequency (<weekly, weekly, daily drinkers). 
3





                  Table 6-4. Dietary intake of caffeine in relation to risk of hip fracture, The Singapore Chinese Health Study, 1993-2010. 
 
 <100 mg/day 100-<200 mg/day 200-<300 mg/day ≥300 mg/day 
Overall (n=63,154)    
      Hip fracture cases 778 351 384 117 
                   Person-years 365,257 209,525 230,031 65,146 
     HR
1 
(95% CI) Reference 0.97 (0.85, 1.10)    0.93  (0.82, 1.06)  1.14  (0.94, 1.39) 
 
     HR
2 
(95% CI) Reference 0.97 (0.86, 1.11)    0.93   (0.82, 1.05)  1.13  (0.92, 1.38) 
Men (n=27,913)    
                   Hip fracture cases 157 97 147 49 
                   Person-years 120,501 7,009 115,802 41,247 
    HR
1 
(95% CI) Reference 0.88  (0.69, 1.14)    1.07  (0.85, 1.34) 1.08  (0.78, 1.51) 
    HR
2 
(95% CI)  Reference 0.88 (0.68, 1.14)    1.09  (0.78, 1.52) 1.09 (0.78, 1.52) 
Women (n=35,241)    
                  Hip fracture cases 621 254 237 68 
                  Person-years 244,755 115,367 114,229 23,899 
   HR
1 
(95% CI) Reference 1.01  (0.87, 1.17) 0.87 0. (0.75, 1.01) 1.21 (0.94, 1.55) 
 
   HR
2 
(95% CI) Reference 1.02 (0.87, 1.18) 0.86  (0.74, 1.00) 1.17  (0.91, 1.52) 
Postmenopausal women (n=25,522)    
                 Hip fracture cases 606 246 223 66 
                 Person-years 174,656 79,369 81,604 17,454 
  HR
1











Hazard ratios (HRs): HRs
1
 were adjusted for gender (whole cohort), age at recruitment (years), year of recruitment (1993-1995, 1995-1998), 
dialect group (Hokkien, Cantonese), body mass index (<20, 20-23.9, 24-27.9, ≥28 kg/m2), level of education in categories (no formal education, 
primary school, secondary school or higher), smoking status with intensity (never smokers, ex-smokers: 1-12 cigarettes/day, 13-22 cigarettes 
/day, >23 cigarettes /day; current smokers: 1-12 cigarettes/day, 13-22 cigarettes /day, >23 cigarettes /day), physical activity (none, 0.5 - <4 hrs 
weekly, ≥4 hrs weekly), at least weekly use of vitamins/mineral (yes, no), menopausal status (women and postmenopausal women; yes, no), use 





 were further adjusted for total energy intake (kcal), calcium quartiles, mg/1,000kcal/day), soy isoflavones (quartiles, mg/1,000kcal/day), 
and vitamin B6 (quartiles, mg/1,000kcal/day); CI, confidence interval. 
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Chapter 7. Dietary patterns and risk of hip fracture 
[This chapter is primarily based on the published manuscript in Journal of 




 Various nutrients and dietary components have been suggested to have 
favorable impact on maintaining bone health and reducing risk of osteoporotic 
fractures (23, 54). These foods and nutrients may strongly correlate with one 
another or interact along similar pathways important for fracture protection 
(242). Thereby, an evaluation of the overall dietary pattern may provide a 
more practical strategy for the prevention of osteoporotic fractures.   
A few observational studies have been conducted on the association 
between dietary patterns and bone health, and findings have been inconsistent. 
For example, although an unhealthy dietary pattern characterized by high 
consumption of refined sugar/cereals, red meat or processed meat, processed 
foods and fried foods was associated with lower bone mineral density (BMD) 
(243, 244, 246, 252), there was no association with fracture risk (245). 
Similarly, a healthy dietary pattern characterized by higher dietary intake of 
fruit and vegetables was associated with positive bone health outcomes in 
some (243, 244, 393) but not all (251, 262) studies. In most of these studies, 
dietary patterns were identified through a posteriori analytic methods [i.e., 
factor analysis and principal components analysis (PCA)], which may be 
subjective in nature and not be easily generalizable across study populations 
(394).  
Previously we have used PCA to identify two distinct Chinese dietary 
patterns in the Singapore Chinese Health Study cohort, namely, the 
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vegetables–fruit–soy (VFS) pattern that is characterized by vegetables, fruit 
and soy foods, and the meat–dim sum (MDS) pattern rich in meat and refined 
starchy foods (395). As a complementary a priori method, we also generated 
scores to evaluate the overall dietary quality according to the Alternate 
Healthy Eating Index (AHEI) 2010 in the whole cohort. The AHEI 2010 
measures dietary intake of seven food groups (vegetables, fruit, whole grains, 
juices, nuts and legumes, red/process meat and alcohol ) and four nutrients 
[trans-fat, long chain n-3 fatty acids, polyunsaturated fatty acids (PUFA) and 
sodium] based on the scoring criteria predictive of chronic disease risk in 
cohorts in the United States (396). Our rationale in choosing AHEI 2010 in 
this Chinese cohort was based on the VFS pattern and the AHEI 2010 having 
similar associations with disease prevention and common beneficial food 
groups. We hypothesized that the VFS pattern and AHEI 2010 may be 
associated with lower hip fracture risk among Chinese men and women in our 
study population.  
7-2. Methods 
 
Dietary patterns as exposures 
 
Dietary patterns were derived based on the baseline dietary intake of 
each participant using PCA conducted among the whole cohort (n=63,257). 
Details on the identification of the two dietary patterns were described 
previously (397). Briefly, the 165 food items in the FFQ were first 
standardized to the same frequency of intakes per month before applying 
factor extraction, followed by orthogonal rotation. The two dietary patterns 
used in this study were determined based on eigenvalues (> 1.0), scree plot, 
factor interpretability and the percentage of variance explained by each dietary 
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pattern (principal component). The dietary pattern scores were linear variables 
and computed by the unweighted sum of standardized frequencies of intake 
for each food associated with the pattern, with zero as the mean. Figure 7.1 
illustrates the concept of this data process using PCA.  
Figure 7.1. Illustration of Principal Component Analysis from initial datasets 
to the principal components  
 
Principal components analyses were conducted using the Factor Procedure in 
SAS version 9 (SAS Institute, Cary, NC) (398). In this cohort, the previously 
identified dietary patterns, namely the vegetable-fruit-soy pattern explained 
7.3% and the meat-dim sum pattern explained 7.2% of the variance (395). 
Then the pattern scores were divided into quintiles based on the distribution of 
the overall cohort.  
In the present study, we adopted the AHEI 2010 as an a priori method 
to assess the overall dietary quality. The scoring criteria for AHEI 2010 were 
described in detail elsewhere (396). Briefly, dietary quality was assessed by 
the absolute intake per day of vegetables, fruit, whole grains, juices, nuts and 
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legumes, red/processed meat, long chain (n-3) fatty acids, sodium and alcohol, 
and percentage of energy for trans-fat and PUFA. The intake of each dietary 
component was scored from 0 (worst diet) to 10 (best diet) based on the pre-
determined scoring criteria. For example, higher dietary intakes of vegetables, 
fruit, and lower sodium consumption were associated with lower risk of 
cardiovascular disease, and thus assigned higher component scores. The lack 
of information on trans-fat intake in our study population precluded us from 
counting this nutrient towards the computation of the AHEI 2010 score.  
Hence, the AHEI 2010 score in our study was the sum of the scores from the 
ten food and nutrient components, and ranged from 0 (minimum) to 100 
(maximum). The scores were then divided into quintiles based on the 
distribution in the whole cohort. The distribution of the AHEI 2010 score was 
similar by gender.  
Statistical analysis 
 
Baseline characteristics and dietary intakes were analyzed across 
quintiles of each dietary pattern score for the overall cohort and each gender 
separately. Cox proportional hazards regression models were used to assess 
the association of dietary pattern scores with hip fracture risk by using the 
lowest quintile score as the reference group. The strength of the association 
between each dietary pattern and risk of hip fracture was estimated by hazard 
ratios (HRs) and their corresponding 95% confidence intervals (CI). To 
examine linear trend, the median values of the quintiles of the dietary pattern 




All models in the analyses included the following covariates: age 
(continuous), year at recruitment (1993-1995 and 1996-1998), dialect group 
(Hokkien, Cantonese), level of education (no formal education, primary 
school, secondary school or higher), body mass index (BMI) (<20, 20–23.9, 
24-27.9, >28 kg/m
2
), smoking status (never smokers, ex-smokers, current 
smokers), moderate physical activity (none, 0.5- <4 hours per week, ≥4 hours 
per week), total energy intake (kcal/day), baseline self-reported physician-
diagnosed history of diabetes mellitus (yes, no) and stroke (yes, no), 
menopause status (women only; yes, no), and use of hormone replacement 
therapy at recruitment (women only; yes, no). All statistical analysis was 
conducted using SAS Version 9.2 (SAS Institute, Inc., Cary, NC). All reported 
p values were two-sided; p<0.05 was considered statistically significant. 
7-3. Results 
  
Baseline characteristics were summarized for men and women 
separately for the VFS and the MDS pattern scores by quintile (Table 7-1). 
For each dietary pattern in both genders, those with higher scores were 
younger and more educated. Both men and women with higher VFS pattern 
scores consumed more vitamin B6, vitamin D, soy isoflavones, β-carotene, 
calcium, vegetables and fruit from the diet compared to those with lower 
scores. Also, those who had higher VFS scores had higher AHEI 2010 scores. 
Conversely, those with higher MDS pattern scores consumed less β-carotene, 
vegetables and fruits, and had lower AHEI 2010 scores. For men, those with 
higher scores for either dietary pattern had higher BMI and were physically 
more active than those with lower scores; and those with lower VFS but 
higher MDS scores were more likely to be ever smokers or daily drinkers. The 
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proportion using vitamin/mineral supplements at least weekly was higher in 
men with higher VFS pattern scores. For women, those had higher VFS but 
lower MDS scores were physically more active; and those with higher scores 
for either dietary pattern were more likely to use hormone replacement therapy 
or to use vitamin/mineral supplements at least weekly. The distribution of 
these baseline characteristics with AHEI 2010 score was similar to the 
distribution with the VFS pattern score (data not shown). Additionally, no 
difference was found in the distribution of the pattern scores (VFS/MDS or 
AHEI 2010) between genders.    
The association for the VFS and the MDS dietary patterns in relation to 
hip fracture risk is presented on Table 7-2. The VFS pattern score was 
inversely associated with risk of hip fracture in a strong dose-dependent 
manner for the overall cohort, as well as for men and women separately (All 
P-trend ≤ 0.008). Compared with the lowest quintile of the VFS pattern score, 
subjects in higher quintiles had 21-34% reduction in hip fracture risk across 
quintile 2 to quintile 5 for overall (all Ps <0.05). In contrast, the MDS pattern 
score was not related to hip fracture risk in either gender. The dietary pattern-
hip fracture risk associations were consistent for men and women (P for 
interaction between gender and VFS pattern score was 0.53 and that for 
interaction between gender and MDS pattern score was 0.56).  
The mean score for each dietary component constituting the AHEI 
2010 score for men and women in this cohort can be found in Table 7-3. A 
higher intake of vegetables, soy foods and fruit is a common characteristic of 
the VFS pattern and a high AHEI 2010 score. The partial energy adjusted 
Pearson’s correlation coefficient between the AHEI 2010 and VFS pattern 
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scores was 0.49 for (p<0.0001). Conversely, the coefficients were -0.20 for the 
correlation between the AHEI 2010 and MDS pattern (p < 0.0001), and -0.09 
for the correlation between VFS and MDS pattern (p < 0.0001), respectively. 
Table 7-4 presents the association between the AHEI 2010 scores and 
risk of hip fracture. We observed a dose-dependent inverse association 
between higher AHEI 2010 scores and hip fracture risk (all P-trend ≤0.005). 
Compared with the lowest quintile, increasing quintile values of AHEI 2010 
scores were associated with reduced hip fracture risk by 23% to 32% (all Ps 
≤0.0007). Results were similar for men and women analyzed separately (P 
for interaction between gender and AHEI 2010 score was 0.36). The risk 
estimates using gender-specific pattern scores (VFS/MDS or AHEI 2010) and 
the pattern scores generated from the whole cohort were essentially the same. 
We also did sensitivity analysis by excluding 1,657 subjects with 
extreme caloric intakes (≤ 600 and ≥ 3,000 kcals), and all the results were 
materially unchanged. When we only included age as a covariate in our 
models to estimate Hazard Ratio for the VFS and MDS patterns, and for the 
AHEI 2010 scores, the magnitude of difference in the risk estimates between 
the age-adjusted and fully adjusted models shown in Tables 7-2 and Table 7-3 
were <10%.  Further adjustment for intakes of calcium and vitamin D, and the 
use of vitamin/mineral supplements at least weekly did not change the results 
materially. 
We considered age distribution in quartile (45-50 years, 50-56 years, 
56-63 years, and above 63 years), BMI (<20, 20-23.9, 24-27.9, ≥28 kg/m2), 
physical activity (none, 0.5-<4 h/week, ≥4 h/week), and dietary intake of 
vitamin D (in quartile) and calcium (in quartile) as potential effect modifiers 
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for the VFS/MDS pattern or the AHEI 2010 score in relation to hip fracture 
risk. We did not observe any difference in the diet-hip fracture association in 
these stratified analyses (all Ps for interaction >0.05). Similarly, no interaction 
was found between baseline history of diabetes or stroke and the VFS pattern 
and AHEI 2010 scores in the relationship with risk of hip fracture (all Ps for 
interaction >0.05). 
 We have previously identified the intake of three nutrients, namely 
soy isoflavones, vitamin B6 and β-carotene, to have statistically significant 
inverse associations with risk of hip fracture either in women or men in this 
cohort (20, 121, 347). To assess whether these nutrients may account for the 
associations with each of the dietary patterns in relation to risk of hip fracture, 
we included dietary intake of soy isoflavones, vitamin B6 and β-carotene as 
covariates in the multivariate regression models. There was a weak to 
moderate correlation between each of these nutrients and the VFS pattern and 
AHEI 2010 scores; the lowest correlation coefficient was between soy 
isoflavones and the AHEI 2010 score (r=0.32), the highest correlation 
coefficient was between β-carotene and the VFS pattern score (r=0.62). In 
contrast, the Pearson’s correlation coefficients between MDS pattern scores 
and intake of soy isoflavones, vitamin B6 and β-carotene were 0.004, 0.03 and 
-0.08, respectively. Although the HRs were slightly attenuated, the dietary 
pattern-hip fracture association remained significant for both the VFS pattern 
and the AHEI 2010 score. Compared with the lowest quintile, subjects in the 
highest quintile had a 26% lower risk (HR: 0.74; 95% CI: 0.59-0.92, P-trend: 
0.05) for the VFS pattern, and also a 26% lower risk (HR: 0.74; 95% CI: 0.62-
0.88; P-trend: 0.002) for the AHEI 2010 score.  
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7-4. Discussion  
 
 In the present study, we examined the relationship between overall 
dietary pattern and hip fracture risk in a large prospective cohort in an Asian 
population. We observed an inverse association with a diet characterized by 
higher intake of vegetables, fruit and soy foods in both men and women. In 
addition, a diet with greater adherence to healthy food choices for prevention 
of chronic diseases defined by the AHEI 2010 also reduced risk of hip fracture 
in both genders. Since factors such as age, gender, BMI, level of education, 
physical activity, or history of diabetes and stroke did not modify the effect of 
diet on hip fracture risk, we feel that our results are therefore generalizable to 
other populations that may be different in the distribution of these factors.  
Most of the previous observational studies have used an a posteriori 
approach to explore the association of dietary patterns with relevant outcomes 
of bone health using factor analysis and PCA (243-246, 252, 262, 399). In 
some of these studies, a dietary pattern characterized by higher intake of fruit, 
vegetables, nuts/cereal and/or fish, but low in red meat and processed meat, 
was associated with higher hip and lumbar spine BMD (243, 246), and lower 
bone resorption (244). In our study, a greater adherence to the VFS pattern or 
the AHEI 2010 was also characterized by a diet with high consumption of 
vegetables, soy foods and fruit, and a low intake of red and processed meat. 
The inverse association between the healthy dietary pattern defined by the 
VFS pattern or the AHEI 2010 scores, and hip fracture risk in the current 
study is consistent with those reported in cohort studies in Western 
populations (245, 393) and a case-control study in a Chinese population (399). 
In a retrospective Canadian cohort, using exploratory factor analysis, two 
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dietary patterns, the nutrient-dense diet with higher intake of fruit, vegetables 
and whole grains, and the energy-dense diet with high consumption of soft 
drinks, potato chips, French fries, meats and desserts were identified. The 
nutrient-dense diet was inversely associated with lower fracture risk in women, 
whilst the energy-dense diet was not related to fracture risk (245). Another 
study among European men and women showed that a greater adherence to 
the Mediterranean diet was related to lower risk of hip fracture (393). In a 
case-control study among elderly Chinese men and women, four dietary 
patterns were identified using PCA. Their findings suggested that a diet with 
high intake of fruit and vegetables, and a prudent diet rich in nuts, mushrooms, 
algae, and seafood were associated with lower risk of hip fracture, whereas a 
diet high in fat was related to higher hip fracture risk (399).  
While some studies found that a dietary pattern high in red or 
processed meat, starch and fried foods was related to lower BMD (244, 252) 
or bone mineral contents (246), other studies failed to show any association 
between the similar dietary patterns and BMD (243, 251) or fracture risk (245). 
The latter concurred with our finding that the MDS pattern in this cohort, 
which was characterized by higher intake of meats, sodium, and refined 
carbohydrates, was not associated with risk of hip fracture in either gender.  
A higher dietary intake of vegetables, soy foods and fruit in this study, 
which characterizes the VFS pattern and a diet with high AHEI 2010 score, 
supported evidence for the beneficial effects of these foods on bone health.  
Interestingly, both the VFS pattern and high AHEI 2010 score were previously 
reported as dietary patterns associated with a lower risk of  other chronic 
diseases such as cancers (396, 397, 400), type 2 diabetes (396, 401) and 
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cardiovascular diseases (396, 401). Consistent with our findings, a recent 
cross-sectional study among 933 Puerto Ricans aged 47 to 79 years suggested 
that greater adherence to the American Heart Association Diet and Lifestyle 
Recommendations, intended for the reduction of cardiovascular disease risk, 
was significantly associated with higher bone mineral density at the femoral 
neck, trochanter, total hip and lumbar spine (250). Diabetes mellitus (278, 402, 
403) and stroke (277, 404-406) have in turn been found to be risk factors of 
hip fracture. Mechanistic factors such as vascular calcification, hormone 
deficiency, inflammation and oxidative stress were suggested to be common to 
the pathophysiological pathways of both cardiovascular disease and 
osteoporotic fractures (277, 407). Thus, the inverse relationship between the 
VFS pattern or the AHEI 2010 scores, and hip fracture risk may reflect the 
beneficial effects of the healthful foods or nutrients common to these two 
patterns on bone health and the cardiovascular system. Also, in vitro evidence 
showed that insulin signaling in osteoblasts could affect bone resorption (408, 
409), and insulin resistance could reduce bone strength (410, 411), which in 
turn would explain the increase in fracture risk for patients with diabetes (278, 
402, 403).   
Although it is plausible that a healthy dietary pattern may reduce hip 
fracture risk via its favorable impact on insulin sensitivity or cardiovascular 
health, significant inverse associations of hip fracture risk with the VFS 
pattern and AHEI 2010 scores remained essentially the same in both groups of 
participants with and without these chronic conditions in our study. This 
suggests that a healthy dietary pattern may have effects on the prevention of 
osteoporotic fractures independent of its benefits on diabetes and 
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cardiovascular disease. For example, studies have shown that dietary quality 
was inversely related to frailty in older men (254, 255) and women (255); and 
frailty was consequently an independent predictor for propensity of falls (256) 
and fracture risk (257, 258). Furthermore, since additional statistical 
adjustment for dietary intake of soy isoflavones, vitamin B6 and β-carotene, 
which were nutrients reported previously to reduce hip fracture risk in this 
cohort (20, 121, 347), did not materially change the results with the VFS 
pattern and AHEI 2010 scores, our findings suggest that these two dietary 
patterns could have other hitherto unidentified nutrients, apart from soy 
isoflavones, vitamin B6 and β-carotene, that might have additional effects in 
reducing fracture risk. Moreover, different beneficial vitamins, minerals and 
phytochemicals enriched in such a diet may interact collectively to influence 
bone turnover. In addition, a diet high in vegetables, fruit and other plant-
based foods may also have effects on the acid-base status and mineral balance 
of bone. Foods such as fruit and vegetables with a low potential renal acid 
load may supply organic molecules such as potassium and bicarbonate to 
decrease calciuria (190, 412, 413), and this in turn may improve calcium 
balance in the bone. In contrast, evidence from animal studies showed that a 
high fat and/or sucrose diet impaired the strength and density of cortical bones 
(414, 415) or cancellous bones (416), suggesting possible detrimental effects 
of saturated fat and refined sugar on bone health. Together, these mechanisms 
may partially explain our finding that dietary patterns rich in vegetables and 
other plant-based foods had a favorable impact on lowering fracture risk.   
Strength of the study includes its prospective study design in a 
population-based cohort, thereby minimizing the likelihood of differential 
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recall bias since information on diet and other risk factors of hip fracture were 
collected at baseline prior to occurrence of fractures. Another strength is the 
large sample size and number of fracture cases during a long period of follow-
up.  Also, migration among participants was negligible and follow-up of vital 
statistics was virtually complete. Singapore is a small city-state with good 
accessibility to medical care, and hip fracture cases would most likely seek 
immediate medical attention and be hospitalized. Hence, case ascertainment 
via linkage with the nationwide hospital database can also be considered 
complete. We also included all established and potential risk factors of hip 
fracture as covariates in our regression-based risk models to minimize the 
likelihood of spurious associations resulting from insufficient control of 
confounding. Specifically, those who have a healthy dietary pattern are more 
likely to follow a healthy lifestyle, such as maintaining a healthy body weight, 
exercising more and smoking less. We have previously reported that lean 
subjects of BMI<20kg/m
2
 (347) and current smokers (20) had significantly 
higher risk of hip fracture. In this study population, although there was no 
apparent relationship between physical activity and risk of hip fracture in men, 
women who had a higher level of physical activity had a lower risk of hip 
fracture. Hence, BMI, level of physical activity, and smoking status were all 
included as covariates in our risk models.  A major limitation of this study is 
that dietary intake was only recorded at baseline and dietary changes during 
the follow-up were not captured. Any subsequent change in diet could lead to 
non-differential misclassification and potentially underestimate the diet-hip 
fracture risk association. Another limitation is the use of estimated food intake 
from FFQ to create the dietary pattern score. Again, this could lead to non-
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differential misclassification that would underestimate the diet-hip fracture 
risk association. The identification of dietary patterns using principal 
components analysis may also not be easily generalizable across study 
populations.  In addition, the lack of information on trans-fat intake in our 
questionnaire prohibited us from assessing its association with risk of hip 
fracture as a component of the AHEI 2010 score. Finally, measurement of 
frailty and bone mineral density at baseline were not available in this cohort. 
Thus, we were unable to evaluate these factors for the potential mediating or 
confounding effect in the relationship between the dietary pattern and hip 
fracture risk. Nevertheless, as this is an observational study, causality should 
be interpreted cautiously and residual/unmeasured confounding, e.g., other 
non-dietary protective factors that we have not considered, may still be 
unaccounted for.  
7-5. Conclusions 
 
In conclusion, we observed that a Chinese diet rich in vegetables, fruit 
and soy products was associated with a substantially lower risk of hip fracture. 
In addition, consuming a plant-based diet enriched vegetables, fruit and soy 
foods, which have been recommended for the prevention of chronic diseases 
such as cancer, cardiovascular disease and diabetes, may also contribute 
importantly to the prevention of osteoporotic hip fractures. It would be of 
public health interest and benefit to examine the combination of lifestyle 
factors that include diet, physical activity, body mass index, smoking status 
and alcohol consumption in association with the risk of hip fracture in further 
studies.  Future intervention studies are warranted to investigate the efficacy 
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Table 7-1. Distribution of baseline characteristics by quintile of vegetable-fruit-soy (VFS) and meat-dim sum (MDS) pattern score for men and 
women, separately 
Baseline characteristics Men (n=27,913) 
  VFS pattern MDS pattern 
 Q1 Q3 Q5 Q1 Q3 Q5 
Age at recruitment, years, mean ±SD 57.7 ±8.2 56.6 ±7.9 55.9 ±7.8 60.0 ±7.9 57.1 ±7.9 54.4 ±7.5 
BMI (kg/m2), mean ±SD 22.7 ±3.2 23.0 ±3.2 23.1 ±3.2 22.8 ±3.2 22.9 ±3.2 23.1 ±3.3 
Secondary school or higher in education (%) 6.3 7.7 8.9 4.3 7.1 11.9 
Ever smokers (%) 14.8 11.0 10.2 7.2 11.4 16.5 
Daily alcohol drinking (%) 8.2 5.4 6.1 3.1 5.6 9.2 
Moderate physical activity of at least 0.5 h/week (%) 4.1 5.1 5.6 4.0 4.8 6.4 
Diabetes mellitus (%) 1.9 1.7 1.8 1.4 1.8 2.1 
Stroke (%) 0.45 0.4 0.3 0.5 0.4 0.3 
Soy isoflavones  (mg/1000kcal/day) mean ±SD 7.4 ± 7.5 10.5 ± 7.5 15.3 ± 9.6 10.7 ±10.0 10.6 ± 8.2 11.2 ± 7.5 
Vitamin B6 intake (mg/1000kcal/day) mean ±SD 0.64 ± 0.14 0.71 ± 0.14 0.77 ± 0.14 0.68 ± 0.18 0.70 ± 0.14 0.71 ± 0.12 
β-Carotene ((mg/1000kcal/day) mean ±SD 0.71 ± 0.44 1.21 ± 0.59 1.84 ± 0.90 1.39 ± 0.90 1.23 ± 0.72 1.13 ± 0.63 
Calcium (mg/1000kcal/day) mean ±SD 204 ± 93  240 ± 97 281 ± 88 261 ± 125 240 ± 101 234 ± 76 
Vitamin D (IU/1000kcal/day)  mean ±SD 57.1 ± 37.2 61.6 ± 35.1 67.1 ± 34.4 57.1 ± 44.6 62.2 ± 36.7 64.2 ± 28.5 
Vegetable intake (g/1000kcal/day) mean ±SD 39 ± 17 63 ± 22 96 ± 36 70 ± 37 64 ± 31 61 ± 26 
Fruit intake (g/1000kcal/day) mean ±SD 77 ± 72 124 ± 85 163 ± 99 137 ± 109 122 ± 91 113 ± 76 
Soy products (g/1000kcal/day) mean ±SD 44 ± 39 63 ± 40 93 ± 55 65 ± 57 63 ± 45 68 ± 42 
Red meat (g/1000kcal/day)  mean ±SD 20 ± 12 20 ± 11 20 ± 12 12 ± 10 19 ± 10 27 ± 11 
Using vitamin/mineral supplements at least weekly (%) 3.3 5.0 6.7 5.0 4.3 5.1 






Baseline characteristics Women (n=35,241) 
  VFS pattern MDS pattern 
 Q1 Q3 Q5 Q1 Q3 Q5 
Age at recruitment, years, mean ±SD 57.9 ±8.4 56.1 ±7.9 55.3 ±7.8 58.8 ±8.1 55.8 ±7.9 53.7 ±7.4 
BMI (kg/m2), mean ±SD 23.3 ±3.3 23.2 ±3.3 23.1 ±3.4 23.1 ±3.2 23.3 ±3.4 23.2 ±3.4 
Secondary school or higher in education (%) 2.6 4.3 5.4 3.7 4.3 4.0 
Ever smokers (%) 2.4 1.6 1.4 2.2 1.7 1.3 
Daily alcohol drinking (%) 1.4 0.9 1.5 0.8 1.2 1.8 
Moderate physical activity of at least 0.5 h/week (%) 2.4 4.3 5.3 5.4 4.0 2.6 
History of diabetes mellitus (%) 2.0 1.8 1.7 2.7 1.7 1.1 
History of stroke (%) 0.3 0.3 0.2 0.5 0.2 0.1 
Postmenopausal at baseline (%) 77.4 71.9 68.8 82.0 70.1 61.5 
Use of hormone replacement therapy among postmenopausal 
women only (%)  
2.8 4.4 5.5 3.0 4.5 5.4 
Soy isoflavones  (mg/1000kcal/day) mean ±SD 8.7 ± 8.6 12.2 ± 8.6 17.5 ± 11.1 11.6 ± 10.4 12.8 ± 9.5 14.1 ± 9.0 
Vitamin B6 intake (mg/1000kcal/day) mean ± SD 0.64 ± 0.14 0.71 ± 0.14 0.78 ± 0.15 0.70 ± 0.16 0.71 ± 0.14 0.72 ± 0.12 
β-Carotene ((mg/1000kcal/day) mean ± SD 0.98 ± 0.56 1.52 ± 0.75 2.27 ± 1.09 1.68 ± 1.05 1.58 ± 0.89 1.45 ± 0.78 
Calcium (mg/1000kcal/day) mean ±SD 250 ± 154 290 ± 135 339 ± 122 304  ± 160 289 ± 134 282 ± 105 
Vitamin D (IU/1000kcal/day) mean ±SD 64.9 ± 46.8 70.0 ± 42.7 75.6 ± 40.0 66.0 ± 50.0 71.6 ± 40.3 73.3 ± 33.4 
Vegetable intake (g/1000kcal/day) mean ±SD 51 ± 22 77 ± 27 113 ± 43 83 ± 43 79 ± 36 75 ± 30 
Fruit intake (g/1000kcal/day) mean ±SD 89 ± 86 136 ± 97 183 ± 114 144 ± 117 136 ± 100 133 ± 89 
Soy foods (g/1000kcal/day) mean ± SD 51 ± 44 72 ± 45 105 ± 62 69 ± 58 76 ± 52 84 ± 48 
Red meat (g/1000kcal/day) mean ±SD 18 ± 11 18 ± 11 17 ± 11 12 ± 10 19 ± 10 26 ± 11.0 
Using vitamin/mineral supplements at least weekly (%) 4.9 7.7 10.0 6.6 7.5 8.4 





Table 7-2. Hazard ratios (HR) for the Vegetable-Fruit-Soy (VFS) and the Meat-Dim Sum (MDS) pattern in relation to hip fracture incidence by gender, The 








Quintile of pattern score 
Median (IQR) Cases, n HR 95% CI   Cases, n HR 95% CI 
 
Cases, n HR 95% CI 
VFS pattern 





 Q2 -7.5 (-8.8~-6.3) 340 0.79 0.68-0.91 
 
90 0.78 0.60-1.02 
 
250 0.79 0.67-0.93 
Q3-2.6 (-3.8~-1.2) 287 0.72 0.62-0.84 
 
70 0.63 0.47-0.85 
 
217 0.76 0.63-0.91 
Q4 3.6 (1.8~5.7) 325 0.84 0.72-0.98 
 
97 0.92 0.70-1.21 
 
228 0.81 0.68-0.98 
Q5 16.4 (11.6~24.5) 240 0.66 0.55-0.78 
 
61 0.57 0.41-0.80 
 
179 0.70 0.57-0.86 
P-trend   <0.0001       0.008       0.004   
MDS pattern 





 Q2 -7.2 (-8.1~-6.3) 366 1.02 0.89-1.17 
 
101 1.33 0.98-1.80 
 
265 0.95 0.81-1.11 
Q3 -3.2 (-4.3~-2.0) 323 1.09 0.94-1.26 
 
105 1.29 0.95-1.76 
 
218 1.04 0.87-1.23 
Q4 2.4 (0.7~4.4) 249 0.99 0.84-1.17 
 
81 1.00 0.72-1.39 
 
168 1.02 0.84-1.24 
Q5 14.4 (9.9~2.5) 217 1.15 0.95-1.40 
 
90 1.12 0.78-1.60 
 
127 1.24 0.98-1.56 
P-trend   0.23       0.68       0.07   
 
HRs were adjusted for age at recruitment (years), year of recruitment (1993-1995, 1995-1998), gender, dialect group (Hokkien, Cantonese), BMI 





energy intake (kcal/day); smoking status (never, ex-smokers, current smokers), moderate physical activity (none, 0.5-4 h/week, 4+ h/week),  
menopausal status (women only; yes, no), use of hormone replacement therapy at recruitment (women only; yes, no), and baseline self-reported 

















AHEI 2010 score 
mean ± SD 
AHEI 2010 score 
mean ± SD 
Vegetables, servings/day (75g/day) 0 ≥5 6.8 ± 2.4 7.1 ± 2.2 
Fruit, servings/day (150g/day) 0 ≥4 3.1 ± 2.3 3.1 ± 2.2 
Whole grains, g/day 0 
90 for men, 
75 for women 
1.9 ± 2.7 2.3 ± 4.0 
Sugar-sweetened beverages and fruit juice, 
servings/day (240mL/day) 
≥1 0 8.4 ± 2.8 8.8 ± 2.3 
Nuts and legumes, servings/day (28g/day) 0 ≥1 7.6 ± 2.8 7.6 ± 2.8 
Red/processed meat, servings/day (85g/day) ≥1.5 0 6.1 ± 2.7 6.5 ± 2.6 
Long-chain (n-3) fats (EPA + DHA), mg/day 0 250 9.95 ± 0.70 9.91 ± 0.91 
PUFA, % of energy ≤2 ≥10 4.8 ± 1.8 5.2 ± 1.9 
Sodium, mg/day Highest decile Lowest decile 3.9 ± 2.8 5.0 ± 2.7 
Alcohol, drinks/day    3.8 ± 2.4 2.8 ± 1.2 
Women ≥2.5 0.5 - 1.5   
Men ≥3.5 0.5 - 1.0   
Total score   46.5 ± 8.4 48.3 ± 8.0 
 





Table 7-4. Hazard ratios (HR) for the Alternate Healthy Eating Index 2010 (AHEI 2010) in relation to hip fracture risk by gender, The 
Singapore Chinese Health Study 1993-2010 
  Overall (N=63,154) Men (N=27,913) Women (N=35,241) 
Quintile of pattern 
score Median (IQR) Cases, n HR 95% CI Cases, n HR 95% CI Cases, n HR 95% CI 






Q2 52.0 (50.5-53.5) 333 0.77 0.66-0.90 97 0.85 0.65-1.12 236 0.74 0.62-0.88 
Q3 56.3 (55.0-57.6) 319 0.74 0.64-0.86 94 0.83 0.63-1.10 225 0.71 0.59-0.85 
Q4 60.5 (59.1-62.1) 326 0.75 0.65-0.87 74 0.68 0.50-0.91 252 0.77 0.65-0.92 
Q5 67.4 (65.1-70.9) 290 0.68 0.58-0.79 69 0.69 0.51-0.94 221 0.67 0.56-0.81 
P-trend   <0.0001     0.005     0.0002   
 
HRs were adjusted for age at recruitment (years), year of recruitment (1993-1995, 1995-1998), gender, dialect group (Hokkien, Cantonese), BMI 
(<20, 20-23.9, 24-27.9, ≥28 kg/m2), level of education in categories (no formal education, primary school, secondary school or higher), total 
energy intake (kcal/day); smoking status (never, ex-smokers, current smokers), moderate physical activity (none, 0.5-4 h/week, 4+ h/week),  
menopausal status (women only; yes, no), use of hormone replacement therapy at recruitment (women only; yes, no), and baseline self-reported 




Chapter 8. Change in body weight after midlife and 
risk of hip fracture 
[This chapter is primarily based on the published manuscript in Osteoporosis 
International (2015); 26(7):1939-47. Dai et al. (417)] 
8-1. Background 
 
Weight loss due to reduced lean mass during aging is common among 
elderly (264, 265, 418). Previous studies conducted in Western populations 
suggested that weight loss was significantly associated with bone loss in 
women (285, 286) and increased fracture risk among middle-aged to elderly 
men and women (287-294). However, results on weight gain were 
inconclusive. While most of the studies did not show statistically significant 
association between weight gain and bone health outcomes, one study among 
Norwegian men and women reported that weight gain over 5.6 kilograms 
significantly increased hip fracture risk in women (287), whilst another study 
showed that weight loss ≥10% reduced risk of hip fracture of borderline 
statistical significance among Caucasian men in the United States (290). 
Leanness is an established independent risk factor of hip fracture in a 
previous meta-analysis (263). We have also reported that low body mass index 
(BMI) increased the risk of hip fracture among men in our cohort of middle-
aged and elderly Chinese in Singapore (347). Asian populations have lower 
BMI and possibly different patterns in weight change during aging as 
compared to their Western counterparts. In the present study, we used 
prospective data from the same cohort to examine the association between 







At baseline 63,257 aged 45-74 years men (n=27,959) and women 
(n=35,298) were enrolled in the study between April 1993 and December 1998. 
The study participants were restricted to two dialect groups of Hokkiens and 
Cantonese who originated from Fujian and Guangdong provinces in southern 
China. During the enrollment period, all of our study participants were 
residents of government housing estates, where 86% of the Singapore 
population was residing at the time of recruitment (320). Participants were re-
contacted for a telephone interview between July 1999 and October 2004. 
After excluding those who had died, were non-contactable, or who were no 
longer able to participate in the follow-up interview due to disability, a total of 
52,322 participants (82.7% of the original cohort) were re-interviewed. The 
Institutional Review Board at the National University of Singapore approved 
this study. All study participants gave written informed consent.  
Exposure assessment 
 
Baseline assessment was conducted between 1993 and 1998 through a 
face-to-face interview with a trained interviewer using a structured 
questionnaire, which included demographics, medical history, cigarette 
smoking, alcohol consumption, physical activity, detailed menstrual and 
reproductive history (women only), and habitual diet recorded by a validated 
semi-quantitative food frequency questionnaire. History of cancer prior to the 
follow-up interview was self-reported and also assessed via linkage with the 
national cancer registry. At the follow-up interview from 1999 to 2004, 
smoking and drinking behavior, medical and health history, menstrual and 
reproductive history (women only) were re-assessed. Current body weight and 
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height were self-reported at both of the baseline and the follow-up assessments 
with an average of 5.7 years apart. BMI is calculated as weight in kilograms 
divided by height in meters squared (kg/m
2
). We excluded participants with 
missing body weight and height at both baseline and follow-up interviews 
(n=9,994). We further excluded 41 participants who developed hip fracture 
prior to baseline and 138 participants who developed hip fracture prior to the 
follow-up interview, thus leaving 42,149 participants in this study for the final 
analysis. Compared to the participants included in this study, the 9,994 
participants excluded from this study were older, had a higher proportion of 
women and were less educated. They were also more likely to be current 
smokers, and had higher prevalence of diabetes mellitus, stroke, and cancer.  
Weight change  
 
 Percent weight change was computed as weight difference divided by 
baseline body weight [(weight at follow-up – weight at baseline) / weight at 
baseline] x 100%]. Weight change was then categorized as follows: loss ≥
10%, loss 5-<10%, stable weight (loss or gain <5%), gain 5-<10%, and gain 
≥10%. These categories of weight change were suggested to be clinically 
relevant and meaningful comparison among participants with wide range of 
weight variation in previous studies (288, 419).  
Statistical analysis 
 
Differences in characteristics among weight change groups were tested 
for statistical significance using chi-square tests for categorical variables and 
ANOVA for continuous variables. For each study subject, person-years were 
counted from the date of the follow-up interview to the date of diagnosis of 
hip fracture, death, migration or December 31, 2010, whichever occurred first. 
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Multivariable Cox proportional hazards regression model was applied to 
assess the association between weight change and risk of hip fracture for the 
whole cohort and for subgroup analyses. The strength of the association 
between weight change and hip fracture risk was estimated by hazard ratios 
(HRs) and their corresponding 95% confidence intervals (CI), using 
participants with stable weight (loss or gain< 5%) as the referent group. We 
did not identify any violation of the proportional hazard assumption or 
multicollinearity among the covariates that were included in the models.  
We examined the association between weight change and risk of hip 
fracture using three models. Model 1 was adjusted for the following covariates: 
age at follow-up interview (years), time interval between baseline and follow-
up assessments (years), dialect group (Hokkien, Cantonese), level of education 
(no formal education, primary school, secondary school or higher), smoking 
status at follow-up interview (never smokers, ex-smokers, current smokers), 
current use of hormone replacement at follow-up interview (women only; yes, 
no), and gender (for the whole cohort). The time interval between baseline and 
follow-up defined the period when weight change occurred, since weight and 
height were assessed at these two occasions. The mean (SD) time interval was 
5.7 (1.4) years and the interquartile ranged 4.5 to 8.8 years. This variable was 
included as a covariate in the regression model because the duration of the 
time interval could influence the degree of weight change and thus confound 
the relationship between weight change and the risk of hip fracture. Model 2 
was adjusted for the above-mentioned covariates plus self-reported physician-
diagnosed history of diabetes mellitus (yes, no), stroke (yes, no), coronary 
heart disease (yes, no), cancer (yes, no) and other fractures (yes, no) prior to 
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baseline or the follow-up interview. Model 3 was further adjusted for BMI 
(<20, 20-23.9, 24-27.9, ≥28 kg/m2) reported at the follow-up interview. We 
also conducted stratified analysis by gender (men and women), age group at 
follow-up (≤ 65 and > 65 years) and baseline BMI category (BMI <20, 20-< 
25 and ≥ 25 kg/m2). Finally, we tested interactions between weight change 
categories and gender, age groups, or baseline BMI categories using the 
likelihood ratio test. The test was done by including in the model five product 
terms between these two sets of variables.  
All statistical analysis was conducted using SAS Version 9.2 (SAS 
Institute, Inc., Cary, North Carolina). A P-value < 0.05 is considered to be 
statistically significant. All reported P values are two-sided. 
8-3. Results 
 
We identified 775 incident cases of hip fracture among 42,149 eligible 
cohort participants during a mean follow-up period of 9.0 [standard deviation 
(SD) 2.1] years. The time interval between the two assessments of body 
weight at baseline and follow-up interviews was 5.7 (SD 1.4) years. Among 
the incident cases of hip fracture, the mean age at fracture was 75.3 (SD 7.3) 
years. Women accounted for 69.2% of all hip fracture cases. The incidence 
rate of hip fractures in women standardized to the age structure of the whole 
cohort was 256 per 100,000 person-years, which was nearly twice that in men 
(143 per 100,000 person-years).  
The characteristics of participants according to weight change are 
shown in Table 8-1. About half of the cohort participants had weight change 
less than 5% and the mean of the absolute weight change was -0.08 (SD 6.36) 
kg. For the other half of participants, the proportion of weight loss and weight 
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gain was distributed similarly, with 11.6% of the cohort reporting extreme 
weight loss and 12.2% reporting extreme weight gain ≥10%. The mean (SD) 
for extreme weight change was -10.7 (7.4) kg for weight loss ≥10% and 9.8 
(5.1) kg for weight gain ≥10%, respectively. Compared to those with stable 
weight, participants with weight loss ≥ 10% were older at follow-up interview, 
more likely to be men, had higher weight and BMI at baseline; they also had 
lower education level, were more likely to be current smokers, and had a 
higher prevalence of diabetes, stroke, coronary heart disease and cancer. 
Among the women, they were more likely to be postmenopausal and less 
likely to use hormone replacement therapy. By contrast, relative to those with 
stable weight, participants who had weight gain ≥ 10% were more likely to be 
women, slightly older at follow-up interview, and had lower weight and BMI 
at baseline; they were also less educated and had a higher proportion of 
current smokers. Among the women, they were also more likely to be 
postmenopausal and less likely to use hormone replacement therapy (Table 8-
1).  
The association between body weight change and risk of hip fracture is 
shown in Table 8-2. Compared to stable weight (loss or gain <5%), 
individuals with weight loss ≥10% experienced a statistically significant 56% 
increase in risk of hip fracture after adjustment for demographic and lifestyle 
factors (model 1). Further adjustment for comorbidities including history of 
diabetes, stroke, coronary heart disease, cancer and other bone fractures 
(model 2) and BMI reported at the follow-up assessment (model 3) did not 
materially alter the results. In the final model, compared to stable weight, 
weight loss ≥10% was associated with 39% increased risk of hip fracture (HR: 
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1.39; 95% CI: 1.14, 1.69]. Conversely, no association was found between 
weight gain and hip fracture risk. The results were materially the same in a 
simpler model that included only age, gender, and BMI at follow-up as 
covariates (Supplemental Table 8-1). In this simpler model, the HR (95 % CI) 
associated with weight loss ≥10 % was 1.55 (1.28, 1.88) and that with weight 
gain ≥10 % was 1.00 (0.78, 1.26). The association between weight change and 
risk of hip fractures did not differ by gender (all P for interaction >0.30).  
We further analyzed the data after excluding participants with history 
of diabetes, stroke, coronary heart disease and cancer reported at the follow-up 
interview, because they would be more likely to experience greater weight loss 
than those without such diseases. Among the 31,875 participants without the 
above-mentioned comorbidities, there were 468 incident cases of hip fracture. 
Compared to stable weight, weight loss ≥10% was significantly associated 
with a statistically significant 55% increase in risk of hip fracture (HR: 1.55; 
95% CI: 1.20, 2.01), whereas no apparent association was found for those with 
weight gain ≥10% (HR: 1.14; 95% CI: 0.85, 1.53).    
Table 8-3 shows the association between weight change and risk of 
hip fracture stratified by baseline BMI in three categories (<20, 20-< 25 and ≥ 
25 kg/m
2
) and age group at follow-up (≤65 and > 65 years). We used BMI <20 
kg/m
2
 as the cut-off for leanness, because it was a significant risk factor for 
hip fracture in this cohort (347) as well as in a meta-analysis that examined 
BMI and fracture risk (263). We used the current recommendation by the 
World Health Organization of BMI ≥25 kg/m2 as the cut-off for the 
overweight category (363). In the stratification by baseline BMI, there was a 
marginal significant difference in the risk estimates associated with weight 
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loss ≥10% between the BMI <20 kg/m2 and BMI 20-<25 kg/m2 categories (P 
=0.09), and also between the BMI <20 kg/m
2
 and BMI ≥25 kg/m2 categories 
(P = 0.06). Weight loss ≥10% was not significantly associated with hip 
fracture risk in participants with baseline BMI <20 kg/m
2
. Conversely, among 
those with baseline BMI ≥20 kg/m2, there was a 48% increase in hip fracture 
risk (HR: 1.48; 95% CI: 1.18, 1.84). The highest risk was observed among 
those who were overweight (BMI ≥25 kg/m2) at baseline (HR: 1.55; 95% CI: 
1.02, 2.37). The risk estimates for hip fracture associated with weight gain ≥10% 
between the three baseline BMI categories were not statistically different (all 
Ps for interaction > 0.18). Compared to stable weight, weight loss ≥10% was 
associated with increased risk of hip fracture similarly in both age groups.  
There was no apparent difference in the relationship between weight change 
and risk of hip fracture by age group (all Ps for interaction > 0.59). 
Furthermore, in the stratum of participants with baseline BMI<20 
kg/m
2
, we excluded those who died before the cut-off date of December 31, 
2010 (n=1,036), leaving 6,513 surviving participants with 148 hip fracture 
incident cases and 6,365 non-cases. Although those who remained alive before 
the cut-off date were likely to be healthier than those who had died, the risk 
estimates for the 6,513 surviving participants remained materially the same. 
Neither weight loss ≥10% (HR: 1.01; 95% CI: 0.56, 1.82) nor weight gain ≥
10% (HR: 0.81; 95% CI: 0.52, 1.25) was associated with risk of hip fracture. 
8-4. Discussion 
 
In this study, we observed a significant increase in risk of hip fracture 
among those who sustained a weight loss of 10 percent. Conversely, no 
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significant association was found between weight gain and risk of hip fracture. 
Results were similar in both men and women.  
Weight loss has been documented to be related to bone loss (285, 286) 
and increased fracture risk (288-290, 292, 293) in previous studies among 
Western populations. Findings from the present study are generally consistent 
with the results reported earlier, where extreme weight loss was associated 
with increased fracture risk in both men and women (288-290, 292, 293). 
Similar to the findings in a community-dwelling prospective cohort study 
among U.S. Caucasian men (290) and women (288), whose weight change 
was measured between age of 50 years and older, weight loss >10% compared 
to stable weight significantly increased risk of hip fracture by nearly three 
folds in men (HR: 2.79; 95% CI: 1.62, 4.79) (290) and in women (HR: 2.9; 95% 
CI: 2.0, 4.1) (288). Another longitudinal study among Norwegian men and 
women also showed that weight loss of more than 3 kg was associated with a 
significant two-fold increase in risk of hip fracture as compared to those who 
had body weight gain of 1.3-5.5 kg (287). Furthermore, in this study, the 
significantly elevated risk with weight loss ≥10% persisted in men and women 
combined, in elderly aged >65 years, in those whose baseline BMI ≥20 kg/m2, 
and among participants without medical history of diabetes, stroke, cancer and 
coronary heart disease. Thus, our data demonstrated the independent role of 
weight change in relation to risk of hip fracture. On the other hand, weight 
gain ≥10% was not statistically significantly associated with hip fracture risk 
in this cohort, which is similar to the previous findings among Caucasian men 
(420) and women (293). In line with these studies (288-290, 293), we did not 
find differences regarding weight change and hip fracture risk by gender or 
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age group (≤65 and >65 years). Compared to the pattern of weight change in 
previous studies, the absolute change in weight among the participants in the 
extreme weight change category (≥10%) in our study was about 4-5 kg less 
than that in the same category in two Caucasian studies (288, 290). However, 
it should be noted that age, lifestyle factors, health conditions and the time 
interval of weight change vary from one study to another.  
This study is the first to examine weight change in relation to risk of 
hip fracture in lean participants with BMI <20 kg/m
2
, which is an independent 
risk factor for hip fracture (263, 347). We found that weight loss ≥10% did not 
further affect the risk of hip fracture among these lean individuals whose 
baseline BMI was already <20 kg/m
2
. Furthermore, after excluding those who 
died between the follow-up assessment and December 31, 2010 in this 
subgroup, our results did not appear to bias towards to the healthier survivors. 
This suggested, at least in part, that in lean individuals who were already at 
risk of hip fracture due to their low BMI, extreme weight loss did not confer 
additional risk for hip fracture. Nevertheless, this could be an observation by 
chance in our study due to the small numbers of participants and hip fracture 
cases in this group. In the previous studies among Caucasian populations, the 
lowest cut-off for baseline BMI was <23 kg/m
2
 among women in the U.S. 
(288) and was ≤22.6 kg/m2 among men in Norway (420). Hence, we are not 
able to compare our results for those with baseline BMI <20 kg/m
2 
with other 
populations. In the study among White women in the U.S., weight loss ≥10% 
was consistently associated with elevated risk of hip fracture in all strata of 
baseline BMI at 50 years of age. However, weight gain ≥10% appeared to be 





it was associated with reduced risk among those with baseline BMI ≥23 kg/m2, 
although the relationship between weight gain ≥10% and hip fracture risk did 
not reach statistical significance (290). Conversely, in the study among 
Norwegian White men, compared to stable weight, weight loss ≤5% decreased 
bone mineral density (BMD) and weight gain ≥5% increased BMD across all 
baseline BMI strata (420). Further studies are needed to validate our finding of 
the null association between extreme weight loss and fracture risk in lean 
individuals with baseline BMI <20 kg/m
2
. 
The potential mechanisms between weight loss and osteoporotic 
fractures have been proposed previously. Weight loss among elderly was 
suggested to decrease more lean mass, especially muscle mass (265, 421), 
resulting in weakened muscle strength and increased frailty (269). This is 
particularly the case among elderly men (422), because men have more muscle 
mass than women (423). In line with this, studies have shown that lean mass 
was an independent contributor to hip bone mineral density (267, 268), 
especially in men (268, 424). Furthermore, decreased lean mass may reduce 
testosterone level (270, 271), which has been shown to be positively 
associated with muscle strength and bone mineral density (270). By contrast, 
loss of fat mass following weight loss may play a more predominant role in 
bone mass among postmenopausal women (268, 424), possibly due to more 
fat tissue in women as compared to men (265). Thus, loss of fat mass could 
contribute to a further decline of estrogen in postmenopausal women (272, 
273), and reduced estrogen could have a negative impact on osteoblasts (425) 
and osteoclasts (426) through the expression of the pro-inflammatory 
cytokines, such as IL-1, IL-6, and TNF-α (427). Other mechanisms underlying 
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weight loss and hip fracture include decreased mechanical loading and weight 
bearing, and loss of fat around the hip, which in turn increase the risk of 
fractures during falls (275, 276). Taken together, weight loss among elderly 
men and women may thus impair bone health and increase risk of fracture.  
On the other hand, the benefit of weight gain in reducing risk of hip 
fracture is less certain. Although weight gain increased weight bearing, 
mechanical loading and padding around the hip (275, 276), all of which may 
protect against falls and fractures, there is generally little lean mass 
conservation with weight gain among elderly men and women (422, 428). In 
the present study, although weight gain ≥10% in those who were not 
overweight at baseline (BMI <25kg/m
2
) was associated with lower risk of hip 
fracture, it did not reach statistical significance. By contrast, weight gain ≥10% 
in those who were overweight (BMI ≥25kg/m2) at baseline was associated 
with a non-significant increase in risk. We speculate that extreme weight gain 
among overweight middle-aged to elderly may be associated with increased 
risk of other chronic diseases, such as cardiovascular disease and type 2 
diabetes (429, 430), which are risk factors for hip fracture (277, 278). In 
addition, body fat may redistribute with increased visceral fat in elderly (265), 
which in turn could impair insulin sensitivity and increase the expression of 
other pro-inflammatory cytokines (430). Furthermore, serum vitamin D status 
was inversely related to adiposity (431), thus extreme weight gain may in turn 
decrease the circulation of vitamin D (432) and affect dietary calcium 
absorption (433). Recently, studies have suggested a positive relationship 
between obesity or morbid obesity and fracture risk, and weight gain may 
reach to the point to obesity (274, 279-281). However, in the Singapore 
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Chinese Health Study, after extreme weight gain ≥10%, the median (IQR) 
BMI was 24.8 (22.5, 27.3). More than 50% of the participants in this weight 
change category were overweight and less than 10% were obese. This may 
also explain, at least in part, a non-significant increased risk in this weight 
change category with hip fractures. Altogether, these are the plausible 
explanations why weight gain may not protect against hip fracture among 
overweight participants in our study population.  
The strength of this study is the large number of incident cases of hip 
fracture identified from a population-based prospective cohort with a long 
follow-up time. Another strength is the presumed lack of recall bias in body 
weight, height, and other potential confounding variables since they were 
reported by participants prior to hip fracture. Singapore is a small city-state 
with a system for easy access to specialized medical care. Since practically all 
hip fracture cases would seek medical attention immediately and be 
hospitalized, as well as a negligible proportion (0.07%) of original cohort 
participants who migrated out of Singapore, our case ascertainment through 
the linkage with the comprehensive, nationwide hospital database can be 
considered complete. A limitation of our study is the lack of information on 
diet and physical activity at the follow-up interview, which did not allow us to 
further examine whether changes in these lifestyle factors may confound the 
association between weight change and risk of hip fracture. The use of self-
reported body weight and height could be prone to non-differential 
misclassification, and thus it would lead to under-estimation of the association 
between weight change and risk of hip fracture. A systematic review of 64 
studies (381) and a study among middle-aged and elderly Australian adults 
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(434) suggested trends of underestimation for self-reported weight and 
overestimation for self-reported height. Furthermore, the systematic review 
also showed that the difference between the self-reported and objectively 
measured BMI was relatively small for those with BMI less than 30kg/m
2 
(381). In line with this, there was a very high correlation between self-reported 
and measured height, weight, and BMI among the middle-aged and elderly 
Australians (r ≥0.95); and those with higher measured BMI tend to have 
greater underestimation (434). Nevertheless, self-report of body weight has 
been shown to be valid across many populations (380), and 96% of our study 
population had BMI<30kg/m
2
. We therefore speculated that the 
underestimation of self-reported weight and height was relatively small in our 
study population. Another limitation is that change of body composition, such 
as that of lean and fat mass, was not investigated in the current study. 
Therefore we were unable to evaluate whether the effect of weight change 
could be mediated by the variation of body composition in the development of 
osteoporosis. Finally, our study excluded those who could not report weight 
and/or height at either interview, and they were different in mean age and in 
the distribution of gender, education level and prevalence of comorbidities 
from those included in this study. Nevertheless, all of our statistical models 
had included these factors as covariates to minimize possible confounding bias 
by these factors. Hence, even though differences between the participants 
included in the study and those who were excluded may affect the 
generalizability of the results, we feel that the conclusions of the present study 





Data from the present study demonstrate that weight loss of 10% or 
more was associated with significant increased risk of hip fracture among 
middle-aged to elderly Chinese men and women in Singapore. Our findings 
highlight the importance of identifying risk of osteoporotic hip fracture in 





Table 8-1. Characteristics of participants [% for categorical variables and mean (SD) for continuous variables] according to weight change 
categories, the Singapore Chinese Health Study (1999-2010) 
 Weight change  
 Loss ≥ 10% Loss 5%-< 10% Stable weight 
(Loss or gain < 5%) 
Gain 5%- < 10% Gain ≥ 10% 
Number of participants (% of cohort)                    4,872 (11.6) 5,259 (12.5) 21,565 (51.2) 5,292 (12.5) 5,161 (12.2) 
Gender      
Men, % 45.5 44.7 44.7 42.7 43.3 
Women, % 54.5 55.3 55.3 57.3 56.7 
Age at follow-up, mean (SD)                     63.5 (8.0) 61.7 (7.7) 60.2 (7.5) 59.9 (7.5) 61.2 (7.9) 
BMI kg/m
2
, mean (SD)      
at baseline 24.6 (4.4) 23.9 (3.5) 23.2 (3.3) 22.6 (3.2) 21.4 (3.1) 
at follow-up 20.7 (3.2) 22.3 (3.3) 23.2 (3.4) 24.2 (3.4) 25.1 (3.8) 
Weight, kg, mean (SD)      
        at baseline                                           62.7 (12.1) 61.1 (10.3) 59.4 (9.9) 57.7 (9.3) 54.4 (8.9) 
        at follow-up                                        52.0 (9.0) 56.7 (9.5) 59.4 (9.9) 61.8 (9.9) 64.1 (10.7) 
Weight change, kg, median (IQR) -9 (-12, -7) -4 (-5, -4) 0 (-1, 1) 4 (3,5) 8 (7,11) 
Secondary school or higher,  % 25.6 31.0 36.9 36.7 28.9 
Current smoker, % 21.2 17.7 15.7 15.9 19.9 
History of diabetes mellitus,  %                     20.9 18.9 13.1 9.9 11.2 
History of stroke,  %                               5.3 3.9 2.7 3.0  3.4  
History of coronary heart disease, %                            9.4 8.0 6.8 6.2 7.1 





History of other fractures,  %                   7.0 8.5 8.0 8.4 8.0 
Postmenopausal (women only), %                                                 95.3 93.3 88.5 87.6 90.1 
Use of HRT among postmenopausal 
women, % 
3.4 5.1 7.8 7.6 5.5 
 





Table 8-2. Association between change in body weight and risk of hip fracture, the Singapore Chinese Health Study (1999-2010) 
 
 Weight change  
 Loss ≥10% Loss 5%-<10% Stable weight 
(Weight change <5%) 
Gain 5%-<10% Gain ≥10% 
Overall (n=42,149)     
       Hip fracture cases 165 106 337 80 87 
        Person-years 40,553 46,638 196,262 48,275 45,876 
HR
1 
 (95% CI) 1.56  (1.29, 1.89) 1.10  (0.88, 1.37) Reference 0.99  (0.78, 1.27) 0.92  (0.73, 1.17) 
HR
2 
 (95% CI) 1.51  (1.25, 1.83) 1.07    (0.86, 1.33) Reference 1.01  (0.79, 1.29) 0.94  (0.74, 1.20) 
HR
3 
 (95% CI) 1.39  (1.14, 1.69) 1.03    (0.83, 1.28) Reference 1.05  (0.82, 1.34) 0.99  (0.78, 1.26) 
Men (n=18,704)     
       Hip fracture cases 43 38 106 28 24 
       Person-years 17,640 20,242 85,630 20,100 19,259 
HR
1 
 (95% CI) 1.45  (1.01,  2.07) 1.27  (0.88, 1.84) Reference 1.16  (0.76, 1.76) 0.88  (0.57, 1.38) 
HR
2 
 (95% CI) 1.42  (0.99,  2.03) 1.26 (0.87, 1.83) Reference 1.19  (0.78, 1.81) 0.90  (0.58, 1.40) 
HR
3 
 (95% CI) 1.28  (0.89, 1.86) 1.22 (0.84, 1.77) Reference 1.22  (0.81, 1.86) 0.94  (0.60, 1.48) 
Women (n=23,445)     
       Hip fracture cases 122 68 231 52 63 
       Person-years 22,913 26,396 110,632 28,175 26,617 
HR
1 
 (95% CI) 1.62  (1.29, 2.02) 1.02  (0.78, 1.34) Reference 0.92  (0.68, 1.24) 0.94  (0.71, 1.25) 
HR
2 
 (95% CI) 1.56  (1.25, 1.94) 0.98  (0.75, 1.28) Reference 0.93  (0.69, 1.26) 0.97  (0.73, 1.28) 
HR
3 









 adjusted for gender (for the whole cohort), age at follow-up interview (years), time interval between baseline and follow-up assessment 
(years), dialect group (Hokkien, Cantonese), level of education (no formal education, primary school, secondary school or higher), smoking 
status at follow-up interview (never smokers, ex-smokers, current smokers), current use of hormone replacement at follow-up interview (women 
only; yes, no); HR
2









Table 8-3. Association between change in body weight and risk of hip fracture by BMI categories at baseline and age group at follow-up, the 
Singapore Chinese Health Study (1999-2010) 
 
 Loss ≥ 10% Loss 5%-< 10% Stable weight 
(Loss or gain < 5%) 
Gain 5%- < 10% Gain ≥ 10% 
BMI at baseline      
< 20 kg/m2 Cases  14 16 66 22 30 
(n=7,549) Person-years 3,814   5,464 32,555 9,917 15,287 
 HR1 (95% CI) 0.93  (0.51, 1.67) 1.08 (0.62,1.86) Reference  1.14  (0.70, 1.85) 0.82  (0.53, 1.26) 
 HR2 (95% CI) 0.91  (0.50, 1.64) 1.06 (0.61,1.83) Reference  1.18  (0.71, 1.95) 0.88  (0.53, 1.47) 
20-<25 kg/m2 Cases  86  61  197 43 45 
(n=23,572) Person-years 20,388 25,679 112,076 28,768 25,431 
 HR1 (95% CI) 1.60  (1.24, 2.06) 1.12 (0.84,1.49) Reference  0.88 (0.63, 1.22) 0.84  (0.61, 1.16) 
 HR2 (95% CI) 1.52  (1.13, 2.05) 1.11  (0.83,1.49) Reference 0.87 (0.62, 1.22)  0.81  (0.57, 1.16) 
≥25 kg/m2 Cases 65  29   74 15 12  
(n=11,028) Person-years   16,350 15,495 51,631 9,589 5,158 
 HR1  (95% CI) 1.85  (1.32, 2.59) 1.06  (0.69,1.63) Reference 1.07  (0.61, 1.86) 1.32 (0.72, 2.44) 
 HR2  (95% CI) 1.55  (1.02, 2.37) 0.98  (0.62,1.53) Reference 1.07  (0.61, 1.88) 1.29 (0.68, 2.47) 
Age at follow-up  
≤65 years Cases 39 28 111 30 27 
(n=30,382) Person-years 26,109 33,317 150,290 37,553 33,917  
 HR1  (95% CI) 1.50  (1.04, 2.17) 0.92  (0.61, 1.39) Reference 1.14  (0.76, 1.70) 0.99  (0.65, 1.51) 
 HR2  (95% CI) 1.39  (0.94, 2.03) 0.90  (0.59, 1.36) Reference 1.16  (0.77, 1.73) 1.01  (0.66, 1.55) 
>65 years Cases  126 78 226 50 60 
(n=11,767) Person-years 14,444 13,321 45,972 10,722 11,959 
 HR1  (95% CI) 1.52  (1.22, 1.90) 1.12  (0.86, 1.45) Reference 0.96 (0.71, 1.31) 0.94  (0.71, 1.25) 








 adjusted for gender, age at follow-up interview (years), time interval between baseline and follow-up assessment (years), dialect group 
(Hokkien, Cantonese), level of education (no formal education, primary school, secondary school or higher), smoking status at follow-up 
interview (never smokers, ex-smokers, current smokers), current use of hormone replacement at follow-up interview (women only; yes, no), 











Supplemental Table 8-1. Association between change in body weight and risk of hip fracture in simple models, the Singapore Chinese Health 
Study (1999-2010) 
 
 Weight change  
 Loss ≥10% Loss 5%-<10% Stable weight 
(Weight change <5%) 
Gain 5%-<10% Gain ≥10% 
Overall (n=42,149)     
      Cases 165 106 337 80 87 
        Person-years 40,553 46,638 196,262 48,275 45,876 
HR
1
 (95% CI) 2.40  (2.00, 2.90) 1.33  (1.07, 1.66) Reference 0.97  (0.76, 1.23) 1.11  (0.88, 1.40) 
HR
2 
 (95% CI) 1.62  (1.34, 1.95) 1.12   (0.90, 1.39) Reference 1.00  (0.79, 1.28) 0.96 (0.76, 1.22) 
HR
3 




: Unadjusted;  
HR
2
: Adjusted for gender and age at follow-up interview (years);  
HR
3
: Adjusted for gender, age at follow-up interview (years) and follow-up body mass index (<20, 20-23.9, 24-27.9, ≥28 kg/m2); CI: 
confidence interval.  
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Chapter 9. Bone turnover biomarkers in relation to 
risk of hip fracture 
(Submitted paper under review) 
 
 9-1. Background 
 
 Bone turnover biomarkers (BTMs) reflect bone formation and 
resorption and therefore inform the status of bone remodeling, which is a 
mechanism underlying osteoporosis (25). BTMs are increased during aging in 
both men and women, and have been suggested to be independent risk factors 
for osteoporotic fractures (304, 305). According to a World Health 
Organization report, the majority of osteoporotic fracture patients had bone 
mineral density (BMD) above the diagnostic criteria (i.e. T score ≤ -2.5) (346), 
indicating the inadequacy of using BMD alone to identify those at risk of 
fracture. Thus, the measurement of BTM may serve either as an independent 
diagnostic and prognostic index or as a complementary indicator to BMD for 
osteoporotic fractures (435). In fact, recently, a joint effort by the International 
Osteoporosis Foundation (IOF) and the International Federation of Clinical 
Chemistry and Laboratory Medicine (IFCC) have recommended BTM as 
promising surrogate markers for the prediction of fracture risk independent of 
BMD (298). In addition, individuals with type II diabetes were reported to 
have higher BMD yet elevated risk of fractures (436, 437), and BTM can 
potentially be a more sensitive surrogate marker in assessing fracture risk, due 
to a linkage of BTM and glucose metabolism (408, 438). 
 BTM includes both bone formation and resorption markers. Bone 
formation biomarkers are synthesized by osteoblasts and therefore reflect 
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specific osteoblastic functions. Bone-specific alkaline phosphatase (BAP) is 
an enzyme that plays an important role in the formation of osteoid and bone 
mineralization (300). Osteocalcin (OC) is a bone-specific protein and is 
considered a specific marker of osteoblasts (301). Amino-terminal propeptide 
of type I procollagen (P1NP), derived from type I collagen, is a precursor of 
bone collagen synthesized by osteoblasts (302). These bone formation markers 
have been proposed as possible predictors for osteoporosis (439-442) and hip 
fracture risk (307, 314). Bone resorption markers are degradation products of 
type I collagen, which accounts for more than 90% of the organic matrix of 
bones (303). Serum carbon-terminal peptide of type I collagen (CTx) and 
serum telopeptides of collagen crosslinks (NTx) represent the carboxy- and 
amino-terminal cross-linked telopeptide of type I collagen, respectively (303). 
Increased CTx and NTx levels have also been reported to inversely correlate 
with BMD among women (439, 441) and significantly predict non-spine 
fractures independent of BMD in various longitudinal studies (308, 315, 439). 
However, the results from the existing evidence are inconsistent and primarily 
among Caucasian populations.  
 The objective of this study was to examine the relationship of bone 
turnover biomarkers with risk of osteoporotic hip fracture in middle-aged to 
elderly Chinese in Singapore. It was hypothesized that higher levels of BTM 
would be associated with increased risk of hip fracture.  
9-2. Materials and Methods 
 
Study population   
During April 1994 to December 1999, a random 3% of the study 
participants donated blood and single-void urine specimens for research. 
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Details of the biospecimen collection, processing and storage procedures have 
been described previously (443). Between January 2000 and April 2005, we 
extended the biospecimen collection from 32,543 participants, which 
represented a consent rate of about 60% of surviving cohort participants at that 
time.  
Cases and controls selection  
 
 Among the 1,630 hip fracture incident cases in the cohort, 127 cases of 
men and 138 cases of women were identified among those who donated blood 
before hip fractures. We then randomly chose 50 hip fracture cases with 50 
non-fracture controls (ratio = 1:1) for each gender with the following matching 
criteria: age at study enrollment (±3 years), dialect group (Hokkien, 
Cantonese), date of study enrollment (±2 year), date of biospecimen collection 
(±6 months). Also, the selected controls must not have any fracture at the time 
of the fracture index case.  Compared with the hip fracture patients who were 
not included in this study (n=1,530), the 100 randomly chosen cases were 
similar in age at hip fracture, dialect group and BMI at baseline (p>0.05).  The 
average age at the onset of hip fracture was 75.1 (SD 6.3) for the 100 cases 
included in this study and 74.4 (SD 7.5) for the 1,530 cases not included in 
this study.  
Bone turnover biomarkers 
 
Serum samples of a given matched set (containing the samples from 
the case and his/her matched control) were arranged in a random order, 
identified only by unique codes, and tested by the Clinical and Translational 
Science Award (CTSA) Immunochemical Core Laboratory at the Mayo Clinic 
in Rochester, Minnesota, U.S. The laboratory personnel were blinded to the 
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status of the case and control samples. Serum samples were thawed at 4 °C 
and individually filtered via 0.22 μm sterile cartridges. Filtered sera were 
collected in aliquots for measurements of five bone turnover biomarkers, BAP, 
OC, P1NP, CTx and NTx. Bone alkaline phosphatase (BAP) was measured 
using an immunoassay and its enzymatic activity was measured [intra- and 
inter-assay coefficient of variation (CV) < 10%  at limit of detection (LOD) of 
18 U/L and <4% at LOD of 16.5 U/L, respectively (the assay has a 3-8 % 
cross-reactivity with liver alkaline phosphatase), Metra Biosystems, 
Mountainview, CA ] (444). Osteocalcin (OC) was measured by a 2-site 
immunenzymatic sandwich assay on the Roche Cobas e411 (intra- and inter- 
assay CV <3% at LOD of 1.62ng/mL and 3.9% at LOD of 15.8 ng/mL, 
respectively; Roche Diagnostics, Indianapolis, IN) (445). Amino-terminal 
propeptide of type I procollagen (P1NP) was measured by a double antibody 
(intra- and inter-assay CV was 2.3% at LOD of 44.5 µg/L and 3.8% at LOD of 
28.0 µg/L, respectively; Orion Diagnostica, Espoo, Finland: distributed by 
Diasorin, Stillwater, MN) (446). Serum carbon-terminal peptide of type I 
collagen (CTx) was measured by a two-site immunenzymatic sandwich assay 
on the Roche Cobas e411 (intra- and inter- assay CV < 7.8% at LOD of 0.046 
ng/mL and <8.5% at LOD of 0.291 ng/mL, respectively; Roche Diagnostics, 
Indianapolis, IN) (447). Serum telopeptides of collagen crosslinks (NTx) was 
measured by a quantitative competitive-inhibition enzyme-linked 
immunosorbent assay (intra- and inter- assay CV was <6.9% at LOD of 7.5 
nmolBCE/L and 7.1% at 26.5 nmolBCE/L, respectively; Ostex International, 





Student’s t-test (for normally distributed continuous variables) and 
Chi-square test (for categorical variables) were used to compare baseline 
characteristics between the hip fracture cases and controls. The distributions of 
all biomarkers measured were markedly skewed with a long tail toward high 
values, which were corrected, to a large extent, by transforming the original 
values to logarithmic values. Therefore, formal statistical test was performed 
on logarithmically transformed values, and geometric means were presented.  
The analysis of covariance (ANCOVA) was used to examine the differences 
in the concentrations of serum biomarkers between hip fracture cases and 
controls, and between those with and without baseline history of diabetes.  
We applied conditional logistic regression to estimate relative risk of 
hip fracture associated with higher levels (2nd to 4th quartiles or Q2 to Q4) of 
each BTM comparing with the lowest quartile (Q1). The quartile cut-off 
values were based on the BTM’s distributions among all controls.  Model 1 
included the matching variables only: age, sex, dialect group, date of study 
enrollment, and date of biospecimen collection. In addition to variables 
included in Model 1, Model 2 included  BMI (kg/m
2
, continuous), level of 
education (no formal education, primary school, secondary school or higher), 
smoking status (never smokers, ex-smokers, current smokers), physical 
activity (none, 0.5-<4 hrs weekly, ≥4 hrs weekly), and dietary soy isoflavones 
(quartiles, mg/1,000 kcal/day), pyridoxine (quartiles, mg/1,000kcal/day), and 
β-carotene (quartiles, µg/1,000kcal/day); all of these covariates were 
associated with risk of hip fracture in our previous analyses (20, 121, 347). In 
addition to variables in Model 2, Model 3 included a variable for self-reported 
history of physician-diagnosed diabetes mellitus (yes, no), which has been 
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shown to significantly increase risk of hip fracture in our study population 
(278). The magnitude of the association was assessed by odds ratio (OR) and 
the corresponding 95% confidence interval (CI). To examine linear trend, 
ordinal values of the quartile of each BTM was entered as a continuous 
variable in the logistic regression model.  
Furthermore, the magnitude of bone turnover biomarkers in explaining 
risk of hip fracture was evaluated by comparing R square between the 
regression models with BTMs (CTx and P1NP) and without BTMs (CTx and 
P1NP) including the following risk factors: age (years), gender, BMI (kg/m
2
), 
level of education in categories (no formal education, primary school, 
secondary school or higher), total energy intake (kcal), soy isoflavones 
(mg/1000kcal, in quartile), vitamin B6 (mg/1000kcal, in quartile), β-carotene 
(µg/1000kcal, in quartile), and vegetable-fruit-soy pattern scores (in quintile), 
smoking status (never, ex-smokers, current smokers), moderate physical 
activity (none, 2-<4 hrs weekly, ≥4 hrs weekly) and baseline self-reported 
physician-diagnosed history of diabetes mellitus (yes, no) and stroke (yes, no). 
 All statistical analysis was conducted using SAS Version 9.2 (SAS 
Institute, Inc., Cary, North Carolina). All reported p values were two-sided, 
and p < 0.05 was considered statistically significant. 
9-3. Results  
 
Among the 100 cases of hip fracture, the mean time interval from 
blood draws to the occurrence of hip fracture was 5.0 years (SD 2.6 years). 
The mean age of patients at the occurrence of hip fracture was 75.1 (SD 7.6) 
years. Baseline characteristics between the hip fracture cases and controls are 
presented in Table 9-1. Compared to the non-hip fracture controls, there was 
 219 
 
no statistically significant differences in BMI, level of education, cigarette 
smoking (status, smoking density and duration), weekly moderate physical 
activity, serum 25(OH)D, dietary intake of calcium, pyridoxine and β-carotene, 
or history of stroke among the hip fracture cases (p>0.05). However, the cases 
had significantly lower dietary intake of soy isoflavones and higher prevalence 
of diabetes mellitus than the controls (p<0.05).  
 Table 9-2 shows the geometric means of all five bone turnover 
biomarkers in serum samples collected at baseline from cohort participants 
who subsequently developed hip fracture (cases) and those who remained free 
of hip fracture (controls). Cases had significantly higher serum levels of OC, 
P1NP, CTx and NTx (p≤0.007) than controls. The serum BAP was higher in 
cases than controls, but the difference was not statistically significant.  The 
Spearman correlation coefficients among the five BTMs after adjustment for 
gender ranged from 0.42 to 0.76; the highest correlation coefficient was 0.76 
between CTx and NTx and 0.75 between OC and P1NP. The correlation 
coefficient was 0.59 between P1NP and CTx (Table 9-3). 
The association between serum BTMs and risk of hip fracture is shown 
in Table 9-4. There was a statistically significant dose-dependent positive 
association for OC, P1NP, CTx and NTx with risk of hip fracture. After 
adjustment for history of diabetes mellitus and other potential confounders, 
ORs (95% CIs) of hip fracture for the highest quartile of OC, P1NP, CTx, and 
NTx were 8.23 (2.26-30.03), 6.63 (2.02-21.81), 4.92 (1.67-14.51) and 4.32 
(1.39-13.45), respectively, comparing  with their respective lowest quartile 
(Q1) (all p for trend ≤0.006).  There was no statistically significant association 
between serum BAP and hip fracture risk. Similarly, the odds ratio in hip 
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fracture risk per SD increase for OC, P1NP, CTx and NTx were statistically 
significant and ranged from 1.55 to 1.95 (Table 9-3).   
To determine the independent risk factors, a stepwise selection 
approach with the conditional logistic regression model was employed with 
the variable entry p-value of 0.30 and the retention p-value of 0.35. The 
stepwise approach yielded P1NP and CTx in the most parsimonious model. 
We further assessed the joint effect of P1NP and CTx on the risk of hip 
fracture (Table 9-5). Currently there are no biologically or clinically defined 
values of low or high levels for these two biomarkers. Hence, we used odds 
ratio (OR) for the quartile categories of P1NP and CTx in Table 9-4 as a guide 
to define the risk-group. For P1NP levels, we re-categorized participants into 
three risk levels with Q1 being the reference, Q2 and Q3 combined as level 2 
because the risk estimates were similar, and Q4 as the highest level. For CTx 
levels, we re-categorized participants into two risk levels with the lower two 
quartiles (Q1-Q2) as the reference and Q3 and Q4 combined as the higher 
level. This approach was chosen because the OR increased by more than 3 
folds at Q3 and Q4 compared to the lower two quartiles (Q1-Q2). We then 
constructed 6 categories based on the combination of P1NP and CTx levels to 
assess the joint effect, and the reference group consisted of P1NP (Q1) and 
CTx (Q1-Q2). Compared to the reference group, those who were in the high-
level group for either P1NP or CTx had 2.21-12.57 fold increase in risk of hip 
fracture. The greatest risk was found among those with CTx (Q3-Q4) and 
P1NP (Q4); there was a 12.6-fold increase in hip fracture risk among this 
group (OR: 12.57; 95% CI: 3.10-51.02) (Table 9-5). The p-value for the 
multiplicative interaction was not significant (p for interaction=0.75).  
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We then examined the association between BTM and hip fracture risk 
by proximity of blood draw to fracture. For blood drawn within 4 years prior 
to hip fracture, compared to those with P1NP (Q1) and CTx (Q1-Q2), 
participants with CTx (Q3-Q4) and P1NP (Q4) had a 60.1-fold increase in risk 
of hip fracture (p=0.03). Conversely, the corresponding increase in risk of hip 
fracture for blood drawn more than 4 years after fracture was much lower at 
10.9-fold (p=0.01). We noted that after controlling for baseline physician-
diagnosed history of diabetes, the adjusted OR became substantially higher, 
suggesting a negative confounding effect by history of diabetes in the 
association of BTM with risk of hip fracture. Further analysis showed that this 
was because among both cases and controls, those with diabetes at baseline 
(n=20) had lower levels of BTM, particularly, OC, P1NP, and NTx as 
compared to those without history of diabetes (Table 9-6). 
9-4. Discussion 
 
 To our best of knowledge, this is the first longitudinal study to 
prospectively assess risk of hip fracture using a panel of five bone turnover 
biomarkers in an Asian population. Our findings showed higher serum levels 
of OC, P1NP, CTx and NTx in pre-fracture blood samples of the hip fracture 
cases as compared to the non-fracture controls, and these BTMs were in turn 
positively associated with risk of hip fracture. Furthermore, our results 
confirmed that serum P1NP and CTx were independent predictors for hip 
fractures among the BTMs we examined in this study. This is consistent with 
the two recommended analytes by the IOF and the IFCC (298). 
 Findings from the present study are generally consistent with those 
from the previous studies among Caucasian populations. Several prospective 
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studies have shown that one or two of the bone formation (OC, P1NP) and/or 
resorption (CTx) markers in the serum were significantly associated with 
increased risk of hip fracture among Caucasian populations (306, 307, 310, 
314, 315). Among these studies, only one study was conducted among elderly 
men (310). A case-cohort study nested in the Osteoporotic Fractures in Men 
(MrOS) cohort of men aged over 65 years showed that, after a follow-up of 5 
years, a higher level of serum P1NP or CTx was related to bone loss and 
significantly increased risk of hip fracture [relative hazards (RH) = 2.13 (95% 
CI: 1.23-2.68) and RH=1.76 (95% CI: 1.04-2.98), respectively], comparing 
the highest quartile to the lower three quartiles. However, further adjusting 
BMD and other clinical risk factors attenuated the associations and the 
statistical significance was lost (310). In a case-control study nested in the 
EPIDOS prospective study of healthy French women aged 75 years or older, 
OC was associated with increased risk of hip fracture by nearly 2 folds (OR: 
1.8, 95% CI: 1.0-3.0) independent of femoral neck bone density after a follow-
up of 22 months (307). Other prospective cohort studies among women also 
suggested that a higher BAP, CTx or NTx level may be associated with greater 
risk of all osteoporotic fractures (308, 309, 316-318).  
 Compared to these studies among Caucasian populations, our findings 
further demonstrated that multiple bone formation and resorption markers may 
significantly increase risk of hip fracture among middle-aged to elderly 
Chinese. Compared to the reference serum levels of the BTM reported among 
healthy Caucasian men and/or women, the BAP level of the controls in the 
present study [median (interquartile): 37.80 (29.4-48.3) U/L] tend to be higher 
than that in these studies (449-451), while the level of OC [18.1 (13.8-24.1) 
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ng/mL], P1NP [44.5 (34.2-55.0) µg/L] and CTx [0.28 (0.21- 0.41) ng/mL] are 
within the reference range specified in these studies (449, 451). The lack of 
association between BAP and risk of hip fracture may include several 
possibilities: 1. BAP may not be a sensitive bone turnover biomarker to 
predict fractures; 2. The current available assay to determine serum level 
of BAP has a 3-8 % cross-reactivity with liver alkaline phosphatase, 
which means the measured BAP would overestimate the bone specific 
BAP; 3. The difference of serum BAP between cases and controls did 
not reach statistical significance.  However, it should be noted that the 
assays for BTM measurement were not standardized but different among 
different studies (449, 451). Furthermore, a number of factors, such as 
circadian, fasting status, lifestyle factors and health condition can affect the 
variability of BTM (298).   
In line with the recommended analytes by the IOF and IFCC, our data 
confirmed that P1NP and CTx were the best risk predictors for hip fractures 
among the five BTMs we examined. In addition, this study is the first to show 
additive effect by combining P1NP and CTx in hip fracture risk, which was 
supported by a recent meta-analysis that reported both serum P1NP and CTx 
significantly increased risk of fracture (452). Furthermore, our result also 
showed that the elevation of combined P1NP and CTx had a much stronger 
association with hip fracture risk during a shorter duration of follow-up (<4 
years) than a longer duration (≥4 years), suggesting P1NP and CTx may be a 
more sensitive biomarker for hip fracture prediction in a short period of time.  
Hence, our finding has provided additional evidence for the utility of P1NP 
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and CTx as a panel of standardized bone turnover markers to predict hip 
fracture risk.  
 More interestingly, in the present study, individuals with a history of 
diabetes mellitus had lower level of BTMs, particularly OC, P1NP, and NTx 
(P<0.05) than those without a history of diabetes in both case and control 
groups. This was supported by several studies that reported lower OC (437, 
438, 453-455) and lower CTx (437) in diabetic patients as compared to non-
diabetic individuals in different populations. While most of these studies were 
conducted in Caucasian populations, there were two relevant Asian studies. A 
cross-sectional study in Chinese postmenopausal women reported lower levels 
of both OC and cortical BMD in the tibia in women with diabetes than those 
without (456). The other case-control study in Japan reported lower levels of 
OC, P1NP and CTx in both men and women with diabetes than their 
counterparts without diabetes (454). Taken together, these findings suggest a 
lower cut-off value of BTMs for the identification of individuals at high risk 
of hip fracture for patients with type 2 diabetes.  
In addition, inclusion of P1NP and CTx with other significant risk 
factors for hip fracture improved the R
2
 by 15% relative to the inclusion of 
other risk factors alone, suggesting the predictive values of BTMs, P1NP and 
CTx had an important role in explaining the risk of hip fracture in our study 
population.  
There are several proposed mechanisms that higher bone turnover may 
be associated with greater fracture risk. First, bone turnover plays a central 
role directly and indirectly in the mechanical resistance of the skeleton (458). 
Bone turnover may also have direct impacts on bone mineral density, bone 
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macro- and micro- architecture, and bone matrix, all of which are risk factors 
for fractures (25, 459). Another speculation is that despite higher bone 
turnover, the newly formed bones are less well mineralized than the mature 
bones (331, 460), which may be due to the lack of enzymatic cross-linking for 
calcium deposition in the collagen matrix in osteoporosis (331). In the present 
study, the association between elevated BTM and risk of hip fracture was 
much higher during a shorter duration of follow-up (within 4 years) than with 
longer duration (≥ 4 years). Some studies also reported that increased serum 
OC was related to higher risk of hip fracture in a follow-up of less than two 
years (307, 314).   Together, these studies and ours support the hypothesis that 
increased bone turnover in elderly may increase the proportion of recently 
synthesized bone which is more fragile than mature bone, and thus increase 
the risk of fracture. In addition, although the clear biological mechanisms 
between diabetes and bone changes and deterioration remain to be elucidated, 
several possible interlinking among insulin, receptor activator of nuclear factor 
kappa-B ligand (RANKL) pathway, Wnt/beta-catenin pathway, alteration of 
collagen crosslinking, and BTM changes have been proposed (436). More data 
is needed to assess the biological sensitive surrogate marker, particularly OC, 
P1NP, CTx and NTx for risk of fracture among diabetic individuals.   
 The strengths of the present study are the presumed lack of recall bias 
in exposure data from the questionnaire and the collection of blood specimens 
prior to hip fracture occurrence. In addition, we considered all of the 
previously reported dietary, lifestyle and health factors in the model, and our 
results suggest that these factors confound the association and underestimate 
the actual associations if unaccounted for. One of the limitations of this study 
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is that the results were based on a single time-point collection of blood 
samples, which may not fully reflect the biomarkers of bone metabolism. 
However, since the serum samples were collected before fractures, such 
misclassifications are generally non-differential in nature, and may result in an 
underestimation of the true effect size of BTM on hip fracture risk. Another 
limitation is the lack of measurements on BMD, hence we were unable to 
examine whether bone turnover biomarkers were independent of BMD on risk 
of hip fracture.   
9-5. Conclusions 
 
In conclusion, the present study demonstrated that higher serum level 
of OC, P1NP, CTx and NTx were associated with subsequent risk of hip 
fracture in an Asian population, and confirmed P1NP and CTx as the best 
BTM predictors for hip fracture risk. Future studies are warranted to determine 
the ideal cut-off to optimize the sensitivity and specificity of these two BTMs 
with and without BMD for the risk prediction of hip fracture, as well as to 
evaluate whether a lower cut-off BTM level is required to identify risk of hip 





Table 9-1. Baseline characteristics [percent or mean (SD)] of individuals who developed hip fracture (cases) and those who 
remained free of hip fracture (controls), The Singapore Chinese Health Study 
 
Characteristics Cases Controls p-value* 
Number of subjects 100 100 … 
Age at blood draw, mean (SD) 70.1 (7.4) 69.9 (7.2) 0.91 
Body mass index (kg/m2), mean (SD) 22.7 (3.4) 23.4 (3.1) 0.15 
Level of education, n (%)  
  
0.85 
No formal education 30 (30) 32 (32) 
 Primary school 50 (50) 46 (46) 
 Secondary school and above 20 (20) 22 (22) 
 Current smokers, n (%) 20 (20) 18 (18) 0.72 
Moderate activity>0.5 hours per week, n (%) 32 (32) 29 (29) 0.65 
Serum 25 (OH)D (ng/mL), geometric mean (95% CI) 24.2 (23.1, 25.4) 23.9 (22.7, 25.1) 0.83 
Calcium (mg/day), mean (SD) 419.0 (232.9) 423.4 (207.2) 0.89 
Soy isoflavones (mg/1000 kcal/day), mean (SD) 10.4 (7.8) 13.4 (11.4) 0.03 
Pyridoxine (mg/1000kcal/day), mean (SD) 0.68 (0.14) 0.71 (0.16) 0.20 
β-Carotene (µg/1000 kcal/day), mean (SD) 1,365.4 (769.6) 1,392.6 (783.8) 0.80 
History of stroke, n (%) 3 (3) 1 (1) 0.32 
History of diabetes mellitus, n (%) 15 (15) 5 (5)  0.02 
* 2-sided  p-value was derived from t test for continuous variables and from chi-squared test for categorical variables.
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Table 9-2. Geometric means (95% confidence intervals) of serum bone turnover 
biomarker (BTM) in individuals who developed hip fracture (cases) and those 




BTM Cases   Controls p-value 
    
BAP  (U/L) 39.4 (36.3-42.7) 36.7 (33.9-39.6) 0.10 
OC  (ng/mL) 19.9 (18.1-21.8) 17.3 (15.8-18.9) 0.006 
P1NP  (µg/L) 48.6 (44.1-53.5) 42.1 (38.3-46.2) 0.007 
CTx (ng/mL) 0.36 (0.32-0.40) 0.28 (0.24-0.32) 0.0003 
NTx (BCE/L) 14.0 (13.1-15.0) 12.3 (11.5-13.1) 0.0006 
 
*Adjusted for matching factors (age, gender, and dialect group), and BMI 
(kg/m
2
, continuous), level of education (no formal education, primary school, 
secondary school or higher), smoking status (never smokers, ex-smokers, 
current smokers), physical activity (none, 0.5-<4hrs weekly, ≥4 hrs weekly), 
soy isoflavones (mg/1,000 kcal/day in quartile), pyridoxine (mg/1,000 kcal/day 
in quartile), β-carotene (µg/1,000 kcal/day in quartile), and baseline self-
reported physician-diagnosed history of diabetes mellitus (yes, no).
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Table 9-3. Spearman rank correlation coefficients between BTMs (n=200) 
 
 BAP OC P1NP CTx NTx 
BAP  0.43 0.65 0.42 0.43 
OC   0.75 0.69 0.65 
P1NP    0.59 0.53 





Table 9-4. Bone turnover biomarkers in relation to hip fracture risk (n=200). 
 
 




Quartile 1  
 
Quartile 2  
 
Quartile 3  
 
Quartile 4  
 





BAP (U/L), Median 
(IQR) 26.5 (23.0-27.8) 34.0 (31.7-36.4) 42.2 (39.8-44.0) 54.6 (50.5-61.1) 
 
 





 1.0 (Referent) 1.68 (0.75-3.80) 2.08 (0.89-4.88) 1.56 (0.66-3.70) 0.28 1.20 (0.89-1.62) 
Model 2
b
 1.0 (Referent) 2.29 (0.91-5.77) 2.74 (1.03-7.26) 2.35 (0.84-6.57) 0.11 1.32 (0.93-1.87) 
Model 3
c
 1.0 (Referent) 2.32 (0.9-5.94) 2.93 (1.07-8.01) 2.41 (0.84-6.95) 0.10 1.40 (0.95-2.07) 
OC (ng/mL), median 
(IQR) 11.3 (10.0-12.5) 16.2 (15.1-16.8) 21.1 (18.9-23.0) 28.9 (26.7-33.3) 
 
 





  1.0 (Referent) 2.10 (0.89-4.97) 2.32 (0.90-5.97) 3.22 (1.26-8.22) 0.02 1.32 (0.93-1.87) 
Model 2
b
 1.0 (Referent) 1.84 (0.72-4.68) 2.48 (0.88-7) 3.38 (1.2-9.47) 0.02 1.32 (0.92-1.90) 
Model 3
c
  1.0 (Referent) 2.86 (0.92-8.90) 6.29 (1.68-23.52) 8.23 (2.26-30.03) 0.001 1.55 (1.04-2.31) 
P1NP (µg/L), median 
(IQR) 26.8 (23.6-30.9) 39.8 (37.1-42.7) 49.3 (46.8-52.7) 67.9 (59.0-82.6) 
 
 





 1.0 (Referent) 1.89 (0.72-4.97) 1.52 (0.58-3.95) 3.39 (1.27-9.07) 0.03 1.35 (0.97-1.88) 
Model 2
b
 1.0 (Referent) 2.30 (0.80-6.60) 1.50 (0.50-4.47) 4.54 (1.49-13.77) 0.02 1.45 (1.02-2.06) 
Model 3
c
  1.0 (Referent) 2.94 (0.97-8.92) 2.09 (0.65-6.69) 6.63 (2.02-21.81) 0.004 1.62 (1.10-2.37) 







CTx (ng/mL), median 
(IQR) 
0.18 (0.13-0.20) 0.25 (0.23-0.27) 0.34 (0.31-0.37) 0.51 (0.47-0.66) 





 1.0 (Referent) 1.54 (0.68-3.48) 2.63 (1.09- 6.37) 2.68 (1.09- 6.57) 0.02 1.43 (1.06-1.94) 
Model 2
b
 1.0 (Referent) 1.53 (0.60-3.91) 3.49 (1.26-9.68) 4.00 (1.43-11.18) 0.004 1.58 (1.14-2.19) 
Model 3
c
  1.0 (Referent) 1.39 (0.54-3.59) 3.66 (1.28-10.46) 4.92 (1.67-14.51) 0.002 1.78 (1.24-2.56) 
       
NTx (BCE/L), median 
(IQR) 9.1(7.9-10.2) 12.2 (11.60-12.60) 14.4 (13.80-15.20) 18.6 (16.90-20.70) 
 
 





 1.0 (Referent) 1.15 (0.49- 2.71) 1.08 (0.42-2.79) 1.93 (0.81-4.61) 0.10 1.42 (1.04-1.93) 
Model 2
b
 1.0 (Referent) 1.33 (0.50-3.52) 1.14 (0.37-3.45) 2.62 (0.93-7.35) 0.04 1.53 (1.08-2.16) 
Model 3
c
  1.0 (Referent) 1.57 (0.56-4.42) 1.70 (0.50-5.73) 4.32 (1.39-13.45) 0.006 1.95 (1.29-2.93) 
 
a
 Model 1: conditional logistic regression model that adjusted for matching factors including age at study enrollment (±3 years), sex, dialect 
group (Hokkien, Cantonese), date of study enrollment (±2 year), and date of biospecimen collection (±6 months).   
 
b 
Model 2 – further adjusted for BMI (kg/m2, continuous), level of education (no formal education, primary school, secondary school or higher), 
smoking status (never smokers, ex-smokers, current smokers), physical activity (none, 0.5-<4hrs weekly, ≥ 4 hrs weekly), soy isoflavones 
(mg/1,000 kcal/day in quartile), pyridoxine (mg/1,000 kcal/day in quartile), β-carotene (µg/1,000 kcal/day in quartile; 
 
c 
Model 3 – further adjusted for self-reported history of physician-diagnosed  diabetes mellitus (yes, no) at baseline. 
 
d





Table 9-5. Joint effects of s-P1NP and s-CTx in hip fracture risk (n=200)  
 
 
P1NP (Q1)  
 
P1NP (Q2-Q3)  
 
P1NP (Q4)  
Cases/Controls OR* (95% CI) Cases/Controls OR* (95% CI) Cases/Controls OR* (95% CI) 
CTx (Q1-Q2) 10/22 Reference 16/21 2.21 (0.66-7.43) 8/7 5.68 (0.89-36.14) 
CTx (Q3-Q4) 6/3 4.65 (0.70-30.90) 29/30 5.03 (1.42-17.81) 31/17 12.57 (3.10-51.02) 
 
*Adjusted for BMI (kg/m2, continuous), level of education (no formal education, primary school, secondary school or higher), smoking status 
(never smokers, ex-smokers, current smokers), physical activity (none, 0.5-<4 hrs weekly, ≥ 4 hrs weekly), soy isoflavones (mg/1,000 kcal/day 
in quartile), pyridoxine (mg/1,000 kcal/day in quartile), β-carotene (µg/1,000 kcal/day in quartile and baseline self-reported physician-diagnosed 





Table 9-6. Comparison of bone turnover biomarkers in participants with and without baseline physician-diagnosed history of diabetes (n=200) 
 
Bone turnover biomarkers                          Geometric mean* (95% CI) 
Both cases and controls Subjects with diabetes Subjects without diabetes p-value 
Number of subjects 20 180 
 BAP  (U/L) 37.48 (32.32-43.48) 38.08 (35.82-40.48) 0.84 
OC  (ng/mL) 13.44 (11.26-16.06) 19.08 (17.74-20.54) 0.0002 
P1NP  (µg/L) 35.18 (29.18-42.42) 46.82 (43.34-50.58) 0.0035 
CTx (ng/mL) 0.26 (0.20-0.34) 0.32 (0.28-0.34) 0.11 
NTx (BCE/L) 11.62 (10.12-13.36) 13.62 (12.86-14.42) 0.03 
Controls only  
  
 Number of subjects 5 95 
 BAP  (U/L) 31.04 (23.2-41.54) 36.82 (33.98-39.92) 0.26 
OC  (ng/mL) 12.62 (8.62-18.46) 17.90 (16.12-19.88) 0.08 
P1NP  (µg/L) 35.14 (23.72-52.06) 43.34 (38.88-48.32) 0.31 
CTx (ng/mL) 0.20 (0.12-0.32) 0.28 (0.26-0.32) 0.14 
NTx (BCE/L) 10.32 (7.76-13.72) 12.74 (11.78-13.8) 0.16 
Cases only  
  
 Number of subjects 15 85 
 BAP  (U/L) 39.58 (33.02-47.46) 39.30 (35.76-43.18) 0.94 
OC  (ng/mL) 14.00 (11.44-17.1) 20.38 (18.36-22.62) 0.0004 
P1NP  (µg/L) 35.72 (28.74-44.4) 50.40 (45.02-56.42) 0.003 
CTx (ng/mL) 0.30 (0.22-0.40) 0.34 (0.30-0.40) 0.28 






*Adjusted for hip fracture status (yes, no, for overall only), age (years, continuous), gender (men, women), BMI (kg/m
2
, continuous), level of 
education (no formal education, primary school, secondary school or higher), smoking status (never smokers, ex-smokers, current smokers), 
physical activity (none, 0.5-<4 hrs weekly, ≥ 4 hrs weekly), soy isoflavones (mg/1,000 kcal/day in quartile), pyridoxine (mg/1,000 kcal/day in 




Chapter 10 – Discussion 
 
10-1. Summary of the findings 
 
The overall objective of this thesis was to advance the understanding 
of important risk factors for hip fractures among middle-aged and elderly 
individuals, particularly in the Asian context. There are several novel findings 
which will shed light and research directions to elucidate the pathophysiology 
of osteoporosis. In this thesis, there is a gender-specific difference found in the 
relationship of several dietary factors, including dietary vitamin B6, 
carotenoids, vegetables, coffee and caffeine with risk of hip fracture. This 
merits more attention in future studies to assess the sex-environment 
interactions in the development of osteoporosis and related fractures.  
Several significant dietary determinants have been identified. 1) 
Dietary vitamin B6 was inversely related to fracture risk observed among 
women with a significant 18-22% decrease in risk from quartile 2 to quartile 4 
(p for trend=0.002). No association, however, was found in men (p for 
interaction = 0.008). 2) Consumption of total vegetables, green vegetables, and 
yellow-orange vegetables as well as total carotenoids, α-carotene, β-carotene, 
and lutein/zeaxanthin was inversely associated with hip fracture risk in men 
but not in women (all p for trend <0.05; p for interaction=0.11 for total 
vegetables and 0.28 for total carotenoids). In addition, BMI modified the 
effect of total vegetables or carotenoids on incident hip fractures, where the 
greatest protective effects of total vegetables and carotenoids were found in 
lean men with BMI <20 kg/m
2 
(p for trend <0.004; p for interaction = 0.01 for 




per day or equivalent to 200-<300 mg of caffeine was related to a significant 
16% lower risk of hip fracture in women only (p for interaction=0.04), while 
daily drinking coffee ≥4 cups may pose possible risk in both genders. 4) A 
greater adherence to a plant-based diet comprising vegetables, fruit and soy 
foods, namely the vegetable-fruit-soy (VFS) pattern derived by principal 
component analysis, or the Alternative Healthy Eating Index (AHEI) 2010 
assessed for dietary quality, was inversely associated with incident hip 
fractures in both men and women. A significant risk reduction by 19-30% and 
by 23-32% across quintile 2-5 was observed for the VFS pattern and the AHEI 
2010, respectively.  
Overall, compared the results on nutritional determinants for hip 
fracture risk in the Singapore Chinese Health Study with studies conducted in 
the Caucasian populations, a healthy dietary pattern characterized as a higher 
intake of fruit, vegetables, and plant-based protein (nuts and soy) but low in 
red or processed meat was shown to have a favorable association on BMD or 
reduced risk of hip fractures in studies conducted in both Asian (247, 399, 461, 
462) and Caucasian populations (243-246, 249, 250, 252). Some but not all 
studies conducted in the Western populations also showed that an energy 
dense dietary pattern with high intake of processed foods, potatoes, and red 
meat was associated with lower BMD (244, 246, 251, 252). However, to the 
best of my knowledge, no studies to date have reported an energy dense diet 
was associated with increased fracture risk (245, 463). As the data of BMD is 
not available in this cohort, it is not possible to compare the MDS pattern that 
was high in refined starch, deep-fried foods and meat from this cohort in 




namely, dietary vitamin B6, carotenoids, vegetables and coffee/caffeine, as 
mentioned above, there was a novelty of gender-specific differences in dietary 
vitamin B6, vegetables, carotenoids and coffee consumption in the 
relationship with risk of hip fracture. Some of our findings are consistent with 
results in other studies conducted in the Caucasian populations, although the 
conclusions remain inconsistent in the literature for single dietary factors in 
relation to fracture risk.  
For the association with body weight change during an average of 6 
years between the baseline and the follow-up assessments, compared to stable 
weight (loss or gain <5 %), weight loss ≥10 % was associated with a 
significant 39 % increased risk in both genders. Such significantly increased 
risk persisted in those with baseline BMI ≥ 20kg/m2, and regardless gender, 
age group or chronic health condition. However, the association between 
weight gain and hip fractures is less certain. Finally in the study of bone 
turnover biomarker, serum OC, P1NP, CTx or NTx was significantly higher in 
the hip fracture cases than the non-fracture controls, and there was a 
statistically significant positive relationship between each of these BTMs and 
risk of hip fracture in both men and women (p for trend≤0.006).  
Regarding comparisons between age groups for the significant 
determinants found in this thesis, Table 10-1 provides such results for dietary 
patterns and weight change for the whole cohort, total vegetable and 
carotenoid intake for men, and dietary vitamin B6 and coffee drinking status 
for women. Due to the small sample size for the associations between bone 
turnover biomarkers and risk of hip fracture, it is not feasible to conduct such 




Table 10-1. Comparison of risk estimate in HR (95% CI)* for the significant 
determinants of hip fracture risk between age groups   
Age groups in years 
 (#cases/non-cases) 
VFS pattern 
score  per SD  
AHEI 2010 score  
per SD  
Age groups in years 
 (#cases/non-cases) 
Weight loss  
≥10% vs. stable 
weight 
All  (n=63,154) 
0.89 (0.84, 0.94) 
(p<0.001) 
0.88 (0.83, 0.92) 
(p<0.001) All (n=42,149) 1.39 (1.14, 1.69)  
<60 (425/40,406) 
0.89 (0.80, 0.99) 
(p=0.03) 
0.89 (0.81, 0.99) 
(p=0.03) <65 (204/28,715) 
1.37 (0.90, 2.07) 
(p=0.14) 
60-<65 (354/9,669) 
0.87 (0.77, 0.99) 
(p<0.03) 
0.89 (0.80, 1.00) 
(p=0.04) 65-<70 (175/6,310) 
1.37 (0.90, 2.09) 
(p=0.14) 
65-<70 (429/7,136) 
0.88 (0.79, 0.98) 
(p=0.02) 
0.80 (0.73, 0.89) 
(p<0.001) 70-<75 (208/4,040) 
1.39 (0.96, 1.99) 
(p=0.08) 
≥70 (422/4,313) 
0.90 (0.80, 1.00) 
(p<0.06) 
0.94 (0.85, 1.04) 
(p=0.20) ≥75 (188/2,309) 
1.52 (1.04, 2.23) 
(p=0.03) 
     
 
Pyridoxine in mg 
per SD 




0.93 (0.87, 0.99) 
(p=0.02) 




0.99 (0.90, 1.08) 
(p=0.73) 




0.83 (0.76, 0.91) 
(p<0.001) 
0.78 (0.62, 0.99) 
(p=<0.05) 
  
     
 
Total vegetables 
in gram per SD 
Total carotenoids 
in µg per SD 
  
Men (n=27,913) 
0.75 (0.66, 0.86) 
(p<0.001) 




0.78 (0.65, 0.94) 
(p=0.01) 




0.81 (0.67, 0.97) 
(p=0.02) 
0.81 (0.67, 0.99) 
(p<0.04) 
  * Covariates were adjusted as in the full model as described in each specific 
chapter  
 
Further analysis showed that the magnitude of the risk estimate 
appeared to be similar among age groups for the VFS pattern and AHEI 2010, 
but the relative risk for extreme weight loss was suggested higher in elderly 
over 75 years. For women, the reduced association between dietary vitamin 
B6 and drinking 2-3 cups of coffee per day suggested to be more significant in 
those over 65 years at baseline. This could be due to a more rapid bone loss 
occurred during the first decade after menopause (median age at baseline for 
menopause was 58 years). For men, the protective relationship for vegetable 
and carotenoid intakes was similar between the age groups. Nevertheless, age 




Finally, a multivariable regression model, including all of the 
established risk factors and confounders, namely, age, gender, BMI at baseline, 
education level, smoking status, alcohol drinking status, moderate physical 
activity, use of multivitamin and mineral supplements, menopausal status and 
HRT use (women only), history of self-reported diabetes and stroke, and the 
significant dietary components such as dietary vitamin B6, soy isoflavones, β-
carotene, and the vegetable-fruit-soy pattern, explained 39% of the variance 
for hip fracture risk for the whole cohort (adjusted R square=0.39), 33.8% for 
men (adjusted R square=0.3375) and 43.0% for women (adjusted R 
square=0.4298). The area under the curve (AUC) is 0.81, 0.79 and 0.81 for 
overall, men and women, respectively. This suggests that the above mentioned 
risk factors provided a better predictability for women in hip fractures as 
compared to men in this cohort. Overall, age and gender were the most 
important contributors to explain risk of hip fracture, while the VFS pattern 
and BMI were the two most important modifiable factors. Although this model 
may not account for all risk factors for hip fracture risk, that the inclusion of 
dietary and lifestyle factors yielded reasonable variance and discrimination in 
the risk of hip fracture implies the importance of good nutrition and healthy 
lifestyle factors in fracture prediction in this cohort.  
10-2. Strength and limitation  
 
 The strength of this project is a large number of incident hip fracture 
cases identified from a population-based prospective cohort with a long 
follow-up time. Since all of the exposure variables were obtained prior to the 
occurrence of hip fracture incidence, temporal relationship is achieved and the 




fracture case ascertainment through a comprehensive linkage with the 
nationwide hospital database can be considered complete, because practically 
all hip fracture cases would seek prompt medical attention and be hospitalized 
under the healthcare system in Singapore. Also, migration out of Singapore 
among the participants is negligible and the follow-up of vital statistics is 
virtually complete. Finally, all established and other possible risk factors for 
hip fracture as covariates have been included in the regression-based risk 
models to reduce the likelihood of spurious associations. 
The nutritional exposures of interest, specifically vitamin B, 
carotenoids, coffee, tea, and caffeine and dietary patterns, were collected or 
derived based on the FFQ. However, dietary information was recorded only at 
baseline. Thus, dietary changes during the follow-up were not captured, and 
any subsequent change in diet could lead to non-differential misclassification 
and may potentially underestimate the associations for fracture risk. Such 
misclassification bias is not related to exposure/non-exposure or disease/non-
disease status, because the information of exposures of interest including 
dietary intake information and body weight is collected before the disease is 
developed in a prospective study design, where misclassification of the 
exposure, if exists, would occur similarly in both groups of the non-hip 
fracture cases and hip fracture cases. As a result, smaller differences would be 
found between the non-cases and cases groups and lead to an attenuated 
association towards null. Thus, the association between the dietary risk factors 
or change in body weight and risk of hip fracture would be diluted and 
underestimated. In this cohort, polychotomous exposure variables are used and 




groups, such as the ratio of the risk in the higher quartile compared to the 
lowest quartile, provided that there no other sources of errors, such as 
selection bias (464), which is not a concern in a population-based prospective 
study design. This form of misclassification is different from differential 
misclassification, which can over- or underestimate the true relative risk, due 
to effect of known disease status on classifying the exposure over or under the 
actual value in one group (for example in the case group) than the other 
(control group). Differential misclassification happens more commonly in a 
case-control study design. As body weight and height were self-reported at 
baseline (1993-1998) as well as the follow-up interview (1999-2004), the lack 
of dietary record during the follow-up interview also preclude the ability to 
assess the confounding effect of dietary factors in the association between 
weight change and hip fractures. The last aim of this thesis was conducted in a 
sex and age matched case-control study nested in the cohort by measuring 
serum bone turnover biomarkers using the serum samples collected prior to 
hip fracture occurrence.  Another note is that the sample size for the nested 
case-control study examining BTM and risk of hip fracture is rather small (50 
case-control sets each gender). More data are needed to validate our results 
and further examine the relationship between the dietary components and the 
level of BTM.  
Lastly, hip fracture incidence was the end-point measure of 
osteoporosis in this thesis; hence the lack of measurement of BMD at baseline 
and during the follow-up may confound the relationships for hip fracture risk. 
Nevertheless, causality should be interpreted cautiously from the findings of 




that may not be accounted for. For example, it is difficult to rule out residual 
confounding, as dietary components in the food may be difficult to separate 
from each other. Also, number of falls and frailty are not measured in this 
cohort and both are risk factors for fractures and can be affected by nutrition. 
In addition, several clinical risk factors, such as previous fractures, parental 
fracture in hips, use of glucocorticords, rheumatoid arthritis, secondary 
osteoporosis, and femoral neck BMD are not available in this cohort, thus 
these factors could not be accounted for in the analysis and may confound the 
results.  
10-4. Gender as an effect modifier 
 
The apparent gender discrepancy in fracture risk has been attributed to 
the sex differences in bone geometry, the dominant sex hormones and the 
pattern of sex hormone changes during aging (22, 338). Compared to men, 
women have a lower peak bone mass during adulthood (Figure 10-1), after 
which women undergo a rapid decline of estrogen during menopause that 
leads to accelerated primarily trabecular bone loss, followed by a relatively 
slow phrase of cortical bone loss (338). 
Figure 10-1. Lifetime bone changes for men and women [Figure adapted from 






The latter bone loss during the later part of menopause is generally named as 
age-related bone loss, which is also common in elderly men (338). By contrast, 
elderly men experience a gradual decline of hormones, which includes 
testosterone and estradiol (338). This may explain why bone loss in men is 
more gradual. In addition to the differences in hormonal changes, the position 
and the extent of bone loss are also different between sexes. For instance, the 
loss of trabecular bone in women is primarily a disruption of trabecular 
connectivity, while in men it is generally associated with thinning of the 
trabecular bars (22). However, net bone loss due to aging is greater in women 
than in men. This is not only because bone formation on the outer surface 
(periosteal) of the cortical bone is smaller and bone resorption on the inner 
surface (endosteal) of the cortex is greater in women than in men (Figure 10-2) 
(22), but also women have smaller bone size and lower peak bone mass than 
men. All of these differences contribute to a consequent higher proportion of 
middle-aged and elderly women to have weaker bone strength and higher 
fracture risk as compared to elderly men.  
Figure 10-2. Differences of position and extent of bone loss in men and 






In the Singapore Chinese Health Study cohort, the age-standardized 
rate for incident hip fractures is about twice in women (234 per 100,000 
person-years) as in men (123 per 100,000 person-years), where women 
account for 72.4 % of all hip fracture incidences. Findings from this thesis 
suggest a gender-specific difference in several dietary determinants in relation 
to hip fracture risk. Particularly, high dietary vitamin B6 and moderate intake 
of coffee/caffeine were associated with a lower risk of hip fracture in women 
alone. Consistent with previous findings from the same cohort that an inverse 
relationship was found between dietary intake of soy foods and risk of hip 
fracture in women but not in men (20) and that a high level of serum free 
estradiol was associated with lower hip fractures in postmenopausal women 
(466), the findings from this thesis further support that estrogen deficiency is 
likely a predominant mechanism for postmenopausal bone loss and fractures. 
By contrast, the protective effect of carotenoids on hip fracture risk was 
observed only in men, particularly in lean men with BMI <20kg/m
2
. Thus, we 
speculate that other mechanisms, for example, oxidative stress, may be 
responsible, at least partially, for the development of osteoporotic hip fractures 
in middled-aged and elderly men in this study population.    
The possible mechanisms in the relationships observed only in women 
between dietary soy isoflavones, vitamin B6 or coffee/caffeine and risk of hip 
fracture are hypothesized to be due to the linkage between these dietary factors 
and estrogen and/or estrogen receptors. Estrogen deficiency has been proposed 
as the predominant and prevailing cause for postmenopausal osteoporosis and 
fractures (467). Estrogen has direct effects in the bone cells as well as in the 




receptors, ER-α and ER-β, are also predominantly expressed in the cortical 
and the trabecular bones, respectively (467). Previous reports from the same 
cohort provided significant results of serum free estradiol and ERα-mediated 
estrogenic activity inversely associated with risk of hip fracture on a dose-
dependent manner (All Ps for trend <0.05), where women in the highest 
quintile of free estradiol had a significant 57% lower risk (466). In addition, a 
statistically significant inverse relationship was also found between dietary 
soy food, soy protein and soy isoflavones and incident hip fractures in women 
only but not in men (All Ps for trend < 0.005) (20). The authors concluded that 
soy isoflavones, as a natural selective estrogen receptor modulator, may exert 
estrogenic effects to protect against hip fracture in postmenopausal women 
only when endogenous estrogen level is deficient (20). Following the estrogen 
centric hypothesis, the sex-specific effects of vitamin B6 and moderate intake 
of coffee/caffeine that were only observed in women in this thesis are also 
biologically plausible. B6 may act as a regulator of estrogen through the 
modulation of the transcriptional activation to regulate the physiological 
actions of the estrogen receptors (341, 342). For coffee/caffeine, that a 
moderate daily intake of 2-3 cups of coffee or equivalent to 200-<300 mg 
caffeine was related to a significant 16% risk reduction in hip fracture in 
women but not in men (p for interaction=0.04 and 0.08, respectively) is in 
agreement with a recent animal study, which showed significant favorable 
skeletal changes after feeding a moderate caffeine diet in estrogen deficient 
ovariectomized rats but not in female rats with normal estrogen levels (210). It 




bones may be observed only in a state of estrogen deficiency after menopause 
in women. Further study is needed to elucidate the mechanism. 
Conversely, oxidative stress that triggers bone loss rather than 
hormonal deficiency may, at least in part, be responsible for driving the age-
related bone loss and hip fractures in men. In this thesis, dietary total 
carotenoids and vegetables were found to be significant protective factors 
against hip fracture on a dose-dependent manner in men but not in women 
(both Ps for trend ≤ 0.006). Furthermore, such protective effects were 
profound in thin men with BMI<20kg/m
2
. Thinness was associated with high 
oxidative damage, particularly in men (361). In addition, when both intake 
levels of vegetables and a specific carotenoid, such as β-carotene were entered 
in the same regression model, the association for risk of hip fracture remained 
stronger for β-carotene (p for trend=0.081) than for vegetables (p for 
trend=0.27). This further supported our hypothesis that the protective effect of 
vegetables in hip fractures was likely to be mediated by carotenoids. Hence 
these observations suggest that the antioxidant properties of carotenoids in 
vegetables may counteract oxidative stress related to thinness leading to bone 
deterioration and fractures in men, which is possible through down-regulation 
of RANKL expression which reduces osteoclastogenesis (354). Unlike women 
who have an abrupt and steep decline of estrogen in early post menopause, 
men experience a more gradual sex hormonal decline during aging (468). 
Although some studies suggested that estradiol may play an important role 
than testosterone in bone loss in men (469, 470), other studies proposed that 
estrogen might not be related to bone loss or fractures in elderly men if the 




472). Further, the levels of total estradiol and free estradiol were reported to be 
higher in men than in postmenopausal women aged 70-80 years (338). If that 
is the case in our study population, this could explain why, at least in part, 
oxidative stress rather than hormonal declines was responsible for osteoporotic 
fractures in men. More data is needed to examine the relationship between sex 
hormones, dietary nutrient intakes, serum dietary markers and specific bone 
histological sites (for example, trabecular vs. cortical bone loss) in 
postmenopausal women and elderly men to elucidate clearer understanding of 




Chapter 11 – Conclusions and future directions 
 
In conclusion, findings from this thesis contribute to the current 
literature of risk factors for osteoporotic hip fracture in middle-aged and 
elderly men and women. These data suggest that in both genders, eating a 
plant-based diet comprising vegetables, fruits and soy foods is related to lower 
risk, while weight loss ≥10% is associated with a higher risk of hip fracture.  
Furthermore, gender as an effect modifier in the relations between dietary 
vitamin B6, carotenoids and moderate intake of coffee/caffeine and risk of hip 
fracture extends the current understanding of the pathogenesis of osteoporotic 
fractures in older adults. Moreover, results from the bone turnover biomarker 
study further support the promising applicability of BTMs in fracture 
prediction in older adult men and women. Since these studies were conducted 
in a population-based prospective cohort, a temporal relationship is warranted.  
These findings may have important public health implication in hip 
fracture risk management in Asian populations and beyond. Particularly, as 
diet and body weight are two important factors that can be modified and 
monitored through lifestyle changes, these findings provide empirical 
evidence in strategizing intervention programs for hip fracture and other sites 
of fracture prevention, as they can be safely adopted as regimens to improve 
bone health in daily practice. From a nutritional perspective, it is 
recommended that middle-aged and elderly men and women should consider 
consuming a plant-based diet primarily comprising fruit, vegetables, and soy-
based products. In addition to reducing hip fracture risk, this plant-based diet 




cardiovascular diseases in the Singapore Chinese Health cohort. Hence, a 
plant-based diet comprising primarily fruit, vegetables and soy foods with at 
least 2 servings of fruit and vegetables per day and at least 50 grams of tofu or 
equivalent soy products are recommended to men and women across all age 
groups for healthy aging. The finding on extreme weight loss ≥10% being 
associated with significantly increased risk of hip fracture has important 
clinical implications. Physicians and individuals should pay attention to 
substantial weight loss after midlife, which is an important risk factor, in 
addition to low body mass index, for osteoporotic fractures. Nevertheless, in 
addition to these potential risk factors, living a healthy lifestyle by consuming 
foods that are enriched with vitamin D and calcium, keeping age-appropriate 
outdoor physical activity, drinking moderately and having a tobacco-free 
environment is also essential to bone health. 
In addition, the findings from the gender-specific differences in several 
dietary protectors for risk of hip fracture found in this cohort also provided 
potential public health implications. For women, consuming soy-based 
products, foods that are rich in vitamin B6 such as fish, brown rice, and 
bananas, and moderate intake of coffee may provide additional benefits in 
lowering risk of osteoporosis and fractures. For men, particularly, those who 
are thin with BMI<20kg/m
2
, consuming at least two servings of vegetables per 
day, particularly green and yellow-orange vegetables, may have favorable 
impact in reducing fracture risk. Nevertheless, these recommendations require 
validation by additional data from future studies that examine the relationships 




intervention studies, in order to confirm the health benefits of these nutritional 
factors in men and women.   
Nevertheless, additional studies are required to further examine 
causality, particularly, for the dietary components-hip fracture association that 
are found in this thesis. Firstly, more studies are required to validate the results 
from this thesis. For example, a longitudinal study design with sequential 
dietary information would be ideal to reduce non-differential misclassification 
bias when assessing the diet-disease temporal relationship. Data from 
intervention studies or randomized control trials are also warranted to 
ascertain the causal relationships. Secondly, because our study population has 
relatively low BMI as compared to other ethnic groups, studies involving 
different ethnic groups and meta-analyses may provide more generalizable 
results for the relationship between body weight change and risk of hip 
fracture. Additionally, assessment of body composition with fat and lean mass 
along with other hormones or biomarkers during age-related weight change 
may further elucidate the mechanism of weight change in the explanation of 
osteoporosis and fractures. Thirdly, for bone turnover biomarkers, more 
studies are needed to quantify the sensitivity and specificity of BTMs with and 
without BMD for risk prediction of hip fractures. Additionally, it merits 
further research to evaluate whether a lower cut-off BTM level is required to 
identify fracture risk among individuals with diabetes. Finally, it will be 
valuable to distinguish different lifestyle risk factors and the trajectory of 
hormonal changes in the development of osteoporosis and related fractures in 
early and late menopausal women, who account for double the risk of 






AHEI    alternative healthy eating index 
ALP    alkaline phosphatase 
cAMP     cyclic adenosine monophosphate  
BAP    bone-specific alkaline phosphatase 
BMC     bone mineral content 
BMD     bone mineral density  
BMI    body mass index 
BTM     bone turnover biomarkers  
CAT     catalase  
CI    confidence intervals 
CTx     carboxyterminal cross-linking telopeptide 
DPD     deoxypyridinoline  
(f) DPD/Cr    (free) deoxypyridinoline cross-links/Creatinine 
DXA    Dual-energy X-ray absorptiometry 
EGCG    (-)-epigallocatechin-3-gallate  
FFQ    food frequency questionnaire 
FN     femoral neck  
GPx     glutathione peroxidase  
HCY     homocysteine 
holoTC   holotranscobalamin 
HR    hazard ratio 
HRT     hormone replacement  
IFCC the International Federation of Clinical 




IOF     International Osteoporosis Foundation  
IU    International Unit 
LOD    Limit of detection 
LS     lumbar spine  
MDS    Meat-dim-sum  
MMA    methylmalonic acid 
MMP     matrix metalloproteinase  
MTHFR   methylenetetrahydrofolate reductase 
NEAP     net endogenous acid production  
NTx    N-telopeptide of collagen crosslinks 
OC    osteocalcin 
OPG     osteoprotegerin 
P1NP    procollagen type 1 N propeptide 
fPYD/Cr    (free) pyridinoline cross-links/creatinine 
RANKL  Receptor activator of nuclear factor kappa-B 
ligand 
 
RDA    Recommended Dietary Allowance 
RCT    randomized control trials  
RBC 5-MTHFR  red blood cell 5-methylenetetrahydrofolate 
SI     soy isoflavone 
SOD     superoxide dismutase 
SP    Soy protein 
TRAP    tartrate-resistant acid phosphatase. 
U.S.    United States 
VFS    Vegetable-fruit-soy  
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